Pierroye personal page - To The Moon

Pierroye

Pierroye

No personal profile

163Follow

1Followers

0Topic

0Badge

2021-08-11

Good to know... what do you think..

Sorry, the original content has been removed

2021-07-25

Great to know.like and comment

Will NIO Stock Follow Tesla's Footsteps? What To Consider Between These Two EV Stocks

2021-06-22

Good analysis , like and comment

Sorry, the original content has been removed

2021-06-29

Good.to.read. like and comment please

Sorry, the original content has been removed

2021-06-14

Like and comment please

Toplines Before US Market Open on Monday

2021-08-28

Is it the time? Comment n like pls

Apple Stock: How It Could Be A Great Inflation Play

2021-08-04

What to do?

EV stocks tumbled in morning trading

2021-07-22

What do you think??

Sorry, the original content has been removed

2021-07-20

Pls like and commenr

3 Areas Where Pfizer Is Crushing Moderna

2021-06-28

Wow.one of it really rising .. like and comment.

These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet

2021-08-05

Yay... like and comment what you think..

3 Unstoppable Healthcare Stocks to Buy Now and Hold Forever

2021-06-16

Good to read. Like and comment, please

Sorry, the original content has been removed

2021-06-12

Good

Novavax says COVID-19 vaccine shows immune response against Beta virus variant

2021-07-12

Good to know

Sorry, the original content has been removed

2021-07-06

Great to read..like and comment please

Nio Expected To Gross 5% More EV Deliveries In 2021 Than Previous Forecast, Says CICC

2021-06-28

Great article.

@小虎AV: 【一分鐘帶你看老虎7週年上海場OpenDay】一起來看攝影師都捕捉到了哪些精彩瞬間！還有我們最帥氣/美麗的虎友們~ $老虎證券(TIGR)$

2021-06-22

$BioNTech SE(BNTX)$to the moon !!!

2021-06-18

Great. Like and comment pls

Dosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma

2021-06-17

Impressive.. like and comment

Sorry, the original content has been removed

2021-06-15

Comment please

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3586511265760559","uuid":"3586511265760559","gmtCreate":1623417241124,"gmtModify":1623489474511,"name":"Pierroye","pinyin":"pierroye","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":163,"tweetSize":21,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"60.17%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":813130544,"gmtCreate":1630145846188,"gmtModify":1676530234712,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Is it the time? Comment n like pls","listText":"Is it the time? Comment n like pls","text":"Is it the time? Comment n like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/813130544","repostId":"1162964424","repostType":4,"repost":{"id":"1162964424","kind":"news","pubTimestamp":1630111098,"share":"https://ttm.financial/m/news/1162964424?lang=&edition=fundamental","pubTime":"2021-08-28 08:38","market":"us","language":"en","title":"Apple Stock: How It Could Be A Great Inflation Play","url":"https://stock-news.laohu8.com/highlight/detail?id=1162964424","media":"TheStreet","summary":"Apple’s iPhone 13 could cost consumers more due to an increase in the price of certain components. This is bad news for users, but probably good news for Apple stock investors.IPhone users thinking of upgrading their devices this year  should expect to reach deeper into their pockets. DigiTimes has reported that Apple’s iPhone 13 could be launched next month at a higher price due to parts inflation.Bad news for consumers could be great news for Apple stock investors. If the price increase is con","content":"<p>Apple’s iPhone 13 could cost consumers more due to an increase in the price of certain components. This is bad news for users, but probably good news for Apple stock investors.</p>\n<p>IPhone users thinking of upgrading their devices this year (or those looking to switch to the iOS-based product) should expect to reach deeper into their pockets. DigiTimes has&nbsp;reported&nbsp;that Apple’s iPhone 13 could be launched next month at a higher price due to parts inflation.</p>\n<p>Bad news for consumers could be great news for Apple stock&nbsp;investors. If the price increase is confirmed, it provides evidence that AAPL might be a great inflation play during these times of worry over rising producer and consumer prices.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d6f4ac9ebc1b90072340731dc5c1e613\" tg-width=\"1240\" tg-height=\"698\" referrerpolicy=\"no-referrer\"><span>Figure 1: Apple's iPhone 12 Pro.</span></p>\n<p><b>What happened?</b></p>\n<p>The iPhone is already considered a pricey tech gadget that can cost as much as $1,400 for the fully loaded, higher-end 12 Pro Max model in the US (see figure below). Due to this year’s components shortage, chip maker TSMC may raise its part prices to Apple by 3% to 5%, which could lead to a similar increase in the price of the yet-to-be-announced iPhone 13.</p>\n<p>It is unlikely that one of the largest and most successful consumer product companies in the world would try to raise prices without confidence that doing so does not impact demand for the new iPhone substantially. Apple can probably afford to hike prices because the company understands the value and the appeal of its luxury brand.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0140b9b68bb9eb5dd7e88aaff384785d\" tg-width=\"707\" tg-height=\"370\" referrerpolicy=\"no-referrer\"><span>Figure 2: iPhone 12 Pro on Apple's store.</span></p>\n<p><b>A quote from Jim Cramer</b></p>\n<p>One of the most concerning headwinds to stocks in the foreseeable future is the possibility of inflation eroding corporate margins and leading to higher interest rates in 2021-2022. But should producer and consumer prices spike, not all stocks will be impacted equally.</p>\n<p>Generally speaking, companies with strong pricing power that are able to pass on the higher production costs to consumers will likely outperform. This is a point that&nbsp;Mad Money’s Jim Cramer has made recently. Here is his quote:</p>\n<blockquote>\n “When you try to think of what’s working in this market... I want you to ask yourself, would you be insensitive to a price increase if the company put one through? [What are] the companies that can raise prices without infuriating you? Go buy their stocks.”\n</blockquote>\n<p><b>The impact to the P&amp;L</b></p>\n<p>Are higher prices a good or a bad thing for a company’s financial performance? The answer is nuanced and depends on a few factors.</p>\n<p>Holding all else constant, higher prices also mean higher revenues (think of the formula for sales: price times quantity). If the increase in price is decoupled from an increase in product or operating costs, then the hike also helps to boost margins – thus profits as well.</p>\n<p>However, “holding all else constant” is not how the world really works. A change in price tends to have an impact on a few key variables, most important of which is demand. If higher prices do not impact units sold by much or at all, this is great news for revenues and, most likely, earnings.</p>\n<p>The other piece to consider is whether the price hike fully or only partially offsets higher costs. Assuming the latter, revenues can still benefit without a corresponding positive effect on margins and profits. The complexity presented by the many moving parts makes it hard to determine with certainty how a more expensive iPhone may impact Apple’s financial statements in the future.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: How It Could Be A Great Inflation Play</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: How It Could Be A Great Inflation Play\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-28 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/iphone/apple-stock-how-it-could-be-a-great-inflation-play><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple’s iPhone 13 could cost consumers more due to an increase in the price of certain components. This is bad news for users, but probably good news for Apple stock investors.\nIPhone users thinking ...</p>\n\n<a href=\"https://www.thestreet.com/apple/iphone/apple-stock-how-it-could-be-a-great-inflation-play\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/iphone/apple-stock-how-it-could-be-a-great-inflation-play","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162964424","content_text":"Apple’s iPhone 13 could cost consumers more due to an increase in the price of certain components. This is bad news for users, but probably good news for Apple stock investors.\nIPhone users thinking of upgrading their devices this year (or those looking to switch to the iOS-based product) should expect to reach deeper into their pockets. DigiTimes has reported that Apple’s iPhone 13 could be launched next month at a higher price due to parts inflation.\nBad news for consumers could be great news for Apple stock investors. If the price increase is confirmed, it provides evidence that AAPL might be a great inflation play during these times of worry over rising producer and consumer prices.\nFigure 1: Apple's iPhone 12 Pro.\nWhat happened?\nThe iPhone is already considered a pricey tech gadget that can cost as much as $1,400 for the fully loaded, higher-end 12 Pro Max model in the US (see figure below). Due to this year’s components shortage, chip maker TSMC may raise its part prices to Apple by 3% to 5%, which could lead to a similar increase in the price of the yet-to-be-announced iPhone 13.\nIt is unlikely that one of the largest and most successful consumer product companies in the world would try to raise prices without confidence that doing so does not impact demand for the new iPhone substantially. Apple can probably afford to hike prices because the company understands the value and the appeal of its luxury brand.\nFigure 2: iPhone 12 Pro on Apple's store.\nA quote from Jim Cramer\nOne of the most concerning headwinds to stocks in the foreseeable future is the possibility of inflation eroding corporate margins and leading to higher interest rates in 2021-2022. But should producer and consumer prices spike, not all stocks will be impacted equally.\nGenerally speaking, companies with strong pricing power that are able to pass on the higher production costs to consumers will likely outperform. This is a point that Mad Money’s Jim Cramer has made recently. Here is his quote:\n\n “When you try to think of what’s working in this market... I want you to ask yourself, would you be insensitive to a price increase if the company put one through? [What are] the companies that can raise prices without infuriating you? Go buy their stocks.”\n\nThe impact to the P&L\nAre higher prices a good or a bad thing for a company’s financial performance? The answer is nuanced and depends on a few factors.\nHolding all else constant, higher prices also mean higher revenues (think of the formula for sales: price times quantity). If the increase in price is decoupled from an increase in product or operating costs, then the hike also helps to boost margins – thus profits as well.\nHowever, “holding all else constant” is not how the world really works. A change in price tends to have an impact on a few key variables, most important of which is demand. If higher prices do not impact units sold by much or at all, this is great news for revenues and, most likely, earnings.\nThe other piece to consider is whether the price hike fully or only partially offsets higher costs. Assuming the latter, revenues can still benefit without a corresponding positive effect on margins and profits. The complexity presented by the many moving parts makes it hard to determine with certainty how a more expensive iPhone may impact Apple’s financial statements in the future.","news_type":1},"isVote":1,"tweetType":1,"viewCount":487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":895097468,"gmtCreate":1628693043254,"gmtModify":1676529824211,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Good to know... what do you think..","listText":"Good to know... what do you think..","text":"Good to know... what do you think..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/895097468","repostId":"2158808282","repostType":4,"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573260715066065","authorId":"3573260715066065","name":"LewisLewis","avatar":"https://static.tigerbbs.com/61c148b5b38fd33489bc18824afe097c","crmLevel":8,"crmLevelSwitch":0,"idStr":"3573260715066065","authorIdStr":"3573260715066065"},"content":"Like back thanks","text":"Like back thanks","html":"Like back thanks"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899143480,"gmtCreate":1628171077640,"gmtModify":1703502504850,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Yay... like and comment what you think..","listText":"Yay... like and comment what you think..","text":"Yay... like and comment what you think..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/899143480","repostId":"2157439561","repostType":4,"isVote":1,"tweetType":1,"viewCount":453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807124203,"gmtCreate":1628008949802,"gmtModify":1703499622222,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"What to do?&nbsp;","listText":"What to do?&nbsp;","text":"What to do?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/807124203","repostId":"1181392592","repostType":4,"repost":{"id":"1181392592","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627999893,"share":"https://ttm.financial/m/news/1181392592?lang=&edition=fundamental","pubTime":"2021-08-03 22:11","market":"us","language":"en","title":"EV stocks tumbled in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1181392592","media":"Tiger Newspress","summary":"(Aug 3) Tesla fell 0.22%, NIO was down 3.45%, Li slid nearly 5%, Xpeng fell 2.67%.","content":"<p>(Aug&nbsp;3)&nbsp;Tesla fell 0.22%, NIO was down 3.45%, Li slid nearly 5%, Xpeng fell 2.67%.</p>\n<p><img src=\"https://static.tigerbbs.com/00cbe46f4bdb1df7e952efb0bc171a96\" tg-width=\"375\" tg-height=\"208\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks tumbled in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks tumbled in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-03 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;3)&nbsp;Tesla fell 0.22%, NIO was down 3.45%, Li slid nearly 5%, Xpeng fell 2.67%.</p>\n<p><img src=\"https://static.tigerbbs.com/00cbe46f4bdb1df7e952efb0bc171a96\" tg-width=\"375\" tg-height=\"208\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181392592","content_text":"(Aug 3) Tesla fell 0.22%, NIO was down 3.45%, Li slid nearly 5%, Xpeng fell 2.67%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":766,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":177126889,"gmtCreate":1627188416941,"gmtModify":1703485328012,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Great to know.like and comment","listText":"Great to know.like and comment","text":"Great to know.like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/177126889","repostId":"1112927800","repostType":4,"repost":{"id":"1112927800","kind":"news","pubTimestamp":1627089375,"share":"https://ttm.financial/m/news/1112927800?lang=&edition=fundamental","pubTime":"2021-07-24 09:16","market":"us","language":"en","title":"Will NIO Stock Follow Tesla's Footsteps? What To Consider Between These Two EV Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1112927800","media":"seekingalpha","summary":"Let's take a look at how NIO compares to Tesla today, NIO's unique selling points, and the similarities between the two companies.NIO is a high-growth choice that does not seem overly expensive relative to how Tesla is valued.NIO is not a low-risk stock, however, and it may not be a good choice for everyone. Investors should also consider NIO's valuation versus legacy car companies.Both companies have benefitted from growing interest in EVs during 2020, a trend that saw share prices of most EV p","content":"<p><b>Summary</b></p>\n<ul>\n <li>Let's take a look at how NIO compares to Tesla today, NIO's unique selling points, and the similarities between the two companies.</li>\n <li>NIO is a high-growth choice that does not seem overly expensive relative to how Tesla is valued.</li>\n <li>NIO is not a low-risk stock, however, and it may not be a good choice for everyone. Investors should also consider NIO's valuation versus legacy car companies.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2f749c70c8a2af3e18d5f6cecc72bfbb\" tg-width=\"1536\" tg-height=\"704\" referrerpolicy=\"no-referrer\"><span>ipopba/iStock via Getty Images</span></p>\n<p><b>Article Thesis</b></p>\n<p>NIO, Inc. (NIO) is one of China's leading EV players, and has, through an attractive brand and its unique BaaS offering, attracted a lot of interest from consumers and investors. Today, however, the company is still way smaller than Tesla (TSLA), which is currently leading the global EV market. NIO is focused on its home market right now, which was true when Tesla was a smaller company as well, but NIO will try to grab market share in overseas markets as well. Shares are pricing in a lot of growth already, but if NIO can replicate Tesla's success, that could be more than justified.</p>\n<p><b>NIO And TSLA Stock Prices</b></p>\n<p>Both companies have benefitted from growing interest in EVs during 2020, a trend that saw share prices of most EV pureplays rise rapidly. The combination of growing market share for EVs, accommodating policies such as subsidies for EV purchases, and massive monetary stimulus let shares of NIO and TSLA rise rapidly. NIO is up 245% over the last year, while TSLA is up 101% over the same time. Both companies are currently trading below their all-time highs, however, which were hit in early 2021 before market sentiment for EV pureplays cooled to some degree.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5ff5ce865807df85283775d2293b41af\" tg-width=\"635\" tg-height=\"481\" referrerpolicy=\"no-referrer\"><span>Data by YCharts</span></p>\n<p>Taking a quick look at analyst price targets, we see that Tesla is trading almost perfectly in line with the consensus, whereas NIO trades about 30% below the analyst target. If the analyst community is right, then NIO is a substantially better investment right here, as Tesla is not expected to see its shares rise meaningfully over the next year, whereas NIO has significant upside to the analyst price target.</p>\n<p><b>Is NIO Similar To Tesla?</b></p>\n<p>The answer to that question depends on what you focus on. There are similarities between the two companies, but there are also differences. One could thus say that, in some ways, the two are similar, but in others, they are not. Let's look at a couple of things:</p>\n<p><b>Business Model</b></p>\n<p>Both companies are focused on the EV space, although Tesla has, over the years, been building out a couple of other businesses as well, such as energy storage. Most of Tesla's revenues are generated through selling electric vehicles, which is also how NIO operates. Both companies are focused on the premium segment of EVs, selling higher-priced vehicles that compete with brands such as BMW, Mercedes, and Lexus. Both companies offer a small range of different vehicles, in Tesla's case those are the well-known S, X, 3, and Y, whereas NIO offers a sedan (ET7), and three SUVs (EC6, ES6, ES8). Despite the fact that NIO is a way smaller company today, the model lineups of the two companies do thus not differ too much.</p>\n<p>Both companies offer some type of charging infrastructure to their customers, in Tesla's case, that's the Supercharger network, where Tesla owners can charge their cars with up to 250kW, depending on what version of Supercharger is installed. NIO is following a different approach, offering a battery-as-a-service solution to its customers. NIO owners can get their battery switched out to a fully-charged battery at NIO's stations, a process that takes a couple of minutes and is thus significantly quicker compared to the regular EV charging offered by Tesla and other EV players. BaaS thus has advantages when it comes to the time it takes for a charge/swap, but it should be noted that Tesla's Superchargers are way more common around the world compared to NIO's battery-swapping stations. Rolling out that feature in additional markets will require large capital expenditures, but NIO's offering is a unique selling point compared to what all other EV players, including Tesla, are offering. It remains to be seen whether that will ultimately pay off, but this could become a major advantage for NIO as competition in the EV space is heating up.</p>\n<p><b>Size, growth, and valuation</b></p>\n<p>The two companies differ significantly in size, both when it comes to revenues and vehicle sales, as well as when it comes to the market value of the two companies. NIO has delivered22,000 vehicles in Q2, up 112% year over year, for an annual pace of around 90,000 vehicles. Tesla, meanwhile, has delivered 201,000 vehicles during Q2, up from 103,000 vehicles delivered during Q2 2020. This is strong growth on a year-over-year basis, although slightly below 100%, and thus below the growth rate that NIO is generating for now.</p>\n<p>Tesla delivers around 9x as many vehicles compared to NIO per quarter, when we look at the market capitalizations of the two companies, we see that the ratio is almost exactly the same, as Tesla's market cap of $640 billion is ~9x as high as that of NIO, at $72 billion. At similar growth rates, that would make perfect sense, but it looks like NIO might be the better deal for now, as it trades at a comparable valuation while generating better growth. This will be especially true in the coming quarters, where Tesla's growth is expected to slow down:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a986ea65130206f99961a46ce6cfed55\" tg-width=\"635\" tg-height=\"515\" referrerpolicy=\"no-referrer\"><span>Data by YCharts</span></p>\n<p>Tesla is forecasted to grow its revenue from $49 billion in 2021 to $83 billion in 2023, for an annual growth rate of 30%. NIO, meanwhile, is expected to see its revenue explode upwards from $5.4 billion to $12.8 billion between 2021 and 2023, for an annual growth rate of 54%. NIO is thus expected to grow way faster than Tesla over the next two years, on a relative basis. This shouldn't be a surprise, to be honest, as the law of large numbers dictates that maintaining massive growth rates becomes increasingly hard for a company the bigger it gets, and Tesla seems to have hit that point by now -- adding 50%+ a year to its top line will not be possible forever. This isn't even necessarily Tesla's fault, in fact, many high-quality growth companies have experienced the same. But investors should still consider this important fact -- Tesla's growth in coming years will be less exciting compared to what we have seen in the past, and peers, such as NIO, are growing faster.</p>\n<p>The same holds true when we take a longer-term view. Revenue estimates for 2025 rest at$22.6 billionfor NIO, up another 80% from the 2023 estimate, and up 320% from what analysts are forecasting for 2021. Tesla, meanwhile, is forecasted to generate revenues of $122.5 billion in 2025 -- a large number, but up by a comparatively weak 48% from 2023, and up by a total of 150% versus 2021. Between 2021 and 2025, NIO will thus 4x its revenue, while Tesla will 2.5x its revenue in the same time span -- a meaningful difference that should, all else equal, allow for a premium valuation for NIO, in the same way Tesla deserves a premium valuation versus legacy players such as Volkswagen (OTCPK:VWAGY).</p>\n<p>Looking at revenue estimates for 2025 relative to how the two companies are valued today, we see that NIO trades at 3.2x 2025 sales, while the 2025 sales multiple for Tesla is 5.2. For a long-term oriented investor, NIO thus seems like the better value today, thanks to the fact that it is trading at a significantly lower sales multiple when we take a look into the future. This does not necessarily mean that NIO is cheap, however, as even a 3.2x 2025 sales multiple is relatively high compared to how legacy auto companies are valued. NIO is looking less expensive than Tesla, however, even if its shares are not cheap on an absolute basis.</p>\n<p><b>Can NIO Be Worth As Much As Tesla?</b></p>\n<p>The answer to that depends on what time frame you are looking at. Today, NIO is significantly smaller than Tesla and thus rightfully trades at a way smaller market cap. It should also be noted that there is no guarantee that Tesla's shares are a great example of how an EV company should be valued -- it is, at least, possible that its shares are significantly&nbsp;overpriced&nbsp;today, I personally believe that as well (Note that some will argue that shares are&nbsp;underpriced, which is also among the possibilities, although I do not hold that belief personally).</p>\n<p>When we do, for a moment, assume that Tesla is correctly valued today and that EV companies do deserve a market cap in the $600 billion range when they sell about 800,000 vehicles a year, then NIO could eventually hit that as well, although not in the near term. NIO will sell about 90,000 vehicles this year, and that amount should grow to about 400,000 in 2025. If NIO were to grow its sales by 15% a year beyond that point, it could sell around 800,000 cars in 2030, or 9 years from now. If one wants to assume faster growth, the 800,000 vehicles a year line could also be crossed before 2030, e.g. in 2028 or 2029. If we do go with 2030 for now, then NIO could, at a similar deliveries-to-market capitalization ratio to Tesla, be valued at $600+ billion in 2030. In other words, NIO could be worth as much as Tesla (today) in nine years, when we assume that current growth projections are realistic and that a Tesla-like valuation is appropriate. Those are two major ifs, of course, and especially the second point is far from certain, I believe. I personally would not be too surprised to see Tesla's valuation compress, and thus NIO could trade well below the $600 billion market cap level in 2030, even if it continues to grow meaningfully. It is also possible that NIO's growth disappoints and that current projections are too bullish, although I think that NIO is well-positioned for growth thanks to its unique BaaS model and its strong brand that is especially well-recognized in its home market.</p>\n<p>It should also be noted that Tesla's market cap in 2030 could be very different from $600 billion, thus even in case NIO hits that level, it is not at all guaranteed that the two companies will have a similar market cap. Tesla might be valued at a way higher valuation by then, e.g. if the ARK model is right (something I personally think is unlikely). To answer the above question, one could thus say that NIO might be worth hundreds of billions of dollars, like Tesla, in 8-10 years, but that is not at all guaranteed. And even if that were to happen, Tesla might be worth significantly more by then.</p>\n<p><b>Is NIO A Good Stock To Buy Or Sell Now?</b></p>\n<p>When considering NIO as an investment, it doesn't really matter all that much whether it will become as large or highly valued as Tesla eventually. Instead, investors should ask themselves what total returns they can expect over the next couple of years, and whether those expected returns are high enough relative to the risks in NIO's business model. Regarding those risks, one should mention the fact that the company isn't profitable yet, which means that NIO is dependent on cash on its balance sheet for growth investments. On top of that, competition in the EV space is growing, and market share battles could pressure margins in coming years, although NIO seems relatively well-positioned thanks to its battery-swapping, which is, I believe, a strong USP. Last but not least, the company's dependence on its home market China is a potential risk that should be kept in mind, although it should also be noted that, for now, it seems like the Chinese government is very accommodating to Chinese EV companies.</p>\n<p>One could argue that valuations across the whole EV industry are too high, relative to how legacy auto companies are valued. Even those legacy players with attractive EV offerings such as Volkswagen or Ford trade at huge discounts compared to EV pureplays. But if one wants to invest in an EV pureplay, NIO doesn't seem like a bad choice. The company combines a strong brand, a unique BaaS offering, high growth rates, and shares trade at a discount compared to how the EV king Tesla is valued. At a little above 3x 2025 revenue, NIO does not seem overly expensive relative to other EV pureplays, although this still represents a premium versus legacy players, of course. If NIO manages to execute well and continues to roll out new models that are well-received by consumers, its shares could have significant upside potential in the long run. If EV stocks ever become an out-of-favor investment, NIO stock also could have considerable downside, however, this thus is not a low-risk pick. Depending on your risk tolerance, NIO could still be of value if you want a high-growth EV pureplay.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will NIO Stock Follow Tesla's Footsteps? What To Consider Between These Two EV Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill NIO Stock Follow Tesla's Footsteps? What To Consider Between These Two EV Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-24 09:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4440950-will-nio-stock-follow-tesla-what-to-consider-ev-stocks><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nLet's take a look at how NIO compares to Tesla today, NIO's unique selling points, and the similarities between the two companies.\nNIO is a high-growth choice that does not seem overly ...</p>\n\n<a href=\"https://seekingalpha.com/article/4440950-will-nio-stock-follow-tesla-what-to-consider-ev-stocks\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4440950-will-nio-stock-follow-tesla-what-to-consider-ev-stocks","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112927800","content_text":"Summary\n\nLet's take a look at how NIO compares to Tesla today, NIO's unique selling points, and the similarities between the two companies.\nNIO is a high-growth choice that does not seem overly expensive relative to how Tesla is valued.\nNIO is not a low-risk stock, however, and it may not be a good choice for everyone. Investors should also consider NIO's valuation versus legacy car companies.\n\nipopba/iStock via Getty Images\nArticle Thesis\nNIO, Inc. (NIO) is one of China's leading EV players, and has, through an attractive brand and its unique BaaS offering, attracted a lot of interest from consumers and investors. Today, however, the company is still way smaller than Tesla (TSLA), which is currently leading the global EV market. NIO is focused on its home market right now, which was true when Tesla was a smaller company as well, but NIO will try to grab market share in overseas markets as well. Shares are pricing in a lot of growth already, but if NIO can replicate Tesla's success, that could be more than justified.\nNIO And TSLA Stock Prices\nBoth companies have benefitted from growing interest in EVs during 2020, a trend that saw share prices of most EV pureplays rise rapidly. The combination of growing market share for EVs, accommodating policies such as subsidies for EV purchases, and massive monetary stimulus let shares of NIO and TSLA rise rapidly. NIO is up 245% over the last year, while TSLA is up 101% over the same time. Both companies are currently trading below their all-time highs, however, which were hit in early 2021 before market sentiment for EV pureplays cooled to some degree.\nData by YCharts\nTaking a quick look at analyst price targets, we see that Tesla is trading almost perfectly in line with the consensus, whereas NIO trades about 30% below the analyst target. If the analyst community is right, then NIO is a substantially better investment right here, as Tesla is not expected to see its shares rise meaningfully over the next year, whereas NIO has significant upside to the analyst price target.\nIs NIO Similar To Tesla?\nThe answer to that question depends on what you focus on. There are similarities between the two companies, but there are also differences. One could thus say that, in some ways, the two are similar, but in others, they are not. Let's look at a couple of things:\nBusiness Model\nBoth companies are focused on the EV space, although Tesla has, over the years, been building out a couple of other businesses as well, such as energy storage. Most of Tesla's revenues are generated through selling electric vehicles, which is also how NIO operates. Both companies are focused on the premium segment of EVs, selling higher-priced vehicles that compete with brands such as BMW, Mercedes, and Lexus. Both companies offer a small range of different vehicles, in Tesla's case those are the well-known S, X, 3, and Y, whereas NIO offers a sedan (ET7), and three SUVs (EC6, ES6, ES8). Despite the fact that NIO is a way smaller company today, the model lineups of the two companies do thus not differ too much.\nBoth companies offer some type of charging infrastructure to their customers, in Tesla's case, that's the Supercharger network, where Tesla owners can charge their cars with up to 250kW, depending on what version of Supercharger is installed. NIO is following a different approach, offering a battery-as-a-service solution to its customers. NIO owners can get their battery switched out to a fully-charged battery at NIO's stations, a process that takes a couple of minutes and is thus significantly quicker compared to the regular EV charging offered by Tesla and other EV players. BaaS thus has advantages when it comes to the time it takes for a charge/swap, but it should be noted that Tesla's Superchargers are way more common around the world compared to NIO's battery-swapping stations. Rolling out that feature in additional markets will require large capital expenditures, but NIO's offering is a unique selling point compared to what all other EV players, including Tesla, are offering. It remains to be seen whether that will ultimately pay off, but this could become a major advantage for NIO as competition in the EV space is heating up.\nSize, growth, and valuation\nThe two companies differ significantly in size, both when it comes to revenues and vehicle sales, as well as when it comes to the market value of the two companies. NIO has delivered22,000 vehicles in Q2, up 112% year over year, for an annual pace of around 90,000 vehicles. Tesla, meanwhile, has delivered 201,000 vehicles during Q2, up from 103,000 vehicles delivered during Q2 2020. This is strong growth on a year-over-year basis, although slightly below 100%, and thus below the growth rate that NIO is generating for now.\nTesla delivers around 9x as many vehicles compared to NIO per quarter, when we look at the market capitalizations of the two companies, we see that the ratio is almost exactly the same, as Tesla's market cap of $640 billion is ~9x as high as that of NIO, at $72 billion. At similar growth rates, that would make perfect sense, but it looks like NIO might be the better deal for now, as it trades at a comparable valuation while generating better growth. This will be especially true in the coming quarters, where Tesla's growth is expected to slow down:\nData by YCharts\nTesla is forecasted to grow its revenue from $49 billion in 2021 to $83 billion in 2023, for an annual growth rate of 30%. NIO, meanwhile, is expected to see its revenue explode upwards from $5.4 billion to $12.8 billion between 2021 and 2023, for an annual growth rate of 54%. NIO is thus expected to grow way faster than Tesla over the next two years, on a relative basis. This shouldn't be a surprise, to be honest, as the law of large numbers dictates that maintaining massive growth rates becomes increasingly hard for a company the bigger it gets, and Tesla seems to have hit that point by now -- adding 50%+ a year to its top line will not be possible forever. This isn't even necessarily Tesla's fault, in fact, many high-quality growth companies have experienced the same. But investors should still consider this important fact -- Tesla's growth in coming years will be less exciting compared to what we have seen in the past, and peers, such as NIO, are growing faster.\nThe same holds true when we take a longer-term view. Revenue estimates for 2025 rest at$22.6 billionfor NIO, up another 80% from the 2023 estimate, and up 320% from what analysts are forecasting for 2021. Tesla, meanwhile, is forecasted to generate revenues of $122.5 billion in 2025 -- a large number, but up by a comparatively weak 48% from 2023, and up by a total of 150% versus 2021. Between 2021 and 2025, NIO will thus 4x its revenue, while Tesla will 2.5x its revenue in the same time span -- a meaningful difference that should, all else equal, allow for a premium valuation for NIO, in the same way Tesla deserves a premium valuation versus legacy players such as Volkswagen (OTCPK:VWAGY).\nLooking at revenue estimates for 2025 relative to how the two companies are valued today, we see that NIO trades at 3.2x 2025 sales, while the 2025 sales multiple for Tesla is 5.2. For a long-term oriented investor, NIO thus seems like the better value today, thanks to the fact that it is trading at a significantly lower sales multiple when we take a look into the future. This does not necessarily mean that NIO is cheap, however, as even a 3.2x 2025 sales multiple is relatively high compared to how legacy auto companies are valued. NIO is looking less expensive than Tesla, however, even if its shares are not cheap on an absolute basis.\nCan NIO Be Worth As Much As Tesla?\nThe answer to that depends on what time frame you are looking at. Today, NIO is significantly smaller than Tesla and thus rightfully trades at a way smaller market cap. It should also be noted that there is no guarantee that Tesla's shares are a great example of how an EV company should be valued -- it is, at least, possible that its shares are significantly overpriced today, I personally believe that as well (Note that some will argue that shares are underpriced, which is also among the possibilities, although I do not hold that belief personally).\nWhen we do, for a moment, assume that Tesla is correctly valued today and that EV companies do deserve a market cap in the $600 billion range when they sell about 800,000 vehicles a year, then NIO could eventually hit that as well, although not in the near term. NIO will sell about 90,000 vehicles this year, and that amount should grow to about 400,000 in 2025. If NIO were to grow its sales by 15% a year beyond that point, it could sell around 800,000 cars in 2030, or 9 years from now. If one wants to assume faster growth, the 800,000 vehicles a year line could also be crossed before 2030, e.g. in 2028 or 2029. If we do go with 2030 for now, then NIO could, at a similar deliveries-to-market capitalization ratio to Tesla, be valued at $600+ billion in 2030. In other words, NIO could be worth as much as Tesla (today) in nine years, when we assume that current growth projections are realistic and that a Tesla-like valuation is appropriate. Those are two major ifs, of course, and especially the second point is far from certain, I believe. I personally would not be too surprised to see Tesla's valuation compress, and thus NIO could trade well below the $600 billion market cap level in 2030, even if it continues to grow meaningfully. It is also possible that NIO's growth disappoints and that current projections are too bullish, although I think that NIO is well-positioned for growth thanks to its unique BaaS model and its strong brand that is especially well-recognized in its home market.\nIt should also be noted that Tesla's market cap in 2030 could be very different from $600 billion, thus even in case NIO hits that level, it is not at all guaranteed that the two companies will have a similar market cap. Tesla might be valued at a way higher valuation by then, e.g. if the ARK model is right (something I personally think is unlikely). To answer the above question, one could thus say that NIO might be worth hundreds of billions of dollars, like Tesla, in 8-10 years, but that is not at all guaranteed. And even if that were to happen, Tesla might be worth significantly more by then.\nIs NIO A Good Stock To Buy Or Sell Now?\nWhen considering NIO as an investment, it doesn't really matter all that much whether it will become as large or highly valued as Tesla eventually. Instead, investors should ask themselves what total returns they can expect over the next couple of years, and whether those expected returns are high enough relative to the risks in NIO's business model. Regarding those risks, one should mention the fact that the company isn't profitable yet, which means that NIO is dependent on cash on its balance sheet for growth investments. On top of that, competition in the EV space is growing, and market share battles could pressure margins in coming years, although NIO seems relatively well-positioned thanks to its battery-swapping, which is, I believe, a strong USP. Last but not least, the company's dependence on its home market China is a potential risk that should be kept in mind, although it should also be noted that, for now, it seems like the Chinese government is very accommodating to Chinese EV companies.\nOne could argue that valuations across the whole EV industry are too high, relative to how legacy auto companies are valued. Even those legacy players with attractive EV offerings such as Volkswagen or Ford trade at huge discounts compared to EV pureplays. But if one wants to invest in an EV pureplay, NIO doesn't seem like a bad choice. The company combines a strong brand, a unique BaaS offering, high growth rates, and shares trade at a discount compared to how the EV king Tesla is valued. At a little above 3x 2025 revenue, NIO does not seem overly expensive relative to other EV pureplays, although this still represents a premium versus legacy players, of course. If NIO manages to execute well and continues to roll out new models that are well-received by consumers, its shares could have significant upside potential in the long run. If EV stocks ever become an out-of-favor investment, NIO stock also could have considerable downside, however, this thus is not a low-risk pick. Depending on your risk tolerance, NIO could still be of value if you want a high-growth EV pureplay.","news_type":1},"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172245960,"gmtCreate":1626964028450,"gmtModify":1703481531477,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"What do you think??","listText":"What do you think??","text":"What do you think??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/172245960","repostId":"2153678131","repostType":4,"repost":{"id":"2153678131","kind":"highlight","pubTimestamp":1626959640,"share":"https://ttm.financial/m/news/2153678131?lang=&edition=fundamental","pubTime":"2021-07-22 21:14","market":"us","language":"en","title":"7 Stocks to Buy Hand Over Fist if the Stock Market Crashes","url":"https://stock-news.laohu8.com/highlight/detail?id=2153678131","media":"Motley Fool","summary":"Big market declines are the perfect opportunity for long-term investors to put their capital to work.","content":"<p>It's a subject that investors often don't like to talk about, but stock market crashes and corrections are a common and inevitable part of the investing cycle. On Monday, the benchmark <b>S&amp;P 500</b> suffered its worst single-session decline in months, raising speculation, once again, that a correction or crash may be around the corner.</p>\n<p>If we turn to history as a guide, a double-digit percentage decline is likely long overdue. For instance, in each of the previous four instances where the S&amp;P 500's Shiller price-to-earnings (P/E) ratio surpassed 30, the index subsequently declined by at least 20%. The S&amp;P 500's Shiller P/E ratio topped 38 last week -- it's highest reading in almost two decades.</p>\n<p>History has also been pretty clear that rebounds from a bear market bottom are never this smooth. In each of the previous eight bear markets prior to the coronavirus crash, there were either <a href=\"https://laohu8.com/S/AONE.U\">one</a> or two double-digit percentage pullbacks within three years of reaching the bottom.</p>\n<p><img src=\"https://static.tigerbbs.com/5a80ad7e631487aa88f5e208e4ab4fb9\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<p>But there's good news, too: Crashes beget opportunity for long-term investors. If this latest bout of volatility leads to a long overdue crash or correction, consider buying the following seven winning stocks hand over fist.</p>\n<h3>CrowdStrike Holdings</h3>\n<p>You know what doesn't change one iota when the market crashes? The demand for cybersecurity solutions. That's why any discount you can get on cybersecurity stock <b>CrowdStrike Holdings</b> (NASDAQ:CRWD) should be considered a blessing.</p>\n<p>CrowdStrike's cloud-native Falcon platform is its superstar. It oversees approximately 6 trillion events weekly and uses artificial intelligence to become more efficient at identifying and responding to threats over time. Because Falcon was built in the cloud, it's usually nimbler than on-premises security solutions, and more cost-effective, as well.</p>\n<p>CrowdStrike's operating results clearly show that its customers love the product. It's retaining 98% of its clients, and 64% of its customers purchased four or more cloud-module subscriptions in the most recent quarter. For some context, four years ago, only 9% of its clients had four or more cloud-module subscriptions. CrowdStrike is a no-brainer buy on weakness.</p>\n<p><img src=\"https://static.tigerbbs.com/18e95ac40519653b9c28e665ae1a6df7\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Home Depot.</p>\n<h3>Home Depot</h3>\n<p>If brand-name stocks are more your thing, a stock market crash or steep correction has historically always been a smart time to load up your cart with shares of do-it-yourself home-improvement chain <b>Home Depot</b> (NYSE:HD).</p>\n<p>The great thing about Home Depot is that it can play both sides of the fence. If the U.S economy is firing on all cylinders, there's a good chance sales to commercial clients and contractors will be strong.</p>\n<p>Comparatively, when economic uncertainty becomes an issue, we've often witnessed homeowners become Home Depot's driving force via remodels and projects. The company is surprisingly well-hedged for virtually all economic scenarios.</p>\n<p>Investors should also note that Home Depot has invested aggressively in digitization. Though brick and mortar remains the core sales driver, Home Depot has seen a big uptick in digital sales over the past couple of years. This seamless integration of the physical and digital experience should help it navigate any near-term market turbulence.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F634240%2Fbuying-house-mortgage-real-estate-apr-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3><a href=\"https://laohu8.com/S/AGNCO\">AGNC Investment Corp.</a></h3>\n<p>Don't worry, I haven't forgotten about you dividend income seekers out there. Should a crash or correction occur, mortgage real estate investment trust (REIT) <b><a href=\"https://laohu8.com/S/AGNCM\">AGNC Investment Corp</a>.</b> (NASDAQ:AGNC) and its 9% dividend yield would be ripe for the picking.</p>\n<p>Mortgage REITs are companies that borrow money at lower short-term rates to buy assets with higher long-term yields, such as mortgage-backed securities. The difference between the yields they receive on their owned assets minus their borrowing rate is known as the net interest margin.</p>\n<p>Typically, the bond yield curve steepens during the early stages of an economic recovery, which is where we are now. When that happens, it's pretty common for mortgage REITs to see their net interest margin expand.</p>\n<p>What's more, AGNC Investment's asset portfolio is almost entirely devoted to agency assets -- i.e., securities backed by the federal government in the event of a default. Having this added protection allows AGNC to wisely use leverage to its advantage in order to increase its profitability.</p>\n<p><img src=\"https://static.tigerbbs.com/0a442339ef77177eb97fecfa070c7ac0\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Bristol Myers Squibb</h3>\n<p>When stock market volatility picks up, putting your money to work in defensive industries and sectors is usually a smart idea. That's why pharmaceutical stock <b>Bristol Myers Squibb</b> (NYSE:BMY) would make for the perfect buy.</p>\n<p>Bristol Myers made one heck of a splash when it acquired cancer and immunology drug developer Celgene in 2019. Celgene's leading cancer drug, Revlimid, has grown sales annually by a double-digit percentage for over a decade, and the company has benefited from strong pricing power, label expansion opportunities, and longer duration of use. Revlimid brought in more than $12 billion for Bristol Myers last year and is protected from a flood of generics until early 2026.</p>\n<p>However, Bristol Myers Squibb isn't just relying on acquisitions to get the job done. Eliquis has become the unquestioned global oral anticoagulant therapy of choice, and cancer immunotherapy Opdivo brought in about $7 billion in sales in 2020. With Opdivo being examined in dozens of ongoing clinical trials, label expansion opportunities offer plenty of promise.</p>\n<p><img src=\"https://static.tigerbbs.com/f0b7d2c00802511f18a779a33e17e079\" tg-width=\"700\" tg-height=\"525\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>NextEra Energy</h3>\n<p>Another defensive stock that can be confidently bought hand over fist during a stock market crash or steep short-term decline is electric utility <b>NextEra Energy</b> (NYSE:NEE).</p>\n<p>Most utility stocks are slow-growing business that rely on the predictability of demand for their services. This is what makes them solid dividend stocks and a good bet to outpace the prevailing U.S. inflation rate more years than not. What makes NextEra so special is its focus on alternative energy.</p>\n<p>NextEra is putting between $50 billion and $55 billion to work on predominantly green-energy projects between 2020 and 2022 and is the leading utility by solar and wind capacity in the country. Leaning on renewable energy has driven down electric-generation costs and pushed the company's growth rate to the high single digits for more than a decade.</p>\n<p>Keep in mind that NextEra's traditional utility operations (i.e., those not powered by wind or solar) are regulated. Though the company can't pass along price hikes whenever it wants to, it has no exposure to potentially volatile wholesale-electricity pricing. This is a highly predictable -- and profitable -- utility stock.</p>\n<p><img src=\"https://static.tigerbbs.com/af564c8e93ad6657d5fad263a6d0b483\" tg-width=\"700\" tg-height=\"525\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Green Thumb Industries</h3>\n<p>An important thing we learned about cannabis during the coronavirus pandemic is that it's treated like a basic-need consumer good. In other words, people keep buying weed, no matter how well or poor the economy is performing. That means a crash would mark an excellent opportunity to buy U.S. multistate operator <b>Green Thumb Industries</b> (OTC:GTBIF).</p>\n<p>Green Thumb currently has 59 operating dispensaries and 110 total retail licenses in 13 legalized states. It's been particularly picky about the states it's chosen to operate in and has focused on states where license issuance is capped by regulators. This will minimize the number of competitors it's up against.</p>\n<p>The real secret to Green Thumb's success, and why it's been able to turn the corner to recurring profitability, is the healthy amount of revenue generated from derivatives, such as vapes, oils, and edibles. Derivatives are far less likely to face oversupply concerns, relative to dried cannabis flower, and they produce superior margins. Suffice to say, Green Thumb can show opportunistic investors the green if bought during a crash.</p>\n<p><img src=\"https://static.tigerbbs.com/2c3c5ad9d1e66b5cc533e681283d4790\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: U.S. Bank (U.S. Bancorp is its parent company).</p>\n<h3>U.S. Bancorp</h3>\n<p>A final company to buy hand over fist is regional banking giant <b>U.S. Bancorp</b> (NYSE:USB).</p>\n<p>Even though bank stocks tend to get hammered during crashes or corrections, U.S. Bancorp has proved time and again that it's in a class of its own among big banks. It consistently offers one of the highest return on assets, and its conservative management team has kept the company from chasing after risky derivative investments that have previously crippled money-center banks. Perhaps it's no surprise that it also offers one of the juiciest U.S. big-bank dividend yields at 3.4%.</p>\n<p>Arguably even more important to U.S. Bancorp's success has been its ability to coerce its customers to bank digitally. In the May-ended quarter, 80% of all transactions were completed digitally, which included just shy of two-thirds of all loan sales. The more its customers embrace digital banking, the more branches the company can close. And the more branches it consolidates, the lower its noninterest expenses will be.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Stocks to Buy Hand Over Fist if the Stock Market Crashes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Stocks to Buy Hand Over Fist if the Stock Market Crashes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-22 21:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/22/7-stocks-buy-hand-over-fist-if-stock-market-crash/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a subject that investors often don't like to talk about, but stock market crashes and corrections are a common and inevitable part of the investing cycle. On Monday, the benchmark S&P 500 ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/22/7-stocks-buy-hand-over-fist-if-stock-market-crash/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","USB":"美国合众银行"},"source_url":"https://www.fool.com/investing/2021/07/22/7-stocks-buy-hand-over-fist-if-stock-market-crash/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153678131","content_text":"It's a subject that investors often don't like to talk about, but stock market crashes and corrections are a common and inevitable part of the investing cycle. On Monday, the benchmark S&P 500 suffered its worst single-session decline in months, raising speculation, once again, that a correction or crash may be around the corner.\nIf we turn to history as a guide, a double-digit percentage decline is likely long overdue. For instance, in each of the previous four instances where the S&P 500's Shiller price-to-earnings (P/E) ratio surpassed 30, the index subsequently declined by at least 20%. The S&P 500's Shiller P/E ratio topped 38 last week -- it's highest reading in almost two decades.\nHistory has also been pretty clear that rebounds from a bear market bottom are never this smooth. In each of the previous eight bear markets prior to the coronavirus crash, there were either one or two double-digit percentage pullbacks within three years of reaching the bottom.\n\nImage source: Getty Images.\nBut there's good news, too: Crashes beget opportunity for long-term investors. If this latest bout of volatility leads to a long overdue crash or correction, consider buying the following seven winning stocks hand over fist.\nCrowdStrike Holdings\nYou know what doesn't change one iota when the market crashes? The demand for cybersecurity solutions. That's why any discount you can get on cybersecurity stock CrowdStrike Holdings (NASDAQ:CRWD) should be considered a blessing.\nCrowdStrike's cloud-native Falcon platform is its superstar. It oversees approximately 6 trillion events weekly and uses artificial intelligence to become more efficient at identifying and responding to threats over time. Because Falcon was built in the cloud, it's usually nimbler than on-premises security solutions, and more cost-effective, as well.\nCrowdStrike's operating results clearly show that its customers love the product. It's retaining 98% of its clients, and 64% of its customers purchased four or more cloud-module subscriptions in the most recent quarter. For some context, four years ago, only 9% of its clients had four or more cloud-module subscriptions. CrowdStrike is a no-brainer buy on weakness.\n\nImage source: Home Depot.\nHome Depot\nIf brand-name stocks are more your thing, a stock market crash or steep correction has historically always been a smart time to load up your cart with shares of do-it-yourself home-improvement chain Home Depot (NYSE:HD).\nThe great thing about Home Depot is that it can play both sides of the fence. If the U.S economy is firing on all cylinders, there's a good chance sales to commercial clients and contractors will be strong.\nComparatively, when economic uncertainty becomes an issue, we've often witnessed homeowners become Home Depot's driving force via remodels and projects. The company is surprisingly well-hedged for virtually all economic scenarios.\nInvestors should also note that Home Depot has invested aggressively in digitization. Though brick and mortar remains the core sales driver, Home Depot has seen a big uptick in digital sales over the past couple of years. This seamless integration of the physical and digital experience should help it navigate any near-term market turbulence.\n\nImage source: Getty Images.\nAGNC Investment Corp.\nDon't worry, I haven't forgotten about you dividend income seekers out there. Should a crash or correction occur, mortgage real estate investment trust (REIT) AGNC Investment Corp. (NASDAQ:AGNC) and its 9% dividend yield would be ripe for the picking.\nMortgage REITs are companies that borrow money at lower short-term rates to buy assets with higher long-term yields, such as mortgage-backed securities. The difference between the yields they receive on their owned assets minus their borrowing rate is known as the net interest margin.\nTypically, the bond yield curve steepens during the early stages of an economic recovery, which is where we are now. When that happens, it's pretty common for mortgage REITs to see their net interest margin expand.\nWhat's more, AGNC Investment's asset portfolio is almost entirely devoted to agency assets -- i.e., securities backed by the federal government in the event of a default. Having this added protection allows AGNC to wisely use leverage to its advantage in order to increase its profitability.\n\nImage source: Getty Images.\nBristol Myers Squibb\nWhen stock market volatility picks up, putting your money to work in defensive industries and sectors is usually a smart idea. That's why pharmaceutical stock Bristol Myers Squibb (NYSE:BMY) would make for the perfect buy.\nBristol Myers made one heck of a splash when it acquired cancer and immunology drug developer Celgene in 2019. Celgene's leading cancer drug, Revlimid, has grown sales annually by a double-digit percentage for over a decade, and the company has benefited from strong pricing power, label expansion opportunities, and longer duration of use. Revlimid brought in more than $12 billion for Bristol Myers last year and is protected from a flood of generics until early 2026.\nHowever, Bristol Myers Squibb isn't just relying on acquisitions to get the job done. Eliquis has become the unquestioned global oral anticoagulant therapy of choice, and cancer immunotherapy Opdivo brought in about $7 billion in sales in 2020. With Opdivo being examined in dozens of ongoing clinical trials, label expansion opportunities offer plenty of promise.\n\nImage source: Getty Images.\nNextEra Energy\nAnother defensive stock that can be confidently bought hand over fist during a stock market crash or steep short-term decline is electric utility NextEra Energy (NYSE:NEE).\nMost utility stocks are slow-growing business that rely on the predictability of demand for their services. This is what makes them solid dividend stocks and a good bet to outpace the prevailing U.S. inflation rate more years than not. What makes NextEra so special is its focus on alternative energy.\nNextEra is putting between $50 billion and $55 billion to work on predominantly green-energy projects between 2020 and 2022 and is the leading utility by solar and wind capacity in the country. Leaning on renewable energy has driven down electric-generation costs and pushed the company's growth rate to the high single digits for more than a decade.\nKeep in mind that NextEra's traditional utility operations (i.e., those not powered by wind or solar) are regulated. Though the company can't pass along price hikes whenever it wants to, it has no exposure to potentially volatile wholesale-electricity pricing. This is a highly predictable -- and profitable -- utility stock.\n\nImage source: Getty Images.\nGreen Thumb Industries\nAn important thing we learned about cannabis during the coronavirus pandemic is that it's treated like a basic-need consumer good. In other words, people keep buying weed, no matter how well or poor the economy is performing. That means a crash would mark an excellent opportunity to buy U.S. multistate operator Green Thumb Industries (OTC:GTBIF).\nGreen Thumb currently has 59 operating dispensaries and 110 total retail licenses in 13 legalized states. It's been particularly picky about the states it's chosen to operate in and has focused on states where license issuance is capped by regulators. This will minimize the number of competitors it's up against.\nThe real secret to Green Thumb's success, and why it's been able to turn the corner to recurring profitability, is the healthy amount of revenue generated from derivatives, such as vapes, oils, and edibles. Derivatives are far less likely to face oversupply concerns, relative to dried cannabis flower, and they produce superior margins. Suffice to say, Green Thumb can show opportunistic investors the green if bought during a crash.\n\nImage source: U.S. Bank (U.S. Bancorp is its parent company).\nU.S. Bancorp\nA final company to buy hand over fist is regional banking giant U.S. Bancorp (NYSE:USB).\nEven though bank stocks tend to get hammered during crashes or corrections, U.S. Bancorp has proved time and again that it's in a class of its own among big banks. It consistently offers one of the highest return on assets, and its conservative management team has kept the company from chasing after risky derivative investments that have previously crippled money-center banks. Perhaps it's no surprise that it also offers one of the juiciest U.S. big-bank dividend yields at 3.4%.\nArguably even more important to U.S. Bancorp's success has been its ability to coerce its customers to bank digitally. In the May-ended quarter, 80% of all transactions were completed digitally, which included just shy of two-thirds of all loan sales. The more its customers embrace digital banking, the more branches the company can close. And the more branches it consolidates, the lower its noninterest expenses will be.","news_type":1},"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178155036,"gmtCreate":1626793468925,"gmtModify":1703765380345,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Pls like and commenr","listText":"Pls like and commenr","text":"Pls like and commenr","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/178155036","repostId":"2152405667","repostType":4,"repost":{"id":"2152405667","kind":"highlight","pubTimestamp":1626790080,"share":"https://ttm.financial/m/news/2152405667?lang=&edition=fundamental","pubTime":"2021-07-20 22:08","market":"us","language":"en","title":"3 Areas Where Pfizer Is Crushing Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2152405667","media":"Motley Fool","summary":"They could result in a broader market for Pfizer's vaccine.","content":"<p><b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> </b>and <b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a></b> have been marching in lockstep for nearly a year. They both announced the start of phase 3 trials for their coronavirus vaccine candidates on the same day last July. Pfizer won Emergency Use Authorization for its vaccine only about a week ahead of Moderna. And the U.S. ordered 300 million doses from each company earlier in the year. That was enough to vaccinate almost the entire population.</p>\n<p>It's fair to say both of these companies today are leading the coronavirus vaccine market. Still, Pfizer has inched ahead in a couple of ways. It has fully vaccinated more Americans than Moderna so far. And recently, it scored an order for as many as 1.8 billion doses from the European Union through 2023. That's in addition to an earlier order. But that's not all. There are three other areas where Pfizer is beating Moderna...</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F634091%2Fgettyimages-surprised-business-person.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3>1. The path to full approval</h3>\n<p>Pfizer and partner <b>BioNTech</b> said last week the U.S. Food and Drug Administration granted their vaccine priority review. The agency's standard review time usually takes between six to 10 months. Priority review takes a maximum of six. So, in this case, the agency's deadline to make an approval decision is in January. In even better news, an FDA official told CNN that regulators may issue a decision in as little as two months.</p>\n<p>Where does Moderna stand? The biotech submitted its request for approval a month behind Pfizer. Moderna also requested priority review. If all goes smoothly for Moderna, it may follow in Pfizer's footsteps. And in this case, we might expect a regulatory decision about a month after the Pfizer decision. If any issues arise, of course, Moderna could fall behind.</p>\n<h3>2. The booster plan</h3>\n<p>Pfizer and Moderna announced work on boosters to address variants earlier this year. Both companies are studying variant-specific candidates as well as an extra dose of their vaccines. But Pfizer made the study of a third vaccine dose the priority. And the company recently said it will ask for regulatory authorization of that dose in the coming weeks. Meanwhile, it plans to begin clinical trials of a variant-specific version of its vaccine in August.</p>\n<p>Moderna simultaneously started clinical trials of three candidates: an extra dose of vaccine, a strain-specific candidate, and a combination of its vaccine and the strain-specific candidate. The company has said it will have a booster ready by fall.</p>\n<p>If Pfizer stays on track, it looks like it will make it to market ahead of Moderna though. Pfizer's data are ready for regulators -- and it may be easier to win authorization for another dose of a vaccine that's already been given to millions of people than a new candidate.</p>\n<h3>3. Back-to-school vaccinations</h3>\n<p>Regulators in the U.S. and Europe authorized Pfizer's vaccine in teens 12 through 15 back in May. The original authorization includes individuals ages 16 and older. The company reported positive trial data on March 31.</p>\n<p>Moderna announced positive results from its teen study in late May -- and the company applied for authorization in the U.S. and Europe about two weeks later. Regulatory decisions may come any day now. But Pfizer has a clear advantage. Its vaccine got the OK before teens headed off to summer activities or vacation. And that's likely when a lot of teens would opt for vaccination to be fully protected before school starts. Pfizer and Moderna vaccines require two doses about a month apart.</p>\n<h3>What does all of this mean for investors?</h3>\n<p>These points are good news for Pfizer. A fully approved vaccine likely will attract many individuals who hesitated to go for an experimental product. So, if the FDA gives a nod, more and more people may request a Pfizer jab. A quicker-to-market booster and an authorization for teens also mean more individuals may go for a Pfizer shot in the near term.</p>\n<p>But none of these points will immediately equal more revenue for Pfizer. Governments already have purchased doses. If Pfizer <i>stays </i>ahead of Moderna on each of the above points, though, these doses may be used up faster than planned. And that may mean more orders down the road. And therefore, more revenue. The first-to-market status also may keep governments coming back for more of the same -- so Pfizer may attract bigger orders.</p>\n<p>All is not lost for Moderna though. Far from it. Yes, Pfizer is dominating in the above areas. And that may even continue. But Moderna isn't far behind. As we've seen so far, there's room for more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> player in this market. Pfizer expects $26 billion in vaccine revenue this year. And Moderna's advance purchase orders total $19.2 billion so far. Both already are winning orders for 2022.</p>\n<p>This means an investment in either of these coronavirus vaccine leaders today is likely to pay off now -- and in the long term.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Areas Where Pfizer Is Crushing Moderna</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Areas Where Pfizer Is Crushing Moderna\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-20 22:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/20/3-areas-where-pfizer-is-crushing-moderna/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer and Moderna, Inc. have been marching in lockstep for nearly a year. They both announced the start of phase 3 trials for their coronavirus vaccine candidates on the same day last July. Pfizer ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/20/3-areas-where-pfizer-is-crushing-moderna/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/07/20/3-areas-where-pfizer-is-crushing-moderna/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152405667","content_text":"Pfizer and Moderna, Inc. have been marching in lockstep for nearly a year. They both announced the start of phase 3 trials for their coronavirus vaccine candidates on the same day last July. Pfizer won Emergency Use Authorization for its vaccine only about a week ahead of Moderna. And the U.S. ordered 300 million doses from each company earlier in the year. That was enough to vaccinate almost the entire population.\nIt's fair to say both of these companies today are leading the coronavirus vaccine market. Still, Pfizer has inched ahead in a couple of ways. It has fully vaccinated more Americans than Moderna so far. And recently, it scored an order for as many as 1.8 billion doses from the European Union through 2023. That's in addition to an earlier order. But that's not all. There are three other areas where Pfizer is beating Moderna...\n\nImage source: Getty Images.\n1. The path to full approval\nPfizer and partner BioNTech said last week the U.S. Food and Drug Administration granted their vaccine priority review. The agency's standard review time usually takes between six to 10 months. Priority review takes a maximum of six. So, in this case, the agency's deadline to make an approval decision is in January. In even better news, an FDA official told CNN that regulators may issue a decision in as little as two months.\nWhere does Moderna stand? The biotech submitted its request for approval a month behind Pfizer. Moderna also requested priority review. If all goes smoothly for Moderna, it may follow in Pfizer's footsteps. And in this case, we might expect a regulatory decision about a month after the Pfizer decision. If any issues arise, of course, Moderna could fall behind.\n2. The booster plan\nPfizer and Moderna announced work on boosters to address variants earlier this year. Both companies are studying variant-specific candidates as well as an extra dose of their vaccines. But Pfizer made the study of a third vaccine dose the priority. And the company recently said it will ask for regulatory authorization of that dose in the coming weeks. Meanwhile, it plans to begin clinical trials of a variant-specific version of its vaccine in August.\nModerna simultaneously started clinical trials of three candidates: an extra dose of vaccine, a strain-specific candidate, and a combination of its vaccine and the strain-specific candidate. The company has said it will have a booster ready by fall.\nIf Pfizer stays on track, it looks like it will make it to market ahead of Moderna though. Pfizer's data are ready for regulators -- and it may be easier to win authorization for another dose of a vaccine that's already been given to millions of people than a new candidate.\n3. Back-to-school vaccinations\nRegulators in the U.S. and Europe authorized Pfizer's vaccine in teens 12 through 15 back in May. The original authorization includes individuals ages 16 and older. The company reported positive trial data on March 31.\nModerna announced positive results from its teen study in late May -- and the company applied for authorization in the U.S. and Europe about two weeks later. Regulatory decisions may come any day now. But Pfizer has a clear advantage. Its vaccine got the OK before teens headed off to summer activities or vacation. And that's likely when a lot of teens would opt for vaccination to be fully protected before school starts. Pfizer and Moderna vaccines require two doses about a month apart.\nWhat does all of this mean for investors?\nThese points are good news for Pfizer. A fully approved vaccine likely will attract many individuals who hesitated to go for an experimental product. So, if the FDA gives a nod, more and more people may request a Pfizer jab. A quicker-to-market booster and an authorization for teens also mean more individuals may go for a Pfizer shot in the near term.\nBut none of these points will immediately equal more revenue for Pfizer. Governments already have purchased doses. If Pfizer stays ahead of Moderna on each of the above points, though, these doses may be used up faster than planned. And that may mean more orders down the road. And therefore, more revenue. The first-to-market status also may keep governments coming back for more of the same -- so Pfizer may attract bigger orders.\nAll is not lost for Moderna though. Far from it. Yes, Pfizer is dominating in the above areas. And that may even continue. But Moderna isn't far behind. As we've seen so far, there's room for more than one player in this market. Pfizer expects $26 billion in vaccine revenue this year. And Moderna's advance purchase orders total $19.2 billion so far. Both already are winning orders for 2022.\nThis means an investment in either of these coronavirus vaccine leaders today is likely to pay off now -- and in the long term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":914,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146792289,"gmtCreate":1626098691541,"gmtModify":1703753375271,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Good to know","listText":"Good to know","text":"Good to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/146792289","repostId":"1167324972","repostType":4,"repost":{"id":"1167324972","kind":"news","pubTimestamp":1626090462,"share":"https://ttm.financial/m/news/1167324972?lang=&edition=fundamental","pubTime":"2021-07-12 19:47","market":"us","language":"en","title":"ByteDance Said to Have Met With Officials Over Data Security","url":"https://stock-news.laohu8.com/highlight/detail?id=1167324972","media":"Bloomberg","summary":"TikTok owner ByteDance Ltd.is working to ensure it complies with data security requirements after me","content":"<p>TikTok owner&nbsp;ByteDance Ltd.is working to ensure it complies with data security requirements after meetings with government officials over the issue earlier this year, a person familiar with the matter said.</p>\n<p>The Chinese tech giant, whose apps also include TikTok’s Chinese twin Douyin and the news aggregator Toutiao, hadkicked offinitial preparations for an IPO of its domestic assets, Bloomberg News reported in April. ByteDance’s considerations about going public had been in flux even beforeDidi Global Inc.’s IPO in New York sparked a regulatory backlash, and the company is approaching any potential IPO cautiously, people familiar with the matter said Monday, asking not to be identified discussing private information.</p>\n<p>ByteDance meets regularly with Beijing regulators about a range of issues, including data security, and the March discussions were part of that ongoing process, according to one person. Founder Zhang Yiming did not attend the March meetings, the person said. A ByteDance representative declined to comment.</p>\n<p>Companies seeking to raise capital in overseas markets are now facing greater scrutiny, after China on Saturday proposednew lawsthat will require virtually all firms heading for an IPO outside of China to undergo a cybersecurity review. Didi had gone ahead to list in New York in June, even though Bloomberg News reported regulators asked it as early as three months ago todelaythe debut. Authorities have since commenced a cybersecurity probe into the firm and removed its services from Chinese app stores.</p>\n<p>The Wall Street Journal earlier reported the March meetings with regulators, adding that ByteDance put on hold indefinitely its intentions to list offshore earlier this year after Chinese officials told the company to address data-security risks. Regulators never called outright for a delay to ByteDance’s possible share offering, but they were concerned about data-security compliance by its apps in the country, according to the report.</p>\n<p>The Cyberspace Administration of China and the China Securities Regulatory Commission didn’t respond to the Journal’s requests for comment.</p>\n<p>Trading of ByteDance’s shares in private markets have held steady at about $330 billion over the past month, according to a person with direct knowledge, although asking prices for the stock have been higher.</p>\n<p>ByteDance had been considering plans to raise at least several billion dollars from a listing of its Chinese assets, Bloomberg reported in April. At that time, it was choosing between Hong Kong and the U.S. as its listing venue. The company in March hired Shou Zi Chew fromXiaomi Corp.as its CFO, fueling speculation an IPO was imminent.</p>\n<p>The company later issued astatementsaying it didn’t meet the conditions to go public and currently didn’t have any such plans.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ByteDance Said to Have Met With Officials Over Data Security</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nByteDance Said to Have Met With Officials Over Data Security\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-12 19:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-07-12/bytedance-shelved-ipo-after-regulators-warn-about-data-dj-says><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TikTok owner ByteDance Ltd.is working to ensure it complies with data security requirements after meetings with government officials over the issue earlier this year, a person familiar with the matter...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-07-12/bytedance-shelved-ipo-after-regulators-warn-about-data-dj-says\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite"},"source_url":"https://www.bloomberg.com/news/articles/2021-07-12/bytedance-shelved-ipo-after-regulators-warn-about-data-dj-says","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167324972","content_text":"TikTok owner ByteDance Ltd.is working to ensure it complies with data security requirements after meetings with government officials over the issue earlier this year, a person familiar with the matter said.\nThe Chinese tech giant, whose apps also include TikTok’s Chinese twin Douyin and the news aggregator Toutiao, hadkicked offinitial preparations for an IPO of its domestic assets, Bloomberg News reported in April. ByteDance’s considerations about going public had been in flux even beforeDidi Global Inc.’s IPO in New York sparked a regulatory backlash, and the company is approaching any potential IPO cautiously, people familiar with the matter said Monday, asking not to be identified discussing private information.\nByteDance meets regularly with Beijing regulators about a range of issues, including data security, and the March discussions were part of that ongoing process, according to one person. Founder Zhang Yiming did not attend the March meetings, the person said. A ByteDance representative declined to comment.\nCompanies seeking to raise capital in overseas markets are now facing greater scrutiny, after China on Saturday proposednew lawsthat will require virtually all firms heading for an IPO outside of China to undergo a cybersecurity review. Didi had gone ahead to list in New York in June, even though Bloomberg News reported regulators asked it as early as three months ago todelaythe debut. Authorities have since commenced a cybersecurity probe into the firm and removed its services from Chinese app stores.\nThe Wall Street Journal earlier reported the March meetings with regulators, adding that ByteDance put on hold indefinitely its intentions to list offshore earlier this year after Chinese officials told the company to address data-security risks. Regulators never called outright for a delay to ByteDance’s possible share offering, but they were concerned about data-security compliance by its apps in the country, according to the report.\nThe Cyberspace Administration of China and the China Securities Regulatory Commission didn’t respond to the Journal’s requests for comment.\nTrading of ByteDance’s shares in private markets have held steady at about $330 billion over the past month, according to a person with direct knowledge, although asking prices for the stock have been higher.\nByteDance had been considering plans to raise at least several billion dollars from a listing of its Chinese assets, Bloomberg reported in April. At that time, it was choosing between Hong Kong and the U.S. as its listing venue. The company in March hired Shou Zi Chew fromXiaomi Corp.as its CFO, fueling speculation an IPO was imminent.\nThe company later issued astatementsaying it didn’t meet the conditions to go public and currently didn’t have any such plans.","news_type":1},"isVote":1,"tweetType":1,"viewCount":565,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157642091,"gmtCreate":1625581561413,"gmtModify":1703744345342,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Great to read..like and comment please","listText":"Great to read..like and comment please","text":"Great to read..like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157642091","repostId":"1107037757","repostType":4,"repost":{"id":"1107037757","kind":"news","pubTimestamp":1625564660,"share":"https://ttm.financial/m/news/1107037757?lang=&edition=fundamental","pubTime":"2021-07-06 17:44","market":"us","language":"en","title":"Nio Expected To Gross 5% More EV Deliveries In 2021 Than Previous Forecast, Says CICC","url":"https://stock-news.laohu8.com/highlight/detail?id=1107037757","media":"Benzinga","summary":"China International Capital Corporation Limited has updated its forecast for Nio Inc, saying it expects the  Chinese electric vehicle maker to sell 98,000 cars in 2021, 5% more than its previous estimate, as per a cnEVpostreport.What Happened:The China-based investment bank estimates Nio’s production and sales to remain strong in the second half of the year.Nio delivered 21,896 units in the second quarter,near the upper end of the company's 21,000- to 22,000-unit delivery guidance, in line with ","content":"<p>China International Capital Corporation Limited has updated its forecast for&nbsp;<b>Nio Inc</b>(NYSE:NIO), saying it expects&nbsp;the&nbsp; Chinese electric vehicle maker&nbsp;to sell 98,000 cars in 2021, 5% more than its previous estimate, as per a cnEVpostreport.</p>\n<p><b>What Happened:</b>The China-based investment bank estimates Nio’s production and sales to remain strong in the second half of the year.</p>\n<p>Nio&nbsp;delivered 21,896 units in the second quarter,near the upper end of the company's 21,000-&nbsp;to 22,000-unit delivery guidance, in line with market expectations.</p>\n<p>The investment bank also raised the sales volume forecast for rival&nbsp;<b>Li Auto</b>(NASDAQ:LI) to 90,000 units, an increase of 12.5%.</p>\n<p>Li Auto’s&nbsp;second-quarter deliveriessoared 166%&nbsp;to 17,575 vehicles compared with a year ago.</p>\n<p><b>Price Action:</b>Nio shares closed 0.98% lower at $50.40 on Friday, while&nbsp;Li Auto stock closed 5.8% lower at $32.67.</p>\n<p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nio Expected To Gross 5% More EV Deliveries In 2021 Than Previous Forecast, Says CICC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNio Expected To Gross 5% More EV Deliveries In 2021 Than Previous Forecast, Says CICC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-06 17:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/analyst-ratings/analyst-color/21/07/21850578/nio-expected-to-gross-5-more-ev-deliveries-in-2021-than-previous-forecast-says-cicc><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>China International Capital Corporation Limited has updated its forecast for Nio Inc(NYSE:NIO), saying it expects the  Chinese electric vehicle maker to sell 98,000 cars in 2021, 5% more than its ...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/21/07/21850578/nio-expected-to-gross-5-more-ev-deliveries-in-2021-than-previous-forecast-says-cicc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","NIO":"蔚来"},"source_url":"https://www.benzinga.com/analyst-ratings/analyst-color/21/07/21850578/nio-expected-to-gross-5-more-ev-deliveries-in-2021-than-previous-forecast-says-cicc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107037757","content_text":"China International Capital Corporation Limited has updated its forecast for Nio Inc(NYSE:NIO), saying it expects the  Chinese electric vehicle maker to sell 98,000 cars in 2021, 5% more than its previous estimate, as per a cnEVpostreport.\nWhat Happened:The China-based investment bank estimates Nio’s production and sales to remain strong in the second half of the year.\nNio delivered 21,896 units in the second quarter,near the upper end of the company's 21,000- to 22,000-unit delivery guidance, in line with market expectations.\nThe investment bank also raised the sales volume forecast for rival Li Auto(NASDAQ:LI) to 90,000 units, an increase of 12.5%.\nLi Auto’s second-quarter deliveriessoared 166% to 17,575 vehicles compared with a year ago.\nPrice Action:Nio shares closed 0.98% lower at $50.40 on Friday, while Li Auto stock closed 5.8% lower at $32.67.","news_type":1},"isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159728190,"gmtCreate":1624981072510,"gmtModify":1703849498665,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Good.to.read. like and comment please","listText":"Good.to.read. like and comment please","text":"Good.to.read. like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/159728190","repostId":"1172874030","repostType":4,"repost":{"id":"1172874030","kind":"news","pubTimestamp":1624879330,"share":"https://ttm.financial/m/news/1172874030?lang=&edition=fundamental","pubTime":"2021-06-28 19:22","market":"us","language":"en","title":"Bed Bath & Beyond Is Set to Report Earnings on Wednesday. What to Know.","url":"https://stock-news.laohu8.com/highlight/detail?id=1172874030","media":"Barrons","summary":"After a wild month on the meme stock rollercoaster, Bed Bath & Beyond shares have settled down right","content":"<p>After a wild month on the meme stock rollercoaster, Bed Bath &amp; Beyond shares have settled down right in time for the retailer’s latest earnings report.</p>\n<p>Bed Bath &amp; Beyond (ticker: BBBY) is set to report fiscal first-quarter earnings results before the market opens on Wednesday. The Wall Street consensus estimate for the quarter has adjusted earnings at nine cents per share and sales at $1.87 billion,&nbsp;according to FactSet. Analysts forecast same-store sales growth of 76% year-over-year.</p>\n<p>Wedbush Securities analyst Seth Basham thinks sales will meet expectations, but he’ll be looking for updates on how the company’s market share is holding up. He notes that Bed Bath is facing a relatively easy comparison from last year’s pandemic-impacted period. That will change in quarters to come, as the company will lap periods that saw in uptick in at-home spending.</p>\n<p>Bed Bath shares were caught in a broader&nbsp;resurgence for meme stocks&nbsp;at the start of June, but have since settled down. That led BofA Global Research analyst Curtis Nagle to bring back a Buy rating for the stock last week. Nagle dropped his rating after shares spiked 62% on June 2 on little news&nbsp;aside from chatter on social media. That’s a hallmark of&nbsp;meme stocks, which are generally highly shorted companies targeted&nbsp;by retail investors on Reddit.</p>\n<p>“Since then, [Bed Bath &amp; Beyond] shares are now trading much closer to levels pre-surge, and non-fundamentals drivers such as number of mentions on retail investor online message boards, trading volumes, and short interest have moderated,” Nagle wrote.</p>\n<p>Nagle also brought back a $38 price objective. He expects the company to hit earnings before interest, taxes, depreciation, and amortization, or Ebitda, of between $850 million and $1 billion by 2023.</p>\n<p>Bed Bath’s meme stock status has somewhat obscured efforts by CEO Mark Tritton to&nbsp;turn the company around. Nagle notes that the company’s balance sheet is in a strong place, with about $1.35 billion in cash and negative net debt of $200 million.</p>\n<p>He also argues the company is heading into its&nbsp;largest new product rollout&nbsp;in history, as the company rolls out new private label brands. Tritton told&nbsp;<i>Barron’s</i>&nbsp;earlier this year such efforts&nbsp;would play a role&nbsp;in the retailer’s turnaround.</p>\n<p>Nagle also points to store closures at underperforming locations and reopening tailwinds from back to school and wedding registry shoppers that should benefit the retailer.</p>\n<p>Of course, investors will need to be wary of social media and short seller activity. June wasn’t the first time the stock was caught in meme stock volatility. Bed Bath saw shares surge in January along with&nbsp;GameStop(GME) and&nbsp;AMC Entertainment Holdings(AMC).</p>\n<p>Analysts are mixed on the company’s prospects. Of the 21 analysts covering Bed Bath stock, two have Buy ratings, 13 have Neutral ratings, while six have Sell or equivalent ratings, according to FactSet. Their mean price target is $26.43, implying 12.1% downside from recent levels.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bed Bath & Beyond Is Set to Report Earnings on Wednesday. What to Know.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBed Bath & Beyond Is Set to Report Earnings on Wednesday. What to Know.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-28 19:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/bed-bath-beyond-reports-earnings-on-wednesday-look-beyond-the-meme-stock-spotlight-51624654711?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After a wild month on the meme stock rollercoaster, Bed Bath & Beyond shares have settled down right in time for the retailer’s latest earnings report.\nBed Bath & Beyond (ticker: BBBY) is set to ...</p>\n\n<a href=\"https://www.barrons.com/articles/bed-bath-beyond-reports-earnings-on-wednesday-look-beyond-the-meme-stock-spotlight-51624654711?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BBBY":"3B家居"},"source_url":"https://www.barrons.com/articles/bed-bath-beyond-reports-earnings-on-wednesday-look-beyond-the-meme-stock-spotlight-51624654711?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172874030","content_text":"After a wild month on the meme stock rollercoaster, Bed Bath & Beyond shares have settled down right in time for the retailer’s latest earnings report.\nBed Bath & Beyond (ticker: BBBY) is set to report fiscal first-quarter earnings results before the market opens on Wednesday. The Wall Street consensus estimate for the quarter has adjusted earnings at nine cents per share and sales at $1.87 billion, according to FactSet. Analysts forecast same-store sales growth of 76% year-over-year.\nWedbush Securities analyst Seth Basham thinks sales will meet expectations, but he’ll be looking for updates on how the company’s market share is holding up. He notes that Bed Bath is facing a relatively easy comparison from last year’s pandemic-impacted period. That will change in quarters to come, as the company will lap periods that saw in uptick in at-home spending.\nBed Bath shares were caught in a broader resurgence for meme stocks at the start of June, but have since settled down. That led BofA Global Research analyst Curtis Nagle to bring back a Buy rating for the stock last week. Nagle dropped his rating after shares spiked 62% on June 2 on little news aside from chatter on social media. That’s a hallmark of meme stocks, which are generally highly shorted companies targeted by retail investors on Reddit.\n“Since then, [Bed Bath & Beyond] shares are now trading much closer to levels pre-surge, and non-fundamentals drivers such as number of mentions on retail investor online message boards, trading volumes, and short interest have moderated,” Nagle wrote.\nNagle also brought back a $38 price objective. He expects the company to hit earnings before interest, taxes, depreciation, and amortization, or Ebitda, of between $850 million and $1 billion by 2023.\nBed Bath’s meme stock status has somewhat obscured efforts by CEO Mark Tritton to turn the company around. Nagle notes that the company’s balance sheet is in a strong place, with about $1.35 billion in cash and negative net debt of $200 million.\nHe also argues the company is heading into its largest new product rollout in history, as the company rolls out new private label brands. Tritton told Barron’s earlier this year such efforts would play a role in the retailer’s turnaround.\nNagle also points to store closures at underperforming locations and reopening tailwinds from back to school and wedding registry shoppers that should benefit the retailer.\nOf course, investors will need to be wary of social media and short seller activity. June wasn’t the first time the stock was caught in meme stock volatility. Bed Bath saw shares surge in January along with GameStop(GME) and AMC Entertainment Holdings(AMC).\nAnalysts are mixed on the company’s prospects. Of the 21 analysts covering Bed Bath stock, two have Buy ratings, 13 have Neutral ratings, while six have Sell or equivalent ratings, according to FactSet. Their mean price target is $26.43, implying 12.1% downside from recent levels.","news_type":1},"isVote":1,"tweetType":1,"viewCount":463,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3586198471249922","authorId":"3586198471249922","name":"EmmaS","avatar":"https://static.tigerbbs.com/41fa8b7739afa8f029d077d18c6201ab","crmLevel":2,"crmLevelSwitch":0,"idStr":"3586198471249922","authorIdStr":"3586198471249922"},"content":"done. Like and comment pls","text":"done. Like and comment pls","html":"done. Like and comment pls"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150876761,"gmtCreate":1624894359053,"gmtModify":1703847421430,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Wow.one of it really rising ..&nbsp; like and comment.","listText":"Wow.one of it really rising ..&nbsp; like and comment.","text":"Wow.one of it really rising .. like and comment.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/150876761","repostId":"2146002845","repostType":4,"repost":{"id":"2146002845","kind":"highlight","pubTimestamp":1624866683,"share":"https://ttm.financial/m/news/2146002845?lang=&edition=fundamental","pubTime":"2021-06-28 15:51","market":"us","language":"en","title":"These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet","url":"https://stock-news.laohu8.com/highlight/detail?id=2146002845","media":"Motley Fool","summary":"Sales for these companies should skyrocket between 400% and 1,118% over the next four years.","content":"<p>For more than a decade, growth stocks have been all the rage on Wall Street. Historically low lending rates, dovish monetary policy, and a free-spending Capitol Hill (at least during the pandemic) have allowed fast-growing companies to thrive.</p>\n<p>Typically, it's smaller companies that generate some of the fastest sales growth, while large-cap stocks (those with market caps of at least $10 billion) grow at a more tempered pace. Larger companies are more likely to have time-tested or mature operating models, making it less common that they generate eye-popping revenue growth.</p>\n<p>However, the following large-cap stocks didn't get that memo. Each and every <a href=\"https://laohu8.com/S/AONE\">one</a> of these companies is on track to, at minimum, quintuple their sales over a four-year period, according to Wall Street's consensus revenue estimate for 2024 (or fiscal 2025). You could rightly say that these are five of the fastest-growing large-cap stocks on the planet.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ccad26103b3c97bbb65d0cad160f21b9\" tg-width=\"700\" tg-height=\"489\"><span>Image source: Getty Images.</span></p>\n<h2>Sea Limited: Implied four-year sales growth of 400%</h2>\n<p>Who said companies with market caps in excess of $100 billion can't grow like their smaller competitors? According to analysts, Singapore-based <b>Sea Limited</b> (NYSE:SE) is expected to see its full-year sales skyrocket from $4.39 billion in 2020 to about $21.9 billion in 2024. That works out to a quintupling in full-year revenue in four years.</p>\n<p>Sea's secret sauce (say that three times fast) is that it has three rapidly growing operating segments. For the moment, it's being anchored by its digital gaming operations. The company ended March with close to 649 million active users, 12.3% of which were paying to play. That's well above the industry average, and it's notably higher than the 8.9% of quarterly active users who were paying <a href=\"https://laohu8.com/S/AONE.U\">one</a> year ago.</p>\n<p>However, the superstar for this company is its e-commerce platform, Shopee. It's the top shopping app downloaded in Southeastern Asia, and it's becoming especially popular in Brazil. In the first quarter of 2021, Shopee saw $12.6 billion in gross merchandise value (GMV) purchased. For some context here, Shopee did $10.3 billion in GMV in all of 2018. Both the coronavirus pandemic and the rise of the middle class throughout Southeastern Asia is driving online purchases.</p>\n<p>Lastly, Sea has its rapidly growing digital financial services segment. More than 26 million people were paying for mobile wallet services at the end of March. Since the company targets a number of underbanked emerging markets, this digital financial services segment could be a major long-term growth driver.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/51b9e73cc74dad844548f15906c23624\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>Plug Power: Implied four-year sales growth of 404%</h2>\n<p>Companies focused on renewable energy solutions should be among the fastest growing this decade. Over the next four years investors will struggle to find a green-energy stock expanding quicker than hydrogen fuel-cell solutions provider <b>Plug Power</b> (NASDAQ:PLUG). After delivering $337 million in sales in 2020, Plug has guided for $1.7 billion in full-year revenue for 2024. That's a cool 404% increase, if it comes to fruition.</p>\n<p>For the time being, climate change is Plug Power's best friend. Joe Biden winning the presidency last year, coupled with Democrats regaining control of the Senate by the narrowest of margins, gives the current administration an opportunity to pass a clean energy bill. While it's unclear what a final infrastructure bill might look like, it's almost a certainty that clean vehicle solutions, such as those developed by Plug Power, will benefit.</p>\n<p>Additionally, the company secured two joint ventures just days apart in January. First, SK Group took a 10% equity stake in the company, with the duo aiming to introduce hydrogen fuel-cell-powered vehicles and hydrogen refilling stations in South Korea. A few days later, Plug landed a deal with French automaker <b>Renault</b> that'll see the two go after Europe's light commercial vehicle market. Both joint ventures should result in Plug Power's orders catapulting higher.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8db519446ea812ab6b8023df3f60f0c3\" tg-width=\"700\" tg-height=\"393\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a>: Implied four-year sales growth of 559%</h2>\n<p>The cloud computing space is home to dozens of fast-growing companies, none of which appear to be increasing its sales faster than cloud data-warehousing company <b>Snowflake</b> (NYSE:SNOW). In fiscal 2021, Snowflake's sales grew by 124% to $592 million. But based on Wall Street's consensus for fiscal 2025, it's on track to generate $3.9 billion in revenue. This would represent a four-year increase of 559%.</p>\n<p>What makes Snowflake so special is the company's competitive advantages. For example, it's shunned subscriptions in favor of a pay-as-you-go operating model. Customers pay for the amount of data they store and the number of Snowflake Compute Credits used. This allows the company's clients to keep better tabs on their expenses.</p>\n<p>Also, since Snowflake's solutions are built atop the most popular cloud infrastructure platforms, customers can share data seamlessly, even across competing services.</p>\n<p>Though it's the fastest-growing cloud stock, Snowflake is also one of the priciest. It's currently valued at 67 times projected sales for fiscal 2022 and roughly 19 times estimated sales four years from now. But if the company makes good on its fiscal 2029 outlook of $10 billion in product sales, paying this premium may be well worth it.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/96d1687ba107475c062f0147fa401ff2\" tg-width=\"700\" tg-height=\"375\"><span>The NIO EC6 EV crossover SUV. Image source: NIO.</span></p>\n<h2>NIO: Implied four-year sales growth of 561%</h2>\n<p>Another absolute beast of a growth trend this decade is the rise of electric vehicles (EV). Though <b>Tesla</b>&nbsp;and the U.S. EV market tend to get a lot of attention, the biggest opportunity is actually China. That's why <b>NIO</b> (NYSE:NIO) finds itself as one of the fastest-growing large-cap stocks on the planet. If all goes well, full-year sales can catapult from about $2.5 billion in 2020 to $16.8 billion in 2024. That's a sales increase of approximately 561%.</p>\n<p>Despite a global chip shortage, NIO has shown Wall Street that it can effectively scale its production. After delivering 20,060 vehicles in the first quarter, the company is on pace to deliver between 21,000 and 22,000 EVs in the second quarter. Once global chip supply issues are resolved, NIO will look to boost its annual delivery capacity to around 150,000 EVs.</p>\n<p>For NIO, innovation is extremely important. It's been introducing one new vehicle each year, with the sportier EC6 crossover SUV hitting showrooms last summer. It's quickly become a hit with EV buyers.</p>\n<p>Additionally, NIO introduced a battery-as-a-service program. For a monthly fee, this subscription service allows buyers to replace or upgrade their vehicle's batteries. It also reduces the initial purchase price of the vehicle. Though NIO is giving up near-term margin by reducing the purchase price of its EVs, it's keeping buyers loyal and generating very high margin residual service revenue.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/849b25e21ebbcd8fae1e28f0543300db\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>Novavax: Implied four-year sales growth of 1,118%</h2>\n<p>The crème de la crème of fast-growing large-cap companies is biotech stock <b>Novavax</b> (NASDAQ:NVAX). Following a pandemic-ravaged year where it brought in $476 million in sales, Wall Street is looking for Novavax to generate $5.8 billion in annual revenue in 2024. That's your run-of-the-mill sales increase of 1,118% over the coming four years.</p>\n<p>As you may have rightly guessed, Novavax's core catalyst is a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, NVX-CoV2373 (these scientific names just roll off the tongue), demonstrated nearly 90% efficacy in a large U.K. study, and recently reported a 90.4% trial efficacy in the United States.&nbsp; With efficacy rates this high, Novavax could potentially displace <b>Johnson &amp; Johnson</b>'s single-dose vaccine, which offered an efficacy of 72%.</p>\n<p>Though you'd think this was a cut-and-dried success story, Novavax has delayed its emergency-use authorization filings in Europe, the U.S., and U.K. until the third quarter, and it likely won't be at full production capacity till the fourth quarter. This waiting game has caused wild vacillations in Novavax's share price of late.</p>\n<p>Nevertheless, Novavax has a good chance of being one of the primary COVID-19 vaccines used in emerging markets, and it could become a key player if booster shots become necessary.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-28 15:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/27/5-of-fastest-growing-large-cap-stocks-on-planet/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a decade, growth stocks have been all the rage on Wall Street. Historically low lending rates, dovish monetary policy, and a free-spending Capitol Hill (at least during the pandemic) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/27/5-of-fastest-growing-large-cap-stocks-on-planet/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd","PLUG":"普拉格能源","SNOW":"Snowflake","NVAX":"诺瓦瓦克斯医药","NIO":"蔚来"},"source_url":"https://www.fool.com/investing/2021/06/27/5-of-fastest-growing-large-cap-stocks-on-planet/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146002845","content_text":"For more than a decade, growth stocks have been all the rage on Wall Street. Historically low lending rates, dovish monetary policy, and a free-spending Capitol Hill (at least during the pandemic) have allowed fast-growing companies to thrive.\nTypically, it's smaller companies that generate some of the fastest sales growth, while large-cap stocks (those with market caps of at least $10 billion) grow at a more tempered pace. Larger companies are more likely to have time-tested or mature operating models, making it less common that they generate eye-popping revenue growth.\nHowever, the following large-cap stocks didn't get that memo. Each and every one of these companies is on track to, at minimum, quintuple their sales over a four-year period, according to Wall Street's consensus revenue estimate for 2024 (or fiscal 2025). You could rightly say that these are five of the fastest-growing large-cap stocks on the planet.\nImage source: Getty Images.\nSea Limited: Implied four-year sales growth of 400%\nWho said companies with market caps in excess of $100 billion can't grow like their smaller competitors? According to analysts, Singapore-based Sea Limited (NYSE:SE) is expected to see its full-year sales skyrocket from $4.39 billion in 2020 to about $21.9 billion in 2024. That works out to a quintupling in full-year revenue in four years.\nSea's secret sauce (say that three times fast) is that it has three rapidly growing operating segments. For the moment, it's being anchored by its digital gaming operations. The company ended March with close to 649 million active users, 12.3% of which were paying to play. That's well above the industry average, and it's notably higher than the 8.9% of quarterly active users who were paying one year ago.\nHowever, the superstar for this company is its e-commerce platform, Shopee. It's the top shopping app downloaded in Southeastern Asia, and it's becoming especially popular in Brazil. In the first quarter of 2021, Shopee saw $12.6 billion in gross merchandise value (GMV) purchased. For some context here, Shopee did $10.3 billion in GMV in all of 2018. Both the coronavirus pandemic and the rise of the middle class throughout Southeastern Asia is driving online purchases.\nLastly, Sea has its rapidly growing digital financial services segment. More than 26 million people were paying for mobile wallet services at the end of March. Since the company targets a number of underbanked emerging markets, this digital financial services segment could be a major long-term growth driver.\nImage source: Getty Images.\nPlug Power: Implied four-year sales growth of 404%\nCompanies focused on renewable energy solutions should be among the fastest growing this decade. Over the next four years investors will struggle to find a green-energy stock expanding quicker than hydrogen fuel-cell solutions provider Plug Power (NASDAQ:PLUG). After delivering $337 million in sales in 2020, Plug has guided for $1.7 billion in full-year revenue for 2024. That's a cool 404% increase, if it comes to fruition.\nFor the time being, climate change is Plug Power's best friend. Joe Biden winning the presidency last year, coupled with Democrats regaining control of the Senate by the narrowest of margins, gives the current administration an opportunity to pass a clean energy bill. While it's unclear what a final infrastructure bill might look like, it's almost a certainty that clean vehicle solutions, such as those developed by Plug Power, will benefit.\nAdditionally, the company secured two joint ventures just days apart in January. First, SK Group took a 10% equity stake in the company, with the duo aiming to introduce hydrogen fuel-cell-powered vehicles and hydrogen refilling stations in South Korea. A few days later, Plug landed a deal with French automaker Renault that'll see the two go after Europe's light commercial vehicle market. Both joint ventures should result in Plug Power's orders catapulting higher.\nImage source: Getty Images.\nSnowflake: Implied four-year sales growth of 559%\nThe cloud computing space is home to dozens of fast-growing companies, none of which appear to be increasing its sales faster than cloud data-warehousing company Snowflake (NYSE:SNOW). In fiscal 2021, Snowflake's sales grew by 124% to $592 million. But based on Wall Street's consensus for fiscal 2025, it's on track to generate $3.9 billion in revenue. This would represent a four-year increase of 559%.\nWhat makes Snowflake so special is the company's competitive advantages. For example, it's shunned subscriptions in favor of a pay-as-you-go operating model. Customers pay for the amount of data they store and the number of Snowflake Compute Credits used. This allows the company's clients to keep better tabs on their expenses.\nAlso, since Snowflake's solutions are built atop the most popular cloud infrastructure platforms, customers can share data seamlessly, even across competing services.\nThough it's the fastest-growing cloud stock, Snowflake is also one of the priciest. It's currently valued at 67 times projected sales for fiscal 2022 and roughly 19 times estimated sales four years from now. But if the company makes good on its fiscal 2029 outlook of $10 billion in product sales, paying this premium may be well worth it.\nThe NIO EC6 EV crossover SUV. Image source: NIO.\nNIO: Implied four-year sales growth of 561%\nAnother absolute beast of a growth trend this decade is the rise of electric vehicles (EV). Though Tesla and the U.S. EV market tend to get a lot of attention, the biggest opportunity is actually China. That's why NIO (NYSE:NIO) finds itself as one of the fastest-growing large-cap stocks on the planet. If all goes well, full-year sales can catapult from about $2.5 billion in 2020 to $16.8 billion in 2024. That's a sales increase of approximately 561%.\nDespite a global chip shortage, NIO has shown Wall Street that it can effectively scale its production. After delivering 20,060 vehicles in the first quarter, the company is on pace to deliver between 21,000 and 22,000 EVs in the second quarter. Once global chip supply issues are resolved, NIO will look to boost its annual delivery capacity to around 150,000 EVs.\nFor NIO, innovation is extremely important. It's been introducing one new vehicle each year, with the sportier EC6 crossover SUV hitting showrooms last summer. It's quickly become a hit with EV buyers.\nAdditionally, NIO introduced a battery-as-a-service program. For a monthly fee, this subscription service allows buyers to replace or upgrade their vehicle's batteries. It also reduces the initial purchase price of the vehicle. Though NIO is giving up near-term margin by reducing the purchase price of its EVs, it's keeping buyers loyal and generating very high margin residual service revenue.\nImage source: Getty Images.\nNovavax: Implied four-year sales growth of 1,118%\nThe crème de la crème of fast-growing large-cap companies is biotech stock Novavax (NASDAQ:NVAX). Following a pandemic-ravaged year where it brought in $476 million in sales, Wall Street is looking for Novavax to generate $5.8 billion in annual revenue in 2024. That's your run-of-the-mill sales increase of 1,118% over the coming four years.\nAs you may have rightly guessed, Novavax's core catalyst is a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, NVX-CoV2373 (these scientific names just roll off the tongue), demonstrated nearly 90% efficacy in a large U.K. study, and recently reported a 90.4% trial efficacy in the United States.  With efficacy rates this high, Novavax could potentially displace Johnson & Johnson's single-dose vaccine, which offered an efficacy of 72%.\nThough you'd think this was a cut-and-dried success story, Novavax has delayed its emergency-use authorization filings in Europe, the U.S., and U.K. until the third quarter, and it likely won't be at full production capacity till the fourth quarter. This waiting game has caused wild vacillations in Novavax's share price of late.\nNevertheless, Novavax has a good chance of being one of the primary COVID-19 vaccines used in emerging markets, and it could become a key player if booster shots become necessary.","news_type":1},"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150962243,"gmtCreate":1624883308182,"gmtModify":1703846929156,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Great article.&nbsp;","listText":"Great article.&nbsp;","text":"Great article.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/150962243","repostId":"150917061","repostType":1,"repost":{"id":150917061,"gmtCreate":1624881997249,"gmtModify":1703846906458,"author":{"id":"3514329116425907","authorId":"3514329116425907","name":"小虎AV","avatar":"https://static.tigerbbs.com/91101bd3142b32495c3131036d5f8afa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3514329116425907","authorIdStr":"3514329116425907"},"themes":[],"htmlText":"\n \n \n  【一分鐘帶你看老虎7週年上海場OpenDay】一起來看攝影師都捕捉到了哪些精彩瞬間！還有我們最帥氣/美麗的虎友們~ <a href=\"https://laohu8.com/S/TIGR\">$老虎證券(TIGR)$</a>\n \n","listText":"【一分鐘帶你看老虎7週年上海場OpenDay】一起來看攝影師都捕捉到了哪些精彩瞬間！還有我們最帥氣/美麗的虎友們~ <a href=\"https://laohu8.com/S/TIGR\">$老虎證券(TIGR)$</a>","text":"【一分鐘帶你看老虎7週年上海場OpenDay】一起來看攝影師都捕捉到了哪些精彩瞬間！還有我們最帥氣/美麗的虎友們~ $老虎證券(TIGR)$","images":[{"img":"https://static.tigerbbs.com/e9ad2a5df2e61fbb8343c34b6da06dcc","width":"0","height":"0"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/150917061","isVote":1,"tweetType":2,"object":{"id":"dac7e3fba82d4a1192afbb60b9436b7c","tweetId":"150917061","videoUrl":"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/6a151b8a3701925920047838458/NVuSBFuyKxgA.mp4","poster":"https://static.tigerbbs.com/e9ad2a5df2e61fbb8343c34b6da06dcc"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129612956,"gmtCreate":1624370784675,"gmtModify":1703834721676,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>to the moon !!!","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>to the moon !!!","text":"$BioNTech SE(BNTX)$to the moon !!!","images":[{"img":"https://static.tigerbbs.com/3108a2ec94ffe934c9dfba402ae06dee","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129612956","isVote":1,"tweetType":1,"viewCount":126,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":129108675,"gmtCreate":1624362915697,"gmtModify":1703834395203,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Good analysis , like and comment","listText":"Good analysis , like and comment","text":"Good analysis , like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/129108675","repostId":"1169318799","repostType":4,"repost":{"id":"1169318799","kind":"news","pubTimestamp":1624349018,"share":"https://ttm.financial/m/news/1169318799?lang=&edition=fundamental","pubTime":"2021-06-22 16:03","market":"us","language":"en","title":"Here's Why Torchlight Energy Resources Stock Skyrocketed Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1169318799","media":"Motley Fool","summary":"The exploration and production company will pay a special dividend to its investors ahead of its upc","content":"<blockquote>\n The exploration and production company will pay a special dividend to its investors ahead of its upcoming merger.\n</blockquote>\n<p>Torchlight Energy&nbsp;rose&nbsp;over&nbsp;8%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/2dcb00868155922f136b4fda7e08b626\" tg-width=\"667\" tg-height=\"500\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Torchlight Energy Resources</b>&nbsp;(NASDAQ:TRCH)soared 58% on Monday after the oil and gas driller extended the closing date of its merger with advanced materials manufacturer<b>Metamaterial</b>.</p>\n<p><b>So what</b></p>\n<p>Torchlight and Metamaterial agreed to push back the transaction date to June 30. This will give Torchlight enough time to pay its shareholders the special dividend it announced on June 14.</p>\n<p>orchlight'scommonstockholders who own shares at the close of the June 24 record date will receive one share of Series A preferred stock for every share of common stock they own. The preferred stock will entitle investors to a portion of the proceeds the combined company receives from the planned sale of its oil and gas assets.</p>\n<p>Torchlight intends to pay the special dividend on June 25.</p>\n<p><b>Now what</b></p>\n<p>Torchlight has garnered attention from traders on Reddit and other social media platforms. Some of these traders are hoping to ignite a short squeeze by driving up the stock's price and forcing short-sellers to exit their positions. Their goal is to cause so much pain for short-sellers that they rush to buy back the shares they shorted, which could help accelerate the steep rise in the stock's price.</p>\n<p>Still, although short squeezes can create sharp upward moves, they also tend to be short-lived. And when a squeeze ends, investors who bought late in the rally can often suffer sizable losses.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Torchlight Energy Resources Stock Skyrocketed Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Torchlight Energy Resources Stock Skyrocketed Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 16:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/21/heres-why-torchlight-energy-resources-stock-skyroc/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The exploration and production company will pay a special dividend to its investors ahead of its upcoming merger.\n\nTorchlight Energy rose over 8% in premarket trading.\n\nWhat happened\nShares of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/21/heres-why-torchlight-energy-resources-stock-skyroc/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MMAT":"Meta Materials Inc."},"source_url":"https://www.fool.com/investing/2021/06/21/heres-why-torchlight-energy-resources-stock-skyroc/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169318799","content_text":"The exploration and production company will pay a special dividend to its investors ahead of its upcoming merger.\n\nTorchlight Energy rose over 8% in premarket trading.\n\nWhat happened\nShares of Torchlight Energy Resources (NASDAQ:TRCH)soared 58% on Monday after the oil and gas driller extended the closing date of its merger with advanced materials manufacturerMetamaterial.\nSo what\nTorchlight and Metamaterial agreed to push back the transaction date to June 30. This will give Torchlight enough time to pay its shareholders the special dividend it announced on June 14.\norchlight'scommonstockholders who own shares at the close of the June 24 record date will receive one share of Series A preferred stock for every share of common stock they own. The preferred stock will entitle investors to a portion of the proceeds the combined company receives from the planned sale of its oil and gas assets.\nTorchlight intends to pay the special dividend on June 25.\nNow what\nTorchlight has garnered attention from traders on Reddit and other social media platforms. Some of these traders are hoping to ignite a short squeeze by driving up the stock's price and forcing short-sellers to exit their positions. Their goal is to cause so much pain for short-sellers that they rush to buy back the shares they shorted, which could help accelerate the steep rise in the stock's price.\nStill, although short squeezes can create sharp upward moves, they also tend to be short-lived. And when a squeeze ends, investors who bought late in the rally can often suffer sizable losses.","news_type":1},"isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166706339,"gmtCreate":1624024281721,"gmtModify":1703826880490,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Great. Like and comment pls","listText":"Great. Like and comment pls","text":"Great. Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166706339","repostId":"1166489816","repostType":4,"repost":{"id":"1166489816","kind":"news","pubTimestamp":1624009298,"share":"https://ttm.financial/m/news/1166489816?lang=&edition=fundamental","pubTime":"2021-06-18 17:41","market":"us","language":"en","title":"Dosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1166489816","media":"seekingalpha","summary":"BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine ","content":"<ul>\n <li>BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase&nbsp;2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed by Regeneron(NASDAQ:REGN)and Sanofi(NASDAQ:SNY)in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma.</li>\n <li>The trial is enrolling a total of 120 patients. The primary endpoint is the overall response rate (ORR) of BNT111 in combination with Libtayo.</li>\n <li>Secondary endpoints include ORR in the single agent arms, duration of response, and safety.</li>\n <li>The first patient has been dosed in the EU. BioNTech retains global commercial rights to BNT111.</li>\n <li>This Phase 2 clinical trial is based on previous results from the Phase 1 Lipo-MERIT dose escalation trial that demonstrated a favorable safety profile in 89 patients with advanced melanoma.</li>\n <li>The Company also plans to start randomized Phase 2 trials with mRNA vaccine product candidates in two additional programs in 2021 (FixVac: BNT113 and iNeST: BNT122).</li>\n <li>The BNT111-01 trial is being conducted in collaboration with Regeneron.</li>\n <li>BioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 17:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed ...</p>\n\n<a href=\"https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1166489816","content_text":"BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed by Regeneron(NASDAQ:REGN)and Sanofi(NASDAQ:SNY)in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma.\nThe trial is enrolling a total of 120 patients. The primary endpoint is the overall response rate (ORR) of BNT111 in combination with Libtayo.\nSecondary endpoints include ORR in the single agent arms, duration of response, and safety.\nThe first patient has been dosed in the EU. BioNTech retains global commercial rights to BNT111.\nThis Phase 2 clinical trial is based on previous results from the Phase 1 Lipo-MERIT dose escalation trial that demonstrated a favorable safety profile in 89 patients with advanced melanoma.\nThe Company also plans to start randomized Phase 2 trials with mRNA vaccine product candidates in two additional programs in 2021 (FixVac: BNT113 and iNeST: BNT122).\nThe BNT111-01 trial is being conducted in collaboration with Regeneron.\nBioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant","news_type":1},"isVote":1,"tweetType":1,"viewCount":161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161253229,"gmtCreate":1623930571461,"gmtModify":1703823764423,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Impressive.. like and comment","listText":"Impressive.. like and comment","text":"Impressive.. like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/161253229","repostId":"1162768247","repostType":4,"repost":{"id":"1162768247","kind":"news","pubTimestamp":1623911907,"share":"https://ttm.financial/m/news/1162768247?lang=&edition=fundamental","pubTime":"2021-06-17 14:38","market":"sh","language":"en","title":"TikTok Owner ByteDance’s Annual Revenue Jumps to $34.3 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1162768247","media":"The Wall Street Journal","summary":"ByteDance’s gross profit rose 93% to $19 billion last year, according to a memo to staff\nByteDance h","content":"<p>ByteDance’s gross profit rose 93% to $19 billion last year, according to a memo to staff</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/13c817a3fe56161425ab51576dd52e5b\" tg-width=\"1260\" tg-height=\"840\"><span>ByteDance had about 1.9 billion monthly active users across all its platforms as of December 2020, according to a company memo.</span></p>\n<p>ByteDance Ltd., the owner of popular short-video app TikTok, told employees that its revenue last year more than doubled to $34.3 billion, underscoring why the Chinese technology giant is one of the world’s hottest startups.</p>\n<p>The privately held company on Thursday shared highlights of its 2020 financial performance with its employees. ByteDance said its total revenue grew 111% from a year ago, while gross profit rose 93% to $19 billion, according to excerpts of a company memo viewed by The Wall Street Journal.</p>\n<p>ByteDance had about 1.9 billion monthly active users across all its platforms as of December 2020, according to the memo. The company also runs viral apps such as Douyin, the domestic Chinese equivalent of TikTok, and a news aggregation app called Jinri Toutiao.</p>\n<p>The Beijing-based firm told staffers that it incurred a $2.1 billion operating loss from January to December last year. The loss was partly due to higher expenses incurred from share-based compensation to workers, according to a person familiar with the matter. For 2019, ByteDance had reported an operating profit of $684 million.</p>\n<p>Its net loss for 2020 totaled $45 billion, due largely to an accounting adjustment the company made for an increase in the fair value of its convertible redeemable preferred shares. Startups that have raised outside funds often have to take these noncash charges as their valuations rise, if they prepare results in line with International Financial Reporting Standards.</p>\n<p>ByteDance, which was started in 2012 by&nbsp;Chinese entrepreneur Zhang Yiming, has raised billions of dollars from global investors including KKR &amp; Co., Sequoia Capital and General Atlantic. The company was valued at $180 billion in late 2020 after a fundraising round that included Fidelity Investments and some of its existing shareholders.</p>\n<p>ByteDance is considering listing in Hong Kong or New York, according to a person familiar with the matter. The company hasn’t mapped out any timeline for an initial public offering.</p>\n<p>Early this year one of ByteDance’s smaller domestic rivals, short-video app operator Kuaishou Technology,listed in Hong Kong&nbsp;after&nbsp;raising $5.4 billion. Kuaishou’s market capitalization was recently about $103 billion, and the company reported 2020 revenues equivalent to about $9.2 billion.</p>\n<p>In China, TikTok is widely viewed as China’s most successful mobile internet export. The wildly popular short-video app has been downloaded more than 240 million times in the U.S., with teenagers and adults alike posting video clips of themselves lip syncing, dancing and even dishing out financial advice.</p>\n<p>ByteDance’s revenues from TikTok come primarily from advertising. The company is also expanding beyond social media into areas such as gaming and e-commerce.</p>\n<p>While ByteDance didn’t break down its 1.9 billion monthly active users by app, its scale rivals that of&nbsp;Alphabet&nbsp;Inc.’s&nbsp;YouTube, which reiterated in April that it had more than 2 billion users that log into its site to watch videos. At the end of 2019, ByteDance had about 1.5 billion monthly active users.</p>\n<p>Last year, ByteDance was caught in the crosshairs of U.S.-China relations when former U.S. President&nbsp;Donald Trump’s administration singled out TikTok as a national-security threat and sought to ban the app. This month, President Biden&nbsp;revoked the ban, instead issuing an executive order mandating a broad review of apps controlled by foreign adversaries.</p>\n<p>At home, ByteDance has also run into some turbulence, as Chinese authorities seek to&nbsp;clamp down on the perceived excesses&nbsp;of its powerful technology sector. ByteDance has been called in by authorities this year for infractions including improper data use and problematic content.</p>\n<p>Last month, Mr. Zhang&nbsp;stepped down from his role&nbsp;as chief executive officer amid growing government scrutiny of the sector. Following the company’s management change, ByteDance launched a share buyback for employees, according to people familiar with the matter.</p>\n<p>In June, two of ByteDance’s apps were included on a list of 129 apps named by the Cyberspace Administration of China for excessive collection of personal information from users. The authority told all the apps to rectify the situation. The move followed a similar order on Douyin the previous month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TikTok Owner ByteDance’s Annual Revenue Jumps to $34.3 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTikTok Owner ByteDance’s Annual Revenue Jumps to $34.3 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 14:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/tiktok-owner-bytedances-annual-revenue-jumps-to-34-3-billion-11623903622?mod=hp_lista_pos1><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ByteDance’s gross profit rose 93% to $19 billion last year, according to a memo to staff\nByteDance had about 1.9 billion monthly active users across all its platforms as of December 2020, according to...</p>\n\n<a href=\"https://www.wsj.com/articles/tiktok-owner-bytedances-annual-revenue-jumps-to-34-3-billion-11623903622?mod=hp_lista_pos1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"01024":"快手-W","00700":"腾讯控股"},"source_url":"https://www.wsj.com/articles/tiktok-owner-bytedances-annual-revenue-jumps-to-34-3-billion-11623903622?mod=hp_lista_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162768247","content_text":"ByteDance’s gross profit rose 93% to $19 billion last year, according to a memo to staff\nByteDance had about 1.9 billion monthly active users across all its platforms as of December 2020, according to a company memo.\nByteDance Ltd., the owner of popular short-video app TikTok, told employees that its revenue last year more than doubled to $34.3 billion, underscoring why the Chinese technology giant is one of the world’s hottest startups.\nThe privately held company on Thursday shared highlights of its 2020 financial performance with its employees. ByteDance said its total revenue grew 111% from a year ago, while gross profit rose 93% to $19 billion, according to excerpts of a company memo viewed by The Wall Street Journal.\nByteDance had about 1.9 billion monthly active users across all its platforms as of December 2020, according to the memo. The company also runs viral apps such as Douyin, the domestic Chinese equivalent of TikTok, and a news aggregation app called Jinri Toutiao.\nThe Beijing-based firm told staffers that it incurred a $2.1 billion operating loss from January to December last year. The loss was partly due to higher expenses incurred from share-based compensation to workers, according to a person familiar with the matter. For 2019, ByteDance had reported an operating profit of $684 million.\nIts net loss for 2020 totaled $45 billion, due largely to an accounting adjustment the company made for an increase in the fair value of its convertible redeemable preferred shares. Startups that have raised outside funds often have to take these noncash charges as their valuations rise, if they prepare results in line with International Financial Reporting Standards.\nByteDance, which was started in 2012 by Chinese entrepreneur Zhang Yiming, has raised billions of dollars from global investors including KKR & Co., Sequoia Capital and General Atlantic. The company was valued at $180 billion in late 2020 after a fundraising round that included Fidelity Investments and some of its existing shareholders.\nByteDance is considering listing in Hong Kong or New York, according to a person familiar with the matter. The company hasn’t mapped out any timeline for an initial public offering.\nEarly this year one of ByteDance’s smaller domestic rivals, short-video app operator Kuaishou Technology,listed in Hong Kong after raising $5.4 billion. Kuaishou’s market capitalization was recently about $103 billion, and the company reported 2020 revenues equivalent to about $9.2 billion.\nIn China, TikTok is widely viewed as China’s most successful mobile internet export. The wildly popular short-video app has been downloaded more than 240 million times in the U.S., with teenagers and adults alike posting video clips of themselves lip syncing, dancing and even dishing out financial advice.\nByteDance’s revenues from TikTok come primarily from advertising. The company is also expanding beyond social media into areas such as gaming and e-commerce.\nWhile ByteDance didn’t break down its 1.9 billion monthly active users by app, its scale rivals that of Alphabet Inc.’s YouTube, which reiterated in April that it had more than 2 billion users that log into its site to watch videos. At the end of 2019, ByteDance had about 1.5 billion monthly active users.\nLast year, ByteDance was caught in the crosshairs of U.S.-China relations when former U.S. President Donald Trump’s administration singled out TikTok as a national-security threat and sought to ban the app. This month, President Biden revoked the ban, instead issuing an executive order mandating a broad review of apps controlled by foreign adversaries.\nAt home, ByteDance has also run into some turbulence, as Chinese authorities seek to clamp down on the perceived excesses of its powerful technology sector. ByteDance has been called in by authorities this year for infractions including improper data use and problematic content.\nLast month, Mr. Zhang stepped down from his role as chief executive officer amid growing government scrutiny of the sector. Following the company’s management change, ByteDance launched a share buyback for employees, according to people familiar with the matter.\nIn June, two of ByteDance’s apps were included on a list of 129 apps named by the Cyberspace Administration of China for excessive collection of personal information from users. The authority told all the apps to rectify the situation. The move followed a similar order on Douyin the previous month.","news_type":1},"isVote":1,"tweetType":1,"viewCount":80,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160479059,"gmtCreate":1623805417671,"gmtModify":1703819908967,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Good to read. Like and comment, please&nbsp;","listText":"Good to read. Like and comment, please&nbsp;","text":"Good to read. Like and comment, please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160479059","repostId":"1179402047","repostType":4,"isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184412057,"gmtCreate":1623721432879,"gmtModify":1704209522921,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Comment please","listText":"Comment please","text":"Comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184412057","repostId":"1146208169","repostType":4,"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184318854,"gmtCreate":1623684028578,"gmtModify":1704208700217,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184318854","repostId":"1114455344","repostType":4,"repost":{"id":"1114455344","kind":"news","pubTimestamp":1623679682,"share":"https://ttm.financial/m/news/1114455344?lang=&edition=fundamental","pubTime":"2021-06-14 22:08","market":"us","language":"en","title":"Qualcomm reportedly offers to invest in Arm as regulators threaten to block Nvidia's $40 billion acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=1114455344","media":"cnbc","summary":"U.S. chip goliath Qualcomm has said it is open to the idea of investing in U.K. chip designer Arm if","content":"<div>\n<p>U.S. chip goliath Qualcomm has said it is open to the idea of investing in U.K. chip designer Arm if the company’s $40 billion sale to Nvidiais blocked by regulators, according toThe ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/14/qualcomm-offers-to-invest-in-arm-as-regulators-threaten-nvidia-deal.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qualcomm reportedly offers to invest in Arm as regulators threaten to block Nvidia's $40 billion acquisition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQualcomm reportedly offers to invest in Arm as regulators threaten to block Nvidia's $40 billion acquisition\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 22:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/14/qualcomm-offers-to-invest-in-arm-as-regulators-threaten-nvidia-deal.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. chip goliath Qualcomm has said it is open to the idea of investing in U.K. chip designer Arm if the company’s $40 billion sale to Nvidiais blocked by regulators, according toThe ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/14/qualcomm-offers-to-invest-in-arm-as-regulators-threaten-nvidia-deal.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","QCOM":"高通"},"source_url":"https://www.cnbc.com/2021/06/14/qualcomm-offers-to-invest-in-arm-as-regulators-threaten-nvidia-deal.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1114455344","content_text":"U.S. chip goliath Qualcomm has said it is open to the idea of investing in U.K. chip designer Arm if the company’s $40 billion sale to Nvidiais blocked by regulators, according toThe Telegraphnewspaper.\nQualcomm’s incoming CEO, Cristiano Amon, said Qualcomm would be willing to buy a stake in Arm alongside other industry investors ifSoftBank, Arm’s current owner, listed the company on the stock market instead of selling it to Nvidia, the newspaper reported Sunday.\n“If Arm has an independent future, I think you will find there is a lot of interest from a lot of the companies within the ecosystem, including Qualcomm, to invest in Arm,” Amon said. “If it moves out of SoftBank and it goes into a process of becoming a publicly-traded company, [with] a consortium of companies that invest, including many of its customers, I think those are great possibilities.”\nAmon added that Qualcomm would “definitely be open to it” and that the company has “had discussions with other companies that feel the same way,” The Telegraph said.\nQualcomm declined to comment when contacted by CNBC, while Nvidia said an IPO wouldn’t be enough to support Arm’s growth. Arm did not immediately respond.\nArm was spun out of an early computing company called Acorn Computers in 1990. The company’s energy-efficient chip architectures are used in 95% of the world’s smartphones and 95% of the chips designed in China. The company licenses its chip designs to more than 500 companies, which use them to make their own chips.\nAn Nvidia spokesperson told CNBC that Arm needed more than an IPO if it is to achieve its full potential.\n“Arm needs an infusion of new technology that it can provide to Arm licensees everywhere, which is why we stepped up and agreed to buy Arm,” the spokesperson said. “Our technologies and Qualcomm’s are highly complementary — we’d welcome Qualcomm’s help in creating new technologies and products for the entire Arm ecosystem.”\nArm’s takeover by Nvidia wasannouncedby the companies last September and it was expected to take around 18 months. Since then, Qualcommhas been telling regulatorsaround the world that it is against the deal, as have Microsoft and Google,according to Bloomberg.\nThe companies say they are opposed to the takeover because there’s a risk that Nvidia could become a gatekeeper of Arm’s technology and prevent other chipmakers from using the company’s intellectual property. They question whether Nvidia will be able to fully capitalize on the acquisition without blocking access to Arm’s chip designs.\nNvidia has repeatedly said it will maintain Arm’s open licensing model and invest heavily in Arm’s headquarters in Cambridge, U.K.\nBut the Federal Trade Commission, the European Commission, the U.K.’s Competition and Markets Authority and China’s State Administration for Market Regulation are in the process of investigating the deal.\nArm has as a joint venture called “Arm China” with Chinese private equity firm Hopu Investments. Arm China is headquartered in Shanghai, meaning China’s Ministry of Commerce and China’s State Administration for Market Regulation has the right to review the deal.\nNvidia hasasked Chinese regulators to approve the dealin recent weeks, according toa reportfrom The Financial Times earlier this month that cites sources familiar with the matter. Nvidia said the regulatory process was confidential, but it remains confident that it will receive approval and “close in early 2022.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185765334,"gmtCreate":1623674221028,"gmtModify":1704208317949,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586511265760559","authorIdStr":"3586511265760559"},"themes":[],"htmlText":"Like and comment please","listText":"Like and comment please","text":"Like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/185765334","repostId":"1172057691","repostType":4,"repost":{"id":"1172057691","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623672122,"share":"https://ttm.financial/m/news/1172057691?lang=&edition=fundamental","pubTime":"2021-06-14 20:02","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1172057691","media":"Tiger Newspress","summary":"U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a ","content":"<p>U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a week that includes a keenly-awaited Federal Reserve meeting.</p>\n<p>At 7 AM ET (1200 GMT), the Dow futures contract was up just 5 points, or less than 0.1%, S&amp;P 500 futures traded 3 points, or 0.1%, higher, and Nasdaq 100 futures climbed 50 points, or 0.3%.</p>\n<p>The three major indices closed just higher Friday, with the broad-based S&amp;P 500 ending up 0.2%, at a new record high. The blue-chip Dow gained under 0.1% while the tech-heavy Nasdaq Composite closed 0.4% higher, helped by a rotation back into growth names.</p>\n<p>The Fed’s two-day policy meeting, ending Wednesday, will likely limit activity in the early part of the week. The central bank is not expected to take any immediate action, but investors will be focusing on the statement to see whether the policy makers open discussions about how and when to taper the $120 billion in monthly central bank bond purchases.</p>\n<p>Crude oil prices pushed higher Monday, trading near multi-year highs, helped by an improved outlook for demand as increased Covid-19 vaccinations push global travel back to near normalcy.</p>\n<p>U.S. daily air travelers have topped 2 million for the first time since the pandemic began with traffic returning to pre-pandemic levels in North America and much of Europe as lockdowns and other restrictions are being eased, although the U.K. could throw a spanner in the works later Monday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Novavax(NVAX)</b> – The drugmaker said its Covid-19 vaccine proved 90% effective overall in a late-stage trial, and 93% effective against the most predominant variants of the virus. It also provided 100% protection against moderate and severe disease. Novavax shares surged 10.4% in premarket trading.</p>\n<p><b>Lordstown Motors(RIDE) </b>– The electric truck maker announced the resignation of CEO Steve Burns and CFO Julio Rodriguez, days after the company warned there was doubt it could continue as a going concern. Lordstown has engaged a search firm to find replacements for Burns and Rodriguez. Shares tumbled 8% in the premarket.</p>\n<p><b>Phillips(PHG)</b> – Phillips shares slid 4.3% in premarket action after saying it would recall up to 4 million CPAP machines due to potential toxicity risks. The foam used in the sleep apnea treatment devices could degrade and potentially become toxic. The Dutch medical equipment company is the largest producer of CPAP machines.</p>\n<p><b>Chipotle Mexican Grill(CMG)</b> – Raymond James upgraded the restaurant chain’s shares to “strong buy” from “outperform”, predicting that recent menu price increases would push second-half profit well beyond consensus forecasts. Chipotle shares gained 1.4% in the premarket.</p>\n<p><b>Ferrari(RACE)</b> – Goldman Sachs gave the automaker’s stock a double downgrade, moving its rating to “sell” from “buy”, noting increased capital spending and a limited scope for positive earnings revisions. Ferrari fell 2.7% in the premarket.</p>\n<p><b>GlaxoSmithKline(GSK)</b> – The drugmaker is collaborating with clinical-stage biopharmaceutical companyiTeos Therapeutics(ITOS) to develop and commercialize EOS-448, a monoclonal antibody in early-stage development as a possible cancer treatment. iTeos soared 60.4% in the premarket.</p>\n<p><b>AstraZeneca(AZN) </b>– The drugmaker’s Covid-19 vaccine has a favorable risk/reward profile for all age groups and particularly for those 60 years and older, according to the head of the European Medicines Agency’s Covid-19 task force. Marco Cavaleri said his quote in an Italian newspaper saying the vaccine should not be given to those over 60 was not interpreted correctly.</p>\n<p><b>Royal Dutch Shell(RDS.A)</b> – The energy giant is considering a sale of shale assets in Texas, according to people familiar with the matter who spoke to Reuters. Such a could be worth more than $10 billion. Shares gained 2% in premarket trading.</p>\n<p><b>Oatly(OTLY) </b>– The oat milk maker received a mixed batch of initial ratings from a handful of investment firms. Oatly received ratings of “perform” (Oppenheimer), “outperform” (Credit Suisse), “equal-weight” (Morgan Stanley), “overweight” (Piper Sandler), “buy” (Jefferies, Guggenheim), “neutral” (JPMorgan Chase) and “sector perform” (RBC Capital). All agree on growth prospects for Oatly – but some firms feel those prospects are already priced into the stock.</p>\n<p><b>Qualcomm(QCOM)</b> – Qualcomm is prepared to invest in UK chipmaker Arm if its $40 billion deal to be acquired byNvidia(NVDA) is blocked by regulators, according to the Telegraph newspaper quoting CEO Cristiano Amon.</p>\n<p><b>Equinix(EQIX)</b> – Equinix struck a deal for additional joint ventures with Singapore’s sovereign wealth fund to expand its data center operations there. The deal will see the fund invest an additional $3.9 billion, bringing the total investment to more than $6.9 billion.</p>\n<p><b>NextGen Acquisition(NGAC) </b>– The special purpose acquisition company is in advanced talks to take Sir Richard Branson’s Virgin Orbit public, according to Sky News. Sky said a deal valuing Virgin Orbit at about $3 billion could be announced within the coming weeks. NextGen shares gained 1.9% in the premarket.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-14 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a week that includes a keenly-awaited Federal Reserve meeting.</p>\n<p>At 7 AM ET (1200 GMT), the Dow futures contract was up just 5 points, or less than 0.1%, S&amp;P 500 futures traded 3 points, or 0.1%, higher, and Nasdaq 100 futures climbed 50 points, or 0.3%.</p>\n<p>The three major indices closed just higher Friday, with the broad-based S&amp;P 500 ending up 0.2%, at a new record high. The blue-chip Dow gained under 0.1% while the tech-heavy Nasdaq Composite closed 0.4% higher, helped by a rotation back into growth names.</p>\n<p>The Fed’s two-day policy meeting, ending Wednesday, will likely limit activity in the early part of the week. The central bank is not expected to take any immediate action, but investors will be focusing on the statement to see whether the policy makers open discussions about how and when to taper the $120 billion in monthly central bank bond purchases.</p>\n<p>Crude oil prices pushed higher Monday, trading near multi-year highs, helped by an improved outlook for demand as increased Covid-19 vaccinations push global travel back to near normalcy.</p>\n<p>U.S. daily air travelers have topped 2 million for the first time since the pandemic began with traffic returning to pre-pandemic levels in North America and much of Europe as lockdowns and other restrictions are being eased, although the U.K. could throw a spanner in the works later Monday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Novavax(NVAX)</b> – The drugmaker said its Covid-19 vaccine proved 90% effective overall in a late-stage trial, and 93% effective against the most predominant variants of the virus. It also provided 100% protection against moderate and severe disease. Novavax shares surged 10.4% in premarket trading.</p>\n<p><b>Lordstown Motors(RIDE) </b>– The electric truck maker announced the resignation of CEO Steve Burns and CFO Julio Rodriguez, days after the company warned there was doubt it could continue as a going concern. Lordstown has engaged a search firm to find replacements for Burns and Rodriguez. Shares tumbled 8% in the premarket.</p>\n<p><b>Phillips(PHG)</b> – Phillips shares slid 4.3% in premarket action after saying it would recall up to 4 million CPAP machines due to potential toxicity risks. The foam used in the sleep apnea treatment devices could degrade and potentially become toxic. The Dutch medical equipment company is the largest producer of CPAP machines.</p>\n<p><b>Chipotle Mexican Grill(CMG)</b> – Raymond James upgraded the restaurant chain’s shares to “strong buy” from “outperform”, predicting that recent menu price increases would push second-half profit well beyond consensus forecasts. Chipotle shares gained 1.4% in the premarket.</p>\n<p><b>Ferrari(RACE)</b> – Goldman Sachs gave the automaker’s stock a double downgrade, moving its rating to “sell” from “buy”, noting increased capital spending and a limited scope for positive earnings revisions. Ferrari fell 2.7% in the premarket.</p>\n<p><b>GlaxoSmithKline(GSK)</b> – The drugmaker is collaborating with clinical-stage biopharmaceutical companyiTeos Therapeutics(ITOS) to develop and commercialize EOS-448, a monoclonal antibody in early-stage development as a possible cancer treatment. iTeos soared 60.4% in the premarket.</p>\n<p><b>AstraZeneca(AZN) </b>– The drugmaker’s Covid-19 vaccine has a favorable risk/reward profile for all age groups and particularly for those 60 years and older, according to the head of the European Medicines Agency’s Covid-19 task force. Marco Cavaleri said his quote in an Italian newspaper saying the vaccine should not be given to those over 60 was not interpreted correctly.</p>\n<p><b>Royal Dutch Shell(RDS.A)</b> – The energy giant is considering a sale of shale assets in Texas, according to people familiar with the matter who spoke to Reuters. Such a could be worth more than $10 billion. Shares gained 2% in premarket trading.</p>\n<p><b>Oatly(OTLY) </b>– The oat milk maker received a mixed batch of initial ratings from a handful of investment firms. Oatly received ratings of “perform” (Oppenheimer), “outperform” (Credit Suisse), “equal-weight” (Morgan Stanley), “overweight” (Piper Sandler), “buy” (Jefferies, Guggenheim), “neutral” (JPMorgan Chase) and “sector perform” (RBC Capital). All agree on growth prospects for Oatly – but some firms feel those prospects are already priced into the stock.</p>\n<p><b>Qualcomm(QCOM)</b> – Qualcomm is prepared to invest in UK chipmaker Arm if its $40 billion deal to be acquired byNvidia(NVDA) is blocked by regulators, according to the Telegraph newspaper quoting CEO Cristiano Amon.</p>\n<p><b>Equinix(EQIX)</b> – Equinix struck a deal for additional joint ventures with Singapore’s sovereign wealth fund to expand its data center operations there. The deal will see the fund invest an additional $3.9 billion, bringing the total investment to more than $6.9 billion.</p>\n<p><b>NextGen Acquisition(NGAC) </b>– The special purpose acquisition company is in advanced talks to take Sir Richard Branson’s Virgin Orbit public, according to Sky News. Sky said a deal valuing Virgin Orbit at about $3 billion could be announced within the coming weeks. NextGen shares gained 1.9% in the premarket.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OTLY":"Oatly Group AB","PHG":"飞利浦","RACE":"法拉利","QCOM":"高通","AZN":"阿斯利康","CMG":"墨式烧烤","RDS.A":"荷兰皇家壳牌石油A类股","NVAX":"诺瓦瓦克斯医药","GSK":"葛兰素史克","EQIX":"易昆尼克斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172057691","content_text":"U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a week that includes a keenly-awaited Federal Reserve meeting.\nAt 7 AM ET (1200 GMT), the Dow futures contract was up just 5 points, or less than 0.1%, S&P 500 futures traded 3 points, or 0.1%, higher, and Nasdaq 100 futures climbed 50 points, or 0.3%.\nThe three major indices closed just higher Friday, with the broad-based S&P 500 ending up 0.2%, at a new record high. The blue-chip Dow gained under 0.1% while the tech-heavy Nasdaq Composite closed 0.4% higher, helped by a rotation back into growth names.\nThe Fed’s two-day policy meeting, ending Wednesday, will likely limit activity in the early part of the week. The central bank is not expected to take any immediate action, but investors will be focusing on the statement to see whether the policy makers open discussions about how and when to taper the $120 billion in monthly central bank bond purchases.\nCrude oil prices pushed higher Monday, trading near multi-year highs, helped by an improved outlook for demand as increased Covid-19 vaccinations push global travel back to near normalcy.\nU.S. daily air travelers have topped 2 million for the first time since the pandemic began with traffic returning to pre-pandemic levels in North America and much of Europe as lockdowns and other restrictions are being eased, although the U.K. could throw a spanner in the works later Monday.\nStocks making the biggest moves in the premarket:\nNovavax(NVAX) – The drugmaker said its Covid-19 vaccine proved 90% effective overall in a late-stage trial, and 93% effective against the most predominant variants of the virus. It also provided 100% protection against moderate and severe disease. Novavax shares surged 10.4% in premarket trading.\nLordstown Motors(RIDE) – The electric truck maker announced the resignation of CEO Steve Burns and CFO Julio Rodriguez, days after the company warned there was doubt it could continue as a going concern. Lordstown has engaged a search firm to find replacements for Burns and Rodriguez. Shares tumbled 8% in the premarket.\nPhillips(PHG) – Phillips shares slid 4.3% in premarket action after saying it would recall up to 4 million CPAP machines due to potential toxicity risks. The foam used in the sleep apnea treatment devices could degrade and potentially become toxic. The Dutch medical equipment company is the largest producer of CPAP machines.\nChipotle Mexican Grill(CMG) – Raymond James upgraded the restaurant chain’s shares to “strong buy” from “outperform”, predicting that recent menu price increases would push second-half profit well beyond consensus forecasts. Chipotle shares gained 1.4% in the premarket.\nFerrari(RACE) – Goldman Sachs gave the automaker’s stock a double downgrade, moving its rating to “sell” from “buy”, noting increased capital spending and a limited scope for positive earnings revisions. Ferrari fell 2.7% in the premarket.\nGlaxoSmithKline(GSK) – The drugmaker is collaborating with clinical-stage biopharmaceutical companyiTeos Therapeutics(ITOS) to develop and commercialize EOS-448, a monoclonal antibody in early-stage development as a possible cancer treatment. iTeos soared 60.4% in the premarket.\nAstraZeneca(AZN) – The drugmaker’s Covid-19 vaccine has a favorable risk/reward profile for all age groups and particularly for those 60 years and older, according to the head of the European Medicines Agency’s Covid-19 task force. Marco Cavaleri said his quote in an Italian newspaper saying the vaccine should not be given to those over 60 was not interpreted correctly.\nRoyal Dutch Shell(RDS.A) – The energy giant is considering a sale of shale assets in Texas, according to people familiar with the matter who spoke to Reuters. Such a could be worth more than $10 billion. Shares gained 2% in premarket trading.\nOatly(OTLY) – The oat milk maker received a mixed batch of initial ratings from a handful of investment firms. Oatly received ratings of “perform” (Oppenheimer), “outperform” (Credit Suisse), “equal-weight” (Morgan Stanley), “overweight” (Piper Sandler), “buy” (Jefferies, Guggenheim), “neutral” (JPMorgan Chase) and “sector perform” (RBC Capital). All agree on growth prospects for Oatly – but some firms feel those prospects are already priced into the stock.\nQualcomm(QCOM) – Qualcomm is prepared to invest in UK chipmaker Arm if its $40 billion deal to be acquired byNvidia(NVDA) is blocked by regulators, according to the Telegraph newspaper quoting CEO Cristiano Amon.\nEquinix(EQIX) – Equinix struck a deal for additional joint ventures with Singapore’s sovereign wealth fund to expand its data center operations there. The deal will see the fund invest an additional $3.9 billion, bringing the total investment to more than $6.9 billion.\nNextGen Acquisition(NGAC) – The special purpose acquisition company is in advanced talks to take Sir Richard Branson’s Virgin Orbit public, according to Sky News. Sky said a deal valuing Virgin Orbit at about $3 billion could be announced within the coming weeks. NextGen shares gained 1.9% in the premarket.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578225630518844","authorId":"3578225630518844","name":"JackOATrades","avatar":"https://static.tigerbbs.com/a864e0513924ced47472353efa85e296","crmLevel":1,"crmLevelSwitch":0,"idStr":"3578225630518844","authorIdStr":"3578225630518844"},"content":"comment n like 2","text":"comment n like 2","html":"comment n like 2"}],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":895097468,"gmtCreate":1628693043254,"gmtModify":1676529824211,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Good to know... what do you think..","listText":"Good to know... what do you think..","text":"Good to know... what do you think..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/895097468","repostId":"2158808282","repostType":4,"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573260715066065","authorId":"3573260715066065","name":"LewisLewis","avatar":"https://static.tigerbbs.com/61c148b5b38fd33489bc18824afe097c","crmLevel":8,"crmLevelSwitch":0,"authorIdStr":"3573260715066065","idStr":"3573260715066065"},"content":"Like back thanks","text":"Like back thanks","html":"Like back thanks"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":177126889,"gmtCreate":1627188416941,"gmtModify":1703485328012,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Great to know.like and comment","listText":"Great to know.like and comment","text":"Great to know.like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/177126889","repostId":"1112927800","repostType":4,"repost":{"id":"1112927800","kind":"news","pubTimestamp":1627089375,"share":"https://ttm.financial/m/news/1112927800?lang=&edition=fundamental","pubTime":"2021-07-24 09:16","market":"us","language":"en","title":"Will NIO Stock Follow Tesla's Footsteps? What To Consider Between These Two EV Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1112927800","media":"seekingalpha","summary":"Let's take a look at how NIO compares to Tesla today, NIO's unique selling points, and the similarities between the two companies.NIO is a high-growth choice that does not seem overly expensive relative to how Tesla is valued.NIO is not a low-risk stock, however, and it may not be a good choice for everyone. Investors should also consider NIO's valuation versus legacy car companies.Both companies have benefitted from growing interest in EVs during 2020, a trend that saw share prices of most EV p","content":"<p><b>Summary</b></p>\n<ul>\n <li>Let's take a look at how NIO compares to Tesla today, NIO's unique selling points, and the similarities between the two companies.</li>\n <li>NIO is a high-growth choice that does not seem overly expensive relative to how Tesla is valued.</li>\n <li>NIO is not a low-risk stock, however, and it may not be a good choice for everyone. Investors should also consider NIO's valuation versus legacy car companies.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2f749c70c8a2af3e18d5f6cecc72bfbb\" tg-width=\"1536\" tg-height=\"704\" referrerpolicy=\"no-referrer\"><span>ipopba/iStock via Getty Images</span></p>\n<p><b>Article Thesis</b></p>\n<p>NIO, Inc. (NIO) is one of China's leading EV players, and has, through an attractive brand and its unique BaaS offering, attracted a lot of interest from consumers and investors. Today, however, the company is still way smaller than Tesla (TSLA), which is currently leading the global EV market. NIO is focused on its home market right now, which was true when Tesla was a smaller company as well, but NIO will try to grab market share in overseas markets as well. Shares are pricing in a lot of growth already, but if NIO can replicate Tesla's success, that could be more than justified.</p>\n<p><b>NIO And TSLA Stock Prices</b></p>\n<p>Both companies have benefitted from growing interest in EVs during 2020, a trend that saw share prices of most EV pureplays rise rapidly. The combination of growing market share for EVs, accommodating policies such as subsidies for EV purchases, and massive monetary stimulus let shares of NIO and TSLA rise rapidly. NIO is up 245% over the last year, while TSLA is up 101% over the same time. Both companies are currently trading below their all-time highs, however, which were hit in early 2021 before market sentiment for EV pureplays cooled to some degree.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5ff5ce865807df85283775d2293b41af\" tg-width=\"635\" tg-height=\"481\" referrerpolicy=\"no-referrer\"><span>Data by YCharts</span></p>\n<p>Taking a quick look at analyst price targets, we see that Tesla is trading almost perfectly in line with the consensus, whereas NIO trades about 30% below the analyst target. If the analyst community is right, then NIO is a substantially better investment right here, as Tesla is not expected to see its shares rise meaningfully over the next year, whereas NIO has significant upside to the analyst price target.</p>\n<p><b>Is NIO Similar To Tesla?</b></p>\n<p>The answer to that question depends on what you focus on. There are similarities between the two companies, but there are also differences. One could thus say that, in some ways, the two are similar, but in others, they are not. Let's look at a couple of things:</p>\n<p><b>Business Model</b></p>\n<p>Both companies are focused on the EV space, although Tesla has, over the years, been building out a couple of other businesses as well, such as energy storage. Most of Tesla's revenues are generated through selling electric vehicles, which is also how NIO operates. Both companies are focused on the premium segment of EVs, selling higher-priced vehicles that compete with brands such as BMW, Mercedes, and Lexus. Both companies offer a small range of different vehicles, in Tesla's case those are the well-known S, X, 3, and Y, whereas NIO offers a sedan (ET7), and three SUVs (EC6, ES6, ES8). Despite the fact that NIO is a way smaller company today, the model lineups of the two companies do thus not differ too much.</p>\n<p>Both companies offer some type of charging infrastructure to their customers, in Tesla's case, that's the Supercharger network, where Tesla owners can charge their cars with up to 250kW, depending on what version of Supercharger is installed. NIO is following a different approach, offering a battery-as-a-service solution to its customers. NIO owners can get their battery switched out to a fully-charged battery at NIO's stations, a process that takes a couple of minutes and is thus significantly quicker compared to the regular EV charging offered by Tesla and other EV players. BaaS thus has advantages when it comes to the time it takes for a charge/swap, but it should be noted that Tesla's Superchargers are way more common around the world compared to NIO's battery-swapping stations. Rolling out that feature in additional markets will require large capital expenditures, but NIO's offering is a unique selling point compared to what all other EV players, including Tesla, are offering. It remains to be seen whether that will ultimately pay off, but this could become a major advantage for NIO as competition in the EV space is heating up.</p>\n<p><b>Size, growth, and valuation</b></p>\n<p>The two companies differ significantly in size, both when it comes to revenues and vehicle sales, as well as when it comes to the market value of the two companies. NIO has delivered22,000 vehicles in Q2, up 112% year over year, for an annual pace of around 90,000 vehicles. Tesla, meanwhile, has delivered 201,000 vehicles during Q2, up from 103,000 vehicles delivered during Q2 2020. This is strong growth on a year-over-year basis, although slightly below 100%, and thus below the growth rate that NIO is generating for now.</p>\n<p>Tesla delivers around 9x as many vehicles compared to NIO per quarter, when we look at the market capitalizations of the two companies, we see that the ratio is almost exactly the same, as Tesla's market cap of $640 billion is ~9x as high as that of NIO, at $72 billion. At similar growth rates, that would make perfect sense, but it looks like NIO might be the better deal for now, as it trades at a comparable valuation while generating better growth. This will be especially true in the coming quarters, where Tesla's growth is expected to slow down:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a986ea65130206f99961a46ce6cfed55\" tg-width=\"635\" tg-height=\"515\" referrerpolicy=\"no-referrer\"><span>Data by YCharts</span></p>\n<p>Tesla is forecasted to grow its revenue from $49 billion in 2021 to $83 billion in 2023, for an annual growth rate of 30%. NIO, meanwhile, is expected to see its revenue explode upwards from $5.4 billion to $12.8 billion between 2021 and 2023, for an annual growth rate of 54%. NIO is thus expected to grow way faster than Tesla over the next two years, on a relative basis. This shouldn't be a surprise, to be honest, as the law of large numbers dictates that maintaining massive growth rates becomes increasingly hard for a company the bigger it gets, and Tesla seems to have hit that point by now -- adding 50%+ a year to its top line will not be possible forever. This isn't even necessarily Tesla's fault, in fact, many high-quality growth companies have experienced the same. But investors should still consider this important fact -- Tesla's growth in coming years will be less exciting compared to what we have seen in the past, and peers, such as NIO, are growing faster.</p>\n<p>The same holds true when we take a longer-term view. Revenue estimates for 2025 rest at$22.6 billionfor NIO, up another 80% from the 2023 estimate, and up 320% from what analysts are forecasting for 2021. Tesla, meanwhile, is forecasted to generate revenues of $122.5 billion in 2025 -- a large number, but up by a comparatively weak 48% from 2023, and up by a total of 150% versus 2021. Between 2021 and 2025, NIO will thus 4x its revenue, while Tesla will 2.5x its revenue in the same time span -- a meaningful difference that should, all else equal, allow for a premium valuation for NIO, in the same way Tesla deserves a premium valuation versus legacy players such as Volkswagen (OTCPK:VWAGY).</p>\n<p>Looking at revenue estimates for 2025 relative to how the two companies are valued today, we see that NIO trades at 3.2x 2025 sales, while the 2025 sales multiple for Tesla is 5.2. For a long-term oriented investor, NIO thus seems like the better value today, thanks to the fact that it is trading at a significantly lower sales multiple when we take a look into the future. This does not necessarily mean that NIO is cheap, however, as even a 3.2x 2025 sales multiple is relatively high compared to how legacy auto companies are valued. NIO is looking less expensive than Tesla, however, even if its shares are not cheap on an absolute basis.</p>\n<p><b>Can NIO Be Worth As Much As Tesla?</b></p>\n<p>The answer to that depends on what time frame you are looking at. Today, NIO is significantly smaller than Tesla and thus rightfully trades at a way smaller market cap. It should also be noted that there is no guarantee that Tesla's shares are a great example of how an EV company should be valued -- it is, at least, possible that its shares are significantly&nbsp;overpriced&nbsp;today, I personally believe that as well (Note that some will argue that shares are&nbsp;underpriced, which is also among the possibilities, although I do not hold that belief personally).</p>\n<p>When we do, for a moment, assume that Tesla is correctly valued today and that EV companies do deserve a market cap in the $600 billion range when they sell about 800,000 vehicles a year, then NIO could eventually hit that as well, although not in the near term. NIO will sell about 90,000 vehicles this year, and that amount should grow to about 400,000 in 2025. If NIO were to grow its sales by 15% a year beyond that point, it could sell around 800,000 cars in 2030, or 9 years from now. If one wants to assume faster growth, the 800,000 vehicles a year line could also be crossed before 2030, e.g. in 2028 or 2029. If we do go with 2030 for now, then NIO could, at a similar deliveries-to-market capitalization ratio to Tesla, be valued at $600+ billion in 2030. In other words, NIO could be worth as much as Tesla (today) in nine years, when we assume that current growth projections are realistic and that a Tesla-like valuation is appropriate. Those are two major ifs, of course, and especially the second point is far from certain, I believe. I personally would not be too surprised to see Tesla's valuation compress, and thus NIO could trade well below the $600 billion market cap level in 2030, even if it continues to grow meaningfully. It is also possible that NIO's growth disappoints and that current projections are too bullish, although I think that NIO is well-positioned for growth thanks to its unique BaaS model and its strong brand that is especially well-recognized in its home market.</p>\n<p>It should also be noted that Tesla's market cap in 2030 could be very different from $600 billion, thus even in case NIO hits that level, it is not at all guaranteed that the two companies will have a similar market cap. Tesla might be valued at a way higher valuation by then, e.g. if the ARK model is right (something I personally think is unlikely). To answer the above question, one could thus say that NIO might be worth hundreds of billions of dollars, like Tesla, in 8-10 years, but that is not at all guaranteed. And even if that were to happen, Tesla might be worth significantly more by then.</p>\n<p><b>Is NIO A Good Stock To Buy Or Sell Now?</b></p>\n<p>When considering NIO as an investment, it doesn't really matter all that much whether it will become as large or highly valued as Tesla eventually. Instead, investors should ask themselves what total returns they can expect over the next couple of years, and whether those expected returns are high enough relative to the risks in NIO's business model. Regarding those risks, one should mention the fact that the company isn't profitable yet, which means that NIO is dependent on cash on its balance sheet for growth investments. On top of that, competition in the EV space is growing, and market share battles could pressure margins in coming years, although NIO seems relatively well-positioned thanks to its battery-swapping, which is, I believe, a strong USP. Last but not least, the company's dependence on its home market China is a potential risk that should be kept in mind, although it should also be noted that, for now, it seems like the Chinese government is very accommodating to Chinese EV companies.</p>\n<p>One could argue that valuations across the whole EV industry are too high, relative to how legacy auto companies are valued. Even those legacy players with attractive EV offerings such as Volkswagen or Ford trade at huge discounts compared to EV pureplays. But if one wants to invest in an EV pureplay, NIO doesn't seem like a bad choice. The company combines a strong brand, a unique BaaS offering, high growth rates, and shares trade at a discount compared to how the EV king Tesla is valued. At a little above 3x 2025 revenue, NIO does not seem overly expensive relative to other EV pureplays, although this still represents a premium versus legacy players, of course. If NIO manages to execute well and continues to roll out new models that are well-received by consumers, its shares could have significant upside potential in the long run. If EV stocks ever become an out-of-favor investment, NIO stock also could have considerable downside, however, this thus is not a low-risk pick. Depending on your risk tolerance, NIO could still be of value if you want a high-growth EV pureplay.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will NIO Stock Follow Tesla's Footsteps? What To Consider Between These Two EV Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill NIO Stock Follow Tesla's Footsteps? What To Consider Between These Two EV Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-24 09:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4440950-will-nio-stock-follow-tesla-what-to-consider-ev-stocks><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nLet's take a look at how NIO compares to Tesla today, NIO's unique selling points, and the similarities between the two companies.\nNIO is a high-growth choice that does not seem overly ...</p>\n\n<a href=\"https://seekingalpha.com/article/4440950-will-nio-stock-follow-tesla-what-to-consider-ev-stocks\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4440950-will-nio-stock-follow-tesla-what-to-consider-ev-stocks","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112927800","content_text":"Summary\n\nLet's take a look at how NIO compares to Tesla today, NIO's unique selling points, and the similarities between the two companies.\nNIO is a high-growth choice that does not seem overly expensive relative to how Tesla is valued.\nNIO is not a low-risk stock, however, and it may not be a good choice for everyone. Investors should also consider NIO's valuation versus legacy car companies.\n\nipopba/iStock via Getty Images\nArticle Thesis\nNIO, Inc. (NIO) is one of China's leading EV players, and has, through an attractive brand and its unique BaaS offering, attracted a lot of interest from consumers and investors. Today, however, the company is still way smaller than Tesla (TSLA), which is currently leading the global EV market. NIO is focused on its home market right now, which was true when Tesla was a smaller company as well, but NIO will try to grab market share in overseas markets as well. Shares are pricing in a lot of growth already, but if NIO can replicate Tesla's success, that could be more than justified.\nNIO And TSLA Stock Prices\nBoth companies have benefitted from growing interest in EVs during 2020, a trend that saw share prices of most EV pureplays rise rapidly. The combination of growing market share for EVs, accommodating policies such as subsidies for EV purchases, and massive monetary stimulus let shares of NIO and TSLA rise rapidly. NIO is up 245% over the last year, while TSLA is up 101% over the same time. Both companies are currently trading below their all-time highs, however, which were hit in early 2021 before market sentiment for EV pureplays cooled to some degree.\nData by YCharts\nTaking a quick look at analyst price targets, we see that Tesla is trading almost perfectly in line with the consensus, whereas NIO trades about 30% below the analyst target. If the analyst community is right, then NIO is a substantially better investment right here, as Tesla is not expected to see its shares rise meaningfully over the next year, whereas NIO has significant upside to the analyst price target.\nIs NIO Similar To Tesla?\nThe answer to that question depends on what you focus on. There are similarities between the two companies, but there are also differences. One could thus say that, in some ways, the two are similar, but in others, they are not. Let's look at a couple of things:\nBusiness Model\nBoth companies are focused on the EV space, although Tesla has, over the years, been building out a couple of other businesses as well, such as energy storage. Most of Tesla's revenues are generated through selling electric vehicles, which is also how NIO operates. Both companies are focused on the premium segment of EVs, selling higher-priced vehicles that compete with brands such as BMW, Mercedes, and Lexus. Both companies offer a small range of different vehicles, in Tesla's case those are the well-known S, X, 3, and Y, whereas NIO offers a sedan (ET7), and three SUVs (EC6, ES6, ES8). Despite the fact that NIO is a way smaller company today, the model lineups of the two companies do thus not differ too much.\nBoth companies offer some type of charging infrastructure to their customers, in Tesla's case, that's the Supercharger network, where Tesla owners can charge their cars with up to 250kW, depending on what version of Supercharger is installed. NIO is following a different approach, offering a battery-as-a-service solution to its customers. NIO owners can get their battery switched out to a fully-charged battery at NIO's stations, a process that takes a couple of minutes and is thus significantly quicker compared to the regular EV charging offered by Tesla and other EV players. BaaS thus has advantages when it comes to the time it takes for a charge/swap, but it should be noted that Tesla's Superchargers are way more common around the world compared to NIO's battery-swapping stations. Rolling out that feature in additional markets will require large capital expenditures, but NIO's offering is a unique selling point compared to what all other EV players, including Tesla, are offering. It remains to be seen whether that will ultimately pay off, but this could become a major advantage for NIO as competition in the EV space is heating up.\nSize, growth, and valuation\nThe two companies differ significantly in size, both when it comes to revenues and vehicle sales, as well as when it comes to the market value of the two companies. NIO has delivered22,000 vehicles in Q2, up 112% year over year, for an annual pace of around 90,000 vehicles. Tesla, meanwhile, has delivered 201,000 vehicles during Q2, up from 103,000 vehicles delivered during Q2 2020. This is strong growth on a year-over-year basis, although slightly below 100%, and thus below the growth rate that NIO is generating for now.\nTesla delivers around 9x as many vehicles compared to NIO per quarter, when we look at the market capitalizations of the two companies, we see that the ratio is almost exactly the same, as Tesla's market cap of $640 billion is ~9x as high as that of NIO, at $72 billion. At similar growth rates, that would make perfect sense, but it looks like NIO might be the better deal for now, as it trades at a comparable valuation while generating better growth. This will be especially true in the coming quarters, where Tesla's growth is expected to slow down:\nData by YCharts\nTesla is forecasted to grow its revenue from $49 billion in 2021 to $83 billion in 2023, for an annual growth rate of 30%. NIO, meanwhile, is expected to see its revenue explode upwards from $5.4 billion to $12.8 billion between 2021 and 2023, for an annual growth rate of 54%. NIO is thus expected to grow way faster than Tesla over the next two years, on a relative basis. This shouldn't be a surprise, to be honest, as the law of large numbers dictates that maintaining massive growth rates becomes increasingly hard for a company the bigger it gets, and Tesla seems to have hit that point by now -- adding 50%+ a year to its top line will not be possible forever. This isn't even necessarily Tesla's fault, in fact, many high-quality growth companies have experienced the same. But investors should still consider this important fact -- Tesla's growth in coming years will be less exciting compared to what we have seen in the past, and peers, such as NIO, are growing faster.\nThe same holds true when we take a longer-term view. Revenue estimates for 2025 rest at$22.6 billionfor NIO, up another 80% from the 2023 estimate, and up 320% from what analysts are forecasting for 2021. Tesla, meanwhile, is forecasted to generate revenues of $122.5 billion in 2025 -- a large number, but up by a comparatively weak 48% from 2023, and up by a total of 150% versus 2021. Between 2021 and 2025, NIO will thus 4x its revenue, while Tesla will 2.5x its revenue in the same time span -- a meaningful difference that should, all else equal, allow for a premium valuation for NIO, in the same way Tesla deserves a premium valuation versus legacy players such as Volkswagen (OTCPK:VWAGY).\nLooking at revenue estimates for 2025 relative to how the two companies are valued today, we see that NIO trades at 3.2x 2025 sales, while the 2025 sales multiple for Tesla is 5.2. For a long-term oriented investor, NIO thus seems like the better value today, thanks to the fact that it is trading at a significantly lower sales multiple when we take a look into the future. This does not necessarily mean that NIO is cheap, however, as even a 3.2x 2025 sales multiple is relatively high compared to how legacy auto companies are valued. NIO is looking less expensive than Tesla, however, even if its shares are not cheap on an absolute basis.\nCan NIO Be Worth As Much As Tesla?\nThe answer to that depends on what time frame you are looking at. Today, NIO is significantly smaller than Tesla and thus rightfully trades at a way smaller market cap. It should also be noted that there is no guarantee that Tesla's shares are a great example of how an EV company should be valued -- it is, at least, possible that its shares are significantly overpriced today, I personally believe that as well (Note that some will argue that shares are underpriced, which is also among the possibilities, although I do not hold that belief personally).\nWhen we do, for a moment, assume that Tesla is correctly valued today and that EV companies do deserve a market cap in the $600 billion range when they sell about 800,000 vehicles a year, then NIO could eventually hit that as well, although not in the near term. NIO will sell about 90,000 vehicles this year, and that amount should grow to about 400,000 in 2025. If NIO were to grow its sales by 15% a year beyond that point, it could sell around 800,000 cars in 2030, or 9 years from now. If one wants to assume faster growth, the 800,000 vehicles a year line could also be crossed before 2030, e.g. in 2028 or 2029. If we do go with 2030 for now, then NIO could, at a similar deliveries-to-market capitalization ratio to Tesla, be valued at $600+ billion in 2030. In other words, NIO could be worth as much as Tesla (today) in nine years, when we assume that current growth projections are realistic and that a Tesla-like valuation is appropriate. Those are two major ifs, of course, and especially the second point is far from certain, I believe. I personally would not be too surprised to see Tesla's valuation compress, and thus NIO could trade well below the $600 billion market cap level in 2030, even if it continues to grow meaningfully. It is also possible that NIO's growth disappoints and that current projections are too bullish, although I think that NIO is well-positioned for growth thanks to its unique BaaS model and its strong brand that is especially well-recognized in its home market.\nIt should also be noted that Tesla's market cap in 2030 could be very different from $600 billion, thus even in case NIO hits that level, it is not at all guaranteed that the two companies will have a similar market cap. Tesla might be valued at a way higher valuation by then, e.g. if the ARK model is right (something I personally think is unlikely). To answer the above question, one could thus say that NIO might be worth hundreds of billions of dollars, like Tesla, in 8-10 years, but that is not at all guaranteed. And even if that were to happen, Tesla might be worth significantly more by then.\nIs NIO A Good Stock To Buy Or Sell Now?\nWhen considering NIO as an investment, it doesn't really matter all that much whether it will become as large or highly valued as Tesla eventually. Instead, investors should ask themselves what total returns they can expect over the next couple of years, and whether those expected returns are high enough relative to the risks in NIO's business model. Regarding those risks, one should mention the fact that the company isn't profitable yet, which means that NIO is dependent on cash on its balance sheet for growth investments. On top of that, competition in the EV space is growing, and market share battles could pressure margins in coming years, although NIO seems relatively well-positioned thanks to its battery-swapping, which is, I believe, a strong USP. Last but not least, the company's dependence on its home market China is a potential risk that should be kept in mind, although it should also be noted that, for now, it seems like the Chinese government is very accommodating to Chinese EV companies.\nOne could argue that valuations across the whole EV industry are too high, relative to how legacy auto companies are valued. Even those legacy players with attractive EV offerings such as Volkswagen or Ford trade at huge discounts compared to EV pureplays. But if one wants to invest in an EV pureplay, NIO doesn't seem like a bad choice. The company combines a strong brand, a unique BaaS offering, high growth rates, and shares trade at a discount compared to how the EV king Tesla is valued. At a little above 3x 2025 revenue, NIO does not seem overly expensive relative to other EV pureplays, although this still represents a premium versus legacy players, of course. If NIO manages to execute well and continues to roll out new models that are well-received by consumers, its shares could have significant upside potential in the long run. If EV stocks ever become an out-of-favor investment, NIO stock also could have considerable downside, however, this thus is not a low-risk pick. Depending on your risk tolerance, NIO could still be of value if you want a high-growth EV pureplay.","news_type":1},"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129108675,"gmtCreate":1624362915697,"gmtModify":1703834395203,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Good analysis , like and comment","listText":"Good analysis , like and comment","text":"Good analysis , like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/129108675","repostId":"1169318799","repostType":4,"isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159728190,"gmtCreate":1624981072510,"gmtModify":1703849498665,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Good.to.read. like and comment please","listText":"Good.to.read. like and comment please","text":"Good.to.read. like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/159728190","repostId":"1172874030","repostType":4,"isVote":1,"tweetType":1,"viewCount":463,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3586198471249922","authorId":"3586198471249922","name":"EmmaS","avatar":"https://static.tigerbbs.com/41fa8b7739afa8f029d077d18c6201ab","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586198471249922","idStr":"3586198471249922"},"content":"done. Like and comment pls","text":"done. Like and comment pls","html":"done. Like and comment pls"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185765334,"gmtCreate":1623674221028,"gmtModify":1704208317949,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Like and comment please","listText":"Like and comment please","text":"Like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/185765334","repostId":"1172057691","repostType":4,"repost":{"id":"1172057691","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623672122,"share":"https://ttm.financial/m/news/1172057691?lang=&edition=fundamental","pubTime":"2021-06-14 20:02","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1172057691","media":"Tiger Newspress","summary":"U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a ","content":"<p>U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a week that includes a keenly-awaited Federal Reserve meeting.</p>\n<p>At 7 AM ET (1200 GMT), the Dow futures contract was up just 5 points, or less than 0.1%, S&amp;P 500 futures traded 3 points, or 0.1%, higher, and Nasdaq 100 futures climbed 50 points, or 0.3%.</p>\n<p>The three major indices closed just higher Friday, with the broad-based S&amp;P 500 ending up 0.2%, at a new record high. The blue-chip Dow gained under 0.1% while the tech-heavy Nasdaq Composite closed 0.4% higher, helped by a rotation back into growth names.</p>\n<p>The Fed’s two-day policy meeting, ending Wednesday, will likely limit activity in the early part of the week. The central bank is not expected to take any immediate action, but investors will be focusing on the statement to see whether the policy makers open discussions about how and when to taper the $120 billion in monthly central bank bond purchases.</p>\n<p>Crude oil prices pushed higher Monday, trading near multi-year highs, helped by an improved outlook for demand as increased Covid-19 vaccinations push global travel back to near normalcy.</p>\n<p>U.S. daily air travelers have topped 2 million for the first time since the pandemic began with traffic returning to pre-pandemic levels in North America and much of Europe as lockdowns and other restrictions are being eased, although the U.K. could throw a spanner in the works later Monday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Novavax(NVAX)</b> – The drugmaker said its Covid-19 vaccine proved 90% effective overall in a late-stage trial, and 93% effective against the most predominant variants of the virus. It also provided 100% protection against moderate and severe disease. Novavax shares surged 10.4% in premarket trading.</p>\n<p><b>Lordstown Motors(RIDE) </b>– The electric truck maker announced the resignation of CEO Steve Burns and CFO Julio Rodriguez, days after the company warned there was doubt it could continue as a going concern. Lordstown has engaged a search firm to find replacements for Burns and Rodriguez. Shares tumbled 8% in the premarket.</p>\n<p><b>Phillips(PHG)</b> – Phillips shares slid 4.3% in premarket action after saying it would recall up to 4 million CPAP machines due to potential toxicity risks. The foam used in the sleep apnea treatment devices could degrade and potentially become toxic. The Dutch medical equipment company is the largest producer of CPAP machines.</p>\n<p><b>Chipotle Mexican Grill(CMG)</b> – Raymond James upgraded the restaurant chain’s shares to “strong buy” from “outperform”, predicting that recent menu price increases would push second-half profit well beyond consensus forecasts. Chipotle shares gained 1.4% in the premarket.</p>\n<p><b>Ferrari(RACE)</b> – Goldman Sachs gave the automaker’s stock a double downgrade, moving its rating to “sell” from “buy”, noting increased capital spending and a limited scope for positive earnings revisions. Ferrari fell 2.7% in the premarket.</p>\n<p><b>GlaxoSmithKline(GSK)</b> – The drugmaker is collaborating with clinical-stage biopharmaceutical companyiTeos Therapeutics(ITOS) to develop and commercialize EOS-448, a monoclonal antibody in early-stage development as a possible cancer treatment. iTeos soared 60.4% in the premarket.</p>\n<p><b>AstraZeneca(AZN) </b>– The drugmaker’s Covid-19 vaccine has a favorable risk/reward profile for all age groups and particularly for those 60 years and older, according to the head of the European Medicines Agency’s Covid-19 task force. Marco Cavaleri said his quote in an Italian newspaper saying the vaccine should not be given to those over 60 was not interpreted correctly.</p>\n<p><b>Royal Dutch Shell(RDS.A)</b> – The energy giant is considering a sale of shale assets in Texas, according to people familiar with the matter who spoke to Reuters. Such a could be worth more than $10 billion. Shares gained 2% in premarket trading.</p>\n<p><b>Oatly(OTLY) </b>– The oat milk maker received a mixed batch of initial ratings from a handful of investment firms. Oatly received ratings of “perform” (Oppenheimer), “outperform” (Credit Suisse), “equal-weight” (Morgan Stanley), “overweight” (Piper Sandler), “buy” (Jefferies, Guggenheim), “neutral” (JPMorgan Chase) and “sector perform” (RBC Capital). All agree on growth prospects for Oatly – but some firms feel those prospects are already priced into the stock.</p>\n<p><b>Qualcomm(QCOM)</b> – Qualcomm is prepared to invest in UK chipmaker Arm if its $40 billion deal to be acquired byNvidia(NVDA) is blocked by regulators, according to the Telegraph newspaper quoting CEO Cristiano Amon.</p>\n<p><b>Equinix(EQIX)</b> – Equinix struck a deal for additional joint ventures with Singapore’s sovereign wealth fund to expand its data center operations there. The deal will see the fund invest an additional $3.9 billion, bringing the total investment to more than $6.9 billion.</p>\n<p><b>NextGen Acquisition(NGAC) </b>– The special purpose acquisition company is in advanced talks to take Sir Richard Branson’s Virgin Orbit public, according to Sky News. Sky said a deal valuing Virgin Orbit at about $3 billion could be announced within the coming weeks. NextGen shares gained 1.9% in the premarket.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-14 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a week that includes a keenly-awaited Federal Reserve meeting.</p>\n<p>At 7 AM ET (1200 GMT), the Dow futures contract was up just 5 points, or less than 0.1%, S&amp;P 500 futures traded 3 points, or 0.1%, higher, and Nasdaq 100 futures climbed 50 points, or 0.3%.</p>\n<p>The three major indices closed just higher Friday, with the broad-based S&amp;P 500 ending up 0.2%, at a new record high. The blue-chip Dow gained under 0.1% while the tech-heavy Nasdaq Composite closed 0.4% higher, helped by a rotation back into growth names.</p>\n<p>The Fed’s two-day policy meeting, ending Wednesday, will likely limit activity in the early part of the week. The central bank is not expected to take any immediate action, but investors will be focusing on the statement to see whether the policy makers open discussions about how and when to taper the $120 billion in monthly central bank bond purchases.</p>\n<p>Crude oil prices pushed higher Monday, trading near multi-year highs, helped by an improved outlook for demand as increased Covid-19 vaccinations push global travel back to near normalcy.</p>\n<p>U.S. daily air travelers have topped 2 million for the first time since the pandemic began with traffic returning to pre-pandemic levels in North America and much of Europe as lockdowns and other restrictions are being eased, although the U.K. could throw a spanner in the works later Monday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Novavax(NVAX)</b> – The drugmaker said its Covid-19 vaccine proved 90% effective overall in a late-stage trial, and 93% effective against the most predominant variants of the virus. It also provided 100% protection against moderate and severe disease. Novavax shares surged 10.4% in premarket trading.</p>\n<p><b>Lordstown Motors(RIDE) </b>– The electric truck maker announced the resignation of CEO Steve Burns and CFO Julio Rodriguez, days after the company warned there was doubt it could continue as a going concern. Lordstown has engaged a search firm to find replacements for Burns and Rodriguez. Shares tumbled 8% in the premarket.</p>\n<p><b>Phillips(PHG)</b> – Phillips shares slid 4.3% in premarket action after saying it would recall up to 4 million CPAP machines due to potential toxicity risks. The foam used in the sleep apnea treatment devices could degrade and potentially become toxic. The Dutch medical equipment company is the largest producer of CPAP machines.</p>\n<p><b>Chipotle Mexican Grill(CMG)</b> – Raymond James upgraded the restaurant chain’s shares to “strong buy” from “outperform”, predicting that recent menu price increases would push second-half profit well beyond consensus forecasts. Chipotle shares gained 1.4% in the premarket.</p>\n<p><b>Ferrari(RACE)</b> – Goldman Sachs gave the automaker’s stock a double downgrade, moving its rating to “sell” from “buy”, noting increased capital spending and a limited scope for positive earnings revisions. Ferrari fell 2.7% in the premarket.</p>\n<p><b>GlaxoSmithKline(GSK)</b> – The drugmaker is collaborating with clinical-stage biopharmaceutical companyiTeos Therapeutics(ITOS) to develop and commercialize EOS-448, a monoclonal antibody in early-stage development as a possible cancer treatment. iTeos soared 60.4% in the premarket.</p>\n<p><b>AstraZeneca(AZN) </b>– The drugmaker’s Covid-19 vaccine has a favorable risk/reward profile for all age groups and particularly for those 60 years and older, according to the head of the European Medicines Agency’s Covid-19 task force. Marco Cavaleri said his quote in an Italian newspaper saying the vaccine should not be given to those over 60 was not interpreted correctly.</p>\n<p><b>Royal Dutch Shell(RDS.A)</b> – The energy giant is considering a sale of shale assets in Texas, according to people familiar with the matter who spoke to Reuters. Such a could be worth more than $10 billion. Shares gained 2% in premarket trading.</p>\n<p><b>Oatly(OTLY) </b>– The oat milk maker received a mixed batch of initial ratings from a handful of investment firms. Oatly received ratings of “perform” (Oppenheimer), “outperform” (Credit Suisse), “equal-weight” (Morgan Stanley), “overweight” (Piper Sandler), “buy” (Jefferies, Guggenheim), “neutral” (JPMorgan Chase) and “sector perform” (RBC Capital). All agree on growth prospects for Oatly – but some firms feel those prospects are already priced into the stock.</p>\n<p><b>Qualcomm(QCOM)</b> – Qualcomm is prepared to invest in UK chipmaker Arm if its $40 billion deal to be acquired byNvidia(NVDA) is blocked by regulators, according to the Telegraph newspaper quoting CEO Cristiano Amon.</p>\n<p><b>Equinix(EQIX)</b> – Equinix struck a deal for additional joint ventures with Singapore’s sovereign wealth fund to expand its data center operations there. The deal will see the fund invest an additional $3.9 billion, bringing the total investment to more than $6.9 billion.</p>\n<p><b>NextGen Acquisition(NGAC) </b>– The special purpose acquisition company is in advanced talks to take Sir Richard Branson’s Virgin Orbit public, according to Sky News. Sky said a deal valuing Virgin Orbit at about $3 billion could be announced within the coming weeks. NextGen shares gained 1.9% in the premarket.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OTLY":"Oatly Group AB","PHG":"飞利浦","RACE":"法拉利","QCOM":"高通","AZN":"阿斯利康","CMG":"墨式烧烤","RDS.A":"荷兰皇家壳牌石油A类股","NVAX":"诺瓦瓦克斯医药","GSK":"葛兰素史克","EQIX":"易昆尼克斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172057691","content_text":"U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a week that includes a keenly-awaited Federal Reserve meeting.\nAt 7 AM ET (1200 GMT), the Dow futures contract was up just 5 points, or less than 0.1%, S&P 500 futures traded 3 points, or 0.1%, higher, and Nasdaq 100 futures climbed 50 points, or 0.3%.\nThe three major indices closed just higher Friday, with the broad-based S&P 500 ending up 0.2%, at a new record high. The blue-chip Dow gained under 0.1% while the tech-heavy Nasdaq Composite closed 0.4% higher, helped by a rotation back into growth names.\nThe Fed’s two-day policy meeting, ending Wednesday, will likely limit activity in the early part of the week. The central bank is not expected to take any immediate action, but investors will be focusing on the statement to see whether the policy makers open discussions about how and when to taper the $120 billion in monthly central bank bond purchases.\nCrude oil prices pushed higher Monday, trading near multi-year highs, helped by an improved outlook for demand as increased Covid-19 vaccinations push global travel back to near normalcy.\nU.S. daily air travelers have topped 2 million for the first time since the pandemic began with traffic returning to pre-pandemic levels in North America and much of Europe as lockdowns and other restrictions are being eased, although the U.K. could throw a spanner in the works later Monday.\nStocks making the biggest moves in the premarket:\nNovavax(NVAX) – The drugmaker said its Covid-19 vaccine proved 90% effective overall in a late-stage trial, and 93% effective against the most predominant variants of the virus. It also provided 100% protection against moderate and severe disease. Novavax shares surged 10.4% in premarket trading.\nLordstown Motors(RIDE) – The electric truck maker announced the resignation of CEO Steve Burns and CFO Julio Rodriguez, days after the company warned there was doubt it could continue as a going concern. Lordstown has engaged a search firm to find replacements for Burns and Rodriguez. Shares tumbled 8% in the premarket.\nPhillips(PHG) – Phillips shares slid 4.3% in premarket action after saying it would recall up to 4 million CPAP machines due to potential toxicity risks. The foam used in the sleep apnea treatment devices could degrade and potentially become toxic. The Dutch medical equipment company is the largest producer of CPAP machines.\nChipotle Mexican Grill(CMG) – Raymond James upgraded the restaurant chain’s shares to “strong buy” from “outperform”, predicting that recent menu price increases would push second-half profit well beyond consensus forecasts. Chipotle shares gained 1.4% in the premarket.\nFerrari(RACE) – Goldman Sachs gave the automaker’s stock a double downgrade, moving its rating to “sell” from “buy”, noting increased capital spending and a limited scope for positive earnings revisions. Ferrari fell 2.7% in the premarket.\nGlaxoSmithKline(GSK) – The drugmaker is collaborating with clinical-stage biopharmaceutical companyiTeos Therapeutics(ITOS) to develop and commercialize EOS-448, a monoclonal antibody in early-stage development as a possible cancer treatment. iTeos soared 60.4% in the premarket.\nAstraZeneca(AZN) – The drugmaker’s Covid-19 vaccine has a favorable risk/reward profile for all age groups and particularly for those 60 years and older, according to the head of the European Medicines Agency’s Covid-19 task force. Marco Cavaleri said his quote in an Italian newspaper saying the vaccine should not be given to those over 60 was not interpreted correctly.\nRoyal Dutch Shell(RDS.A) – The energy giant is considering a sale of shale assets in Texas, according to people familiar with the matter who spoke to Reuters. Such a could be worth more than $10 billion. Shares gained 2% in premarket trading.\nOatly(OTLY) – The oat milk maker received a mixed batch of initial ratings from a handful of investment firms. Oatly received ratings of “perform” (Oppenheimer), “outperform” (Credit Suisse), “equal-weight” (Morgan Stanley), “overweight” (Piper Sandler), “buy” (Jefferies, Guggenheim), “neutral” (JPMorgan Chase) and “sector perform” (RBC Capital). All agree on growth prospects for Oatly – but some firms feel those prospects are already priced into the stock.\nQualcomm(QCOM) – Qualcomm is prepared to invest in UK chipmaker Arm if its $40 billion deal to be acquired byNvidia(NVDA) is blocked by regulators, according to the Telegraph newspaper quoting CEO Cristiano Amon.\nEquinix(EQIX) – Equinix struck a deal for additional joint ventures with Singapore’s sovereign wealth fund to expand its data center operations there. The deal will see the fund invest an additional $3.9 billion, bringing the total investment to more than $6.9 billion.\nNextGen Acquisition(NGAC) – The special purpose acquisition company is in advanced talks to take Sir Richard Branson’s Virgin Orbit public, according to Sky News. Sky said a deal valuing Virgin Orbit at about $3 billion could be announced within the coming weeks. NextGen shares gained 1.9% in the premarket.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578225630518844","authorId":"3578225630518844","name":"JackOATrades","avatar":"https://static.tigerbbs.com/a864e0513924ced47472353efa85e296","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3578225630518844","idStr":"3578225630518844"},"content":"comment n like 2","text":"comment n like 2","html":"comment n like 2"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813130544,"gmtCreate":1630145846188,"gmtModify":1676530234712,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Is it the time? Comment n like pls","listText":"Is it the time? Comment n like pls","text":"Is it the time? Comment n like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/813130544","repostId":"1162964424","repostType":4,"repost":{"id":"1162964424","kind":"news","pubTimestamp":1630111098,"share":"https://ttm.financial/m/news/1162964424?lang=&edition=fundamental","pubTime":"2021-08-28 08:38","market":"us","language":"en","title":"Apple Stock: How It Could Be A Great Inflation Play","url":"https://stock-news.laohu8.com/highlight/detail?id=1162964424","media":"TheStreet","summary":"Apple’s iPhone 13 could cost consumers more due to an increase in the price of certain components. This is bad news for users, but probably good news for Apple stock investors.IPhone users thinking of upgrading their devices this year  should expect to reach deeper into their pockets. DigiTimes has reported that Apple’s iPhone 13 could be launched next month at a higher price due to parts inflation.Bad news for consumers could be great news for Apple stock investors. If the price increase is con","content":"<p>Apple’s iPhone 13 could cost consumers more due to an increase in the price of certain components. This is bad news for users, but probably good news for Apple stock investors.</p>\n<p>IPhone users thinking of upgrading their devices this year (or those looking to switch to the iOS-based product) should expect to reach deeper into their pockets. DigiTimes has&nbsp;reported&nbsp;that Apple’s iPhone 13 could be launched next month at a higher price due to parts inflation.</p>\n<p>Bad news for consumers could be great news for Apple stock&nbsp;investors. If the price increase is confirmed, it provides evidence that AAPL might be a great inflation play during these times of worry over rising producer and consumer prices.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d6f4ac9ebc1b90072340731dc5c1e613\" tg-width=\"1240\" tg-height=\"698\" referrerpolicy=\"no-referrer\"><span>Figure 1: Apple's iPhone 12 Pro.</span></p>\n<p><b>What happened?</b></p>\n<p>The iPhone is already considered a pricey tech gadget that can cost as much as $1,400 for the fully loaded, higher-end 12 Pro Max model in the US (see figure below). Due to this year’s components shortage, chip maker TSMC may raise its part prices to Apple by 3% to 5%, which could lead to a similar increase in the price of the yet-to-be-announced iPhone 13.</p>\n<p>It is unlikely that one of the largest and most successful consumer product companies in the world would try to raise prices without confidence that doing so does not impact demand for the new iPhone substantially. Apple can probably afford to hike prices because the company understands the value and the appeal of its luxury brand.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0140b9b68bb9eb5dd7e88aaff384785d\" tg-width=\"707\" tg-height=\"370\" referrerpolicy=\"no-referrer\"><span>Figure 2: iPhone 12 Pro on Apple's store.</span></p>\n<p><b>A quote from Jim Cramer</b></p>\n<p>One of the most concerning headwinds to stocks in the foreseeable future is the possibility of inflation eroding corporate margins and leading to higher interest rates in 2021-2022. But should producer and consumer prices spike, not all stocks will be impacted equally.</p>\n<p>Generally speaking, companies with strong pricing power that are able to pass on the higher production costs to consumers will likely outperform. This is a point that&nbsp;Mad Money’s Jim Cramer has made recently. Here is his quote:</p>\n<blockquote>\n “When you try to think of what’s working in this market... I want you to ask yourself, would you be insensitive to a price increase if the company put one through? [What are] the companies that can raise prices without infuriating you? Go buy their stocks.”\n</blockquote>\n<p><b>The impact to the P&amp;L</b></p>\n<p>Are higher prices a good or a bad thing for a company’s financial performance? The answer is nuanced and depends on a few factors.</p>\n<p>Holding all else constant, higher prices also mean higher revenues (think of the formula for sales: price times quantity). If the increase in price is decoupled from an increase in product or operating costs, then the hike also helps to boost margins – thus profits as well.</p>\n<p>However, “holding all else constant” is not how the world really works. A change in price tends to have an impact on a few key variables, most important of which is demand. If higher prices do not impact units sold by much or at all, this is great news for revenues and, most likely, earnings.</p>\n<p>The other piece to consider is whether the price hike fully or only partially offsets higher costs. Assuming the latter, revenues can still benefit without a corresponding positive effect on margins and profits. The complexity presented by the many moving parts makes it hard to determine with certainty how a more expensive iPhone may impact Apple’s financial statements in the future.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: How It Could Be A Great Inflation Play</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: How It Could Be A Great Inflation Play\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-28 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/iphone/apple-stock-how-it-could-be-a-great-inflation-play><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple’s iPhone 13 could cost consumers more due to an increase in the price of certain components. This is bad news for users, but probably good news for Apple stock investors.\nIPhone users thinking ...</p>\n\n<a href=\"https://www.thestreet.com/apple/iphone/apple-stock-how-it-could-be-a-great-inflation-play\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/iphone/apple-stock-how-it-could-be-a-great-inflation-play","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162964424","content_text":"Apple’s iPhone 13 could cost consumers more due to an increase in the price of certain components. This is bad news for users, but probably good news for Apple stock investors.\nIPhone users thinking of upgrading their devices this year (or those looking to switch to the iOS-based product) should expect to reach deeper into their pockets. DigiTimes has reported that Apple’s iPhone 13 could be launched next month at a higher price due to parts inflation.\nBad news for consumers could be great news for Apple stock investors. If the price increase is confirmed, it provides evidence that AAPL might be a great inflation play during these times of worry over rising producer and consumer prices.\nFigure 1: Apple's iPhone 12 Pro.\nWhat happened?\nThe iPhone is already considered a pricey tech gadget that can cost as much as $1,400 for the fully loaded, higher-end 12 Pro Max model in the US (see figure below). Due to this year’s components shortage, chip maker TSMC may raise its part prices to Apple by 3% to 5%, which could lead to a similar increase in the price of the yet-to-be-announced iPhone 13.\nIt is unlikely that one of the largest and most successful consumer product companies in the world would try to raise prices without confidence that doing so does not impact demand for the new iPhone substantially. Apple can probably afford to hike prices because the company understands the value and the appeal of its luxury brand.\nFigure 2: iPhone 12 Pro on Apple's store.\nA quote from Jim Cramer\nOne of the most concerning headwinds to stocks in the foreseeable future is the possibility of inflation eroding corporate margins and leading to higher interest rates in 2021-2022. But should producer and consumer prices spike, not all stocks will be impacted equally.\nGenerally speaking, companies with strong pricing power that are able to pass on the higher production costs to consumers will likely outperform. This is a point that Mad Money’s Jim Cramer has made recently. Here is his quote:\n\n “When you try to think of what’s working in this market... I want you to ask yourself, would you be insensitive to a price increase if the company put one through? [What are] the companies that can raise prices without infuriating you? Go buy their stocks.”\n\nThe impact to the P&L\nAre higher prices a good or a bad thing for a company’s financial performance? The answer is nuanced and depends on a few factors.\nHolding all else constant, higher prices also mean higher revenues (think of the formula for sales: price times quantity). If the increase in price is decoupled from an increase in product or operating costs, then the hike also helps to boost margins – thus profits as well.\nHowever, “holding all else constant” is not how the world really works. A change in price tends to have an impact on a few key variables, most important of which is demand. If higher prices do not impact units sold by much or at all, this is great news for revenues and, most likely, earnings.\nThe other piece to consider is whether the price hike fully or only partially offsets higher costs. Assuming the latter, revenues can still benefit without a corresponding positive effect on margins and profits. The complexity presented by the many moving parts makes it hard to determine with certainty how a more expensive iPhone may impact Apple’s financial statements in the future.","news_type":1},"isVote":1,"tweetType":1,"viewCount":487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807124203,"gmtCreate":1628008949802,"gmtModify":1703499622222,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"What to do?&nbsp;","listText":"What to do?&nbsp;","text":"What to do?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/807124203","repostId":"1181392592","repostType":4,"repost":{"id":"1181392592","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627999893,"share":"https://ttm.financial/m/news/1181392592?lang=&edition=fundamental","pubTime":"2021-08-03 22:11","market":"us","language":"en","title":"EV stocks tumbled in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1181392592","media":"Tiger Newspress","summary":"(Aug 3) Tesla fell 0.22%, NIO was down 3.45%, Li slid nearly 5%, Xpeng fell 2.67%.","content":"<p>(Aug&nbsp;3)&nbsp;Tesla fell 0.22%, NIO was down 3.45%, Li slid nearly 5%, Xpeng fell 2.67%.</p>\n<p><img src=\"https://static.tigerbbs.com/00cbe46f4bdb1df7e952efb0bc171a96\" tg-width=\"375\" tg-height=\"208\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks tumbled in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks tumbled in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-03 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;3)&nbsp;Tesla fell 0.22%, NIO was down 3.45%, Li slid nearly 5%, Xpeng fell 2.67%.</p>\n<p><img src=\"https://static.tigerbbs.com/00cbe46f4bdb1df7e952efb0bc171a96\" tg-width=\"375\" tg-height=\"208\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181392592","content_text":"(Aug 3) Tesla fell 0.22%, NIO was down 3.45%, Li slid nearly 5%, Xpeng fell 2.67%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":766,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172245960,"gmtCreate":1626964028450,"gmtModify":1703481531477,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"What do you think??","listText":"What do you think??","text":"What do you think??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/172245960","repostId":"2153678131","repostType":4,"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178155036,"gmtCreate":1626793468925,"gmtModify":1703765380345,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Pls like and commenr","listText":"Pls like and commenr","text":"Pls like and commenr","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/178155036","repostId":"2152405667","repostType":4,"repost":{"id":"2152405667","kind":"highlight","pubTimestamp":1626790080,"share":"https://ttm.financial/m/news/2152405667?lang=&edition=fundamental","pubTime":"2021-07-20 22:08","market":"us","language":"en","title":"3 Areas Where Pfizer Is Crushing Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2152405667","media":"Motley Fool","summary":"They could result in a broader market for Pfizer's vaccine.","content":"<p><b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> </b>and <b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a></b> have been marching in lockstep for nearly a year. They both announced the start of phase 3 trials for their coronavirus vaccine candidates on the same day last July. Pfizer won Emergency Use Authorization for its vaccine only about a week ahead of Moderna. And the U.S. ordered 300 million doses from each company earlier in the year. That was enough to vaccinate almost the entire population.</p>\n<p>It's fair to say both of these companies today are leading the coronavirus vaccine market. Still, Pfizer has inched ahead in a couple of ways. It has fully vaccinated more Americans than Moderna so far. And recently, it scored an order for as many as 1.8 billion doses from the European Union through 2023. That's in addition to an earlier order. But that's not all. There are three other areas where Pfizer is beating Moderna...</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F634091%2Fgettyimages-surprised-business-person.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3>1. The path to full approval</h3>\n<p>Pfizer and partner <b>BioNTech</b> said last week the U.S. Food and Drug Administration granted their vaccine priority review. The agency's standard review time usually takes between six to 10 months. Priority review takes a maximum of six. So, in this case, the agency's deadline to make an approval decision is in January. In even better news, an FDA official told CNN that regulators may issue a decision in as little as two months.</p>\n<p>Where does Moderna stand? The biotech submitted its request for approval a month behind Pfizer. Moderna also requested priority review. If all goes smoothly for Moderna, it may follow in Pfizer's footsteps. And in this case, we might expect a regulatory decision about a month after the Pfizer decision. If any issues arise, of course, Moderna could fall behind.</p>\n<h3>2. The booster plan</h3>\n<p>Pfizer and Moderna announced work on boosters to address variants earlier this year. Both companies are studying variant-specific candidates as well as an extra dose of their vaccines. But Pfizer made the study of a third vaccine dose the priority. And the company recently said it will ask for regulatory authorization of that dose in the coming weeks. Meanwhile, it plans to begin clinical trials of a variant-specific version of its vaccine in August.</p>\n<p>Moderna simultaneously started clinical trials of three candidates: an extra dose of vaccine, a strain-specific candidate, and a combination of its vaccine and the strain-specific candidate. The company has said it will have a booster ready by fall.</p>\n<p>If Pfizer stays on track, it looks like it will make it to market ahead of Moderna though. Pfizer's data are ready for regulators -- and it may be easier to win authorization for another dose of a vaccine that's already been given to millions of people than a new candidate.</p>\n<h3>3. Back-to-school vaccinations</h3>\n<p>Regulators in the U.S. and Europe authorized Pfizer's vaccine in teens 12 through 15 back in May. The original authorization includes individuals ages 16 and older. The company reported positive trial data on March 31.</p>\n<p>Moderna announced positive results from its teen study in late May -- and the company applied for authorization in the U.S. and Europe about two weeks later. Regulatory decisions may come any day now. But Pfizer has a clear advantage. Its vaccine got the OK before teens headed off to summer activities or vacation. And that's likely when a lot of teens would opt for vaccination to be fully protected before school starts. Pfizer and Moderna vaccines require two doses about a month apart.</p>\n<h3>What does all of this mean for investors?</h3>\n<p>These points are good news for Pfizer. A fully approved vaccine likely will attract many individuals who hesitated to go for an experimental product. So, if the FDA gives a nod, more and more people may request a Pfizer jab. A quicker-to-market booster and an authorization for teens also mean more individuals may go for a Pfizer shot in the near term.</p>\n<p>But none of these points will immediately equal more revenue for Pfizer. Governments already have purchased doses. If Pfizer <i>stays </i>ahead of Moderna on each of the above points, though, these doses may be used up faster than planned. And that may mean more orders down the road. And therefore, more revenue. The first-to-market status also may keep governments coming back for more of the same -- so Pfizer may attract bigger orders.</p>\n<p>All is not lost for Moderna though. Far from it. Yes, Pfizer is dominating in the above areas. And that may even continue. But Moderna isn't far behind. As we've seen so far, there's room for more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> player in this market. Pfizer expects $26 billion in vaccine revenue this year. And Moderna's advance purchase orders total $19.2 billion so far. Both already are winning orders for 2022.</p>\n<p>This means an investment in either of these coronavirus vaccine leaders today is likely to pay off now -- and in the long term.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Areas Where Pfizer Is Crushing Moderna</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Areas Where Pfizer Is Crushing Moderna\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-20 22:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/20/3-areas-where-pfizer-is-crushing-moderna/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer and Moderna, Inc. have been marching in lockstep for nearly a year. They both announced the start of phase 3 trials for their coronavirus vaccine candidates on the same day last July. Pfizer ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/20/3-areas-where-pfizer-is-crushing-moderna/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/07/20/3-areas-where-pfizer-is-crushing-moderna/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152405667","content_text":"Pfizer and Moderna, Inc. have been marching in lockstep for nearly a year. They both announced the start of phase 3 trials for their coronavirus vaccine candidates on the same day last July. Pfizer won Emergency Use Authorization for its vaccine only about a week ahead of Moderna. And the U.S. ordered 300 million doses from each company earlier in the year. That was enough to vaccinate almost the entire population.\nIt's fair to say both of these companies today are leading the coronavirus vaccine market. Still, Pfizer has inched ahead in a couple of ways. It has fully vaccinated more Americans than Moderna so far. And recently, it scored an order for as many as 1.8 billion doses from the European Union through 2023. That's in addition to an earlier order. But that's not all. There are three other areas where Pfizer is beating Moderna...\n\nImage source: Getty Images.\n1. The path to full approval\nPfizer and partner BioNTech said last week the U.S. Food and Drug Administration granted their vaccine priority review. The agency's standard review time usually takes between six to 10 months. Priority review takes a maximum of six. So, in this case, the agency's deadline to make an approval decision is in January. In even better news, an FDA official told CNN that regulators may issue a decision in as little as two months.\nWhere does Moderna stand? The biotech submitted its request for approval a month behind Pfizer. Moderna also requested priority review. If all goes smoothly for Moderna, it may follow in Pfizer's footsteps. And in this case, we might expect a regulatory decision about a month after the Pfizer decision. If any issues arise, of course, Moderna could fall behind.\n2. The booster plan\nPfizer and Moderna announced work on boosters to address variants earlier this year. Both companies are studying variant-specific candidates as well as an extra dose of their vaccines. But Pfizer made the study of a third vaccine dose the priority. And the company recently said it will ask for regulatory authorization of that dose in the coming weeks. Meanwhile, it plans to begin clinical trials of a variant-specific version of its vaccine in August.\nModerna simultaneously started clinical trials of three candidates: an extra dose of vaccine, a strain-specific candidate, and a combination of its vaccine and the strain-specific candidate. The company has said it will have a booster ready by fall.\nIf Pfizer stays on track, it looks like it will make it to market ahead of Moderna though. Pfizer's data are ready for regulators -- and it may be easier to win authorization for another dose of a vaccine that's already been given to millions of people than a new candidate.\n3. Back-to-school vaccinations\nRegulators in the U.S. and Europe authorized Pfizer's vaccine in teens 12 through 15 back in May. The original authorization includes individuals ages 16 and older. The company reported positive trial data on March 31.\nModerna announced positive results from its teen study in late May -- and the company applied for authorization in the U.S. and Europe about two weeks later. Regulatory decisions may come any day now. But Pfizer has a clear advantage. Its vaccine got the OK before teens headed off to summer activities or vacation. And that's likely when a lot of teens would opt for vaccination to be fully protected before school starts. Pfizer and Moderna vaccines require two doses about a month apart.\nWhat does all of this mean for investors?\nThese points are good news for Pfizer. A fully approved vaccine likely will attract many individuals who hesitated to go for an experimental product. So, if the FDA gives a nod, more and more people may request a Pfizer jab. A quicker-to-market booster and an authorization for teens also mean more individuals may go for a Pfizer shot in the near term.\nBut none of these points will immediately equal more revenue for Pfizer. Governments already have purchased doses. If Pfizer stays ahead of Moderna on each of the above points, though, these doses may be used up faster than planned. And that may mean more orders down the road. And therefore, more revenue. The first-to-market status also may keep governments coming back for more of the same -- so Pfizer may attract bigger orders.\nAll is not lost for Moderna though. Far from it. Yes, Pfizer is dominating in the above areas. And that may even continue. But Moderna isn't far behind. As we've seen so far, there's room for more than one player in this market. Pfizer expects $26 billion in vaccine revenue this year. And Moderna's advance purchase orders total $19.2 billion so far. Both already are winning orders for 2022.\nThis means an investment in either of these coronavirus vaccine leaders today is likely to pay off now -- and in the long term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":914,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150876761,"gmtCreate":1624894359053,"gmtModify":1703847421430,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Wow.one of it really rising ..&nbsp; like and comment.","listText":"Wow.one of it really rising ..&nbsp; like and comment.","text":"Wow.one of it really rising .. like and comment.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/150876761","repostId":"2146002845","repostType":4,"repost":{"id":"2146002845","kind":"highlight","pubTimestamp":1624866683,"share":"https://ttm.financial/m/news/2146002845?lang=&edition=fundamental","pubTime":"2021-06-28 15:51","market":"us","language":"en","title":"These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet","url":"https://stock-news.laohu8.com/highlight/detail?id=2146002845","media":"Motley Fool","summary":"Sales for these companies should skyrocket between 400% and 1,118% over the next four years.","content":"<p>For more than a decade, growth stocks have been all the rage on Wall Street. Historically low lending rates, dovish monetary policy, and a free-spending Capitol Hill (at least during the pandemic) have allowed fast-growing companies to thrive.</p>\n<p>Typically, it's smaller companies that generate some of the fastest sales growth, while large-cap stocks (those with market caps of at least $10 billion) grow at a more tempered pace. Larger companies are more likely to have time-tested or mature operating models, making it less common that they generate eye-popping revenue growth.</p>\n<p>However, the following large-cap stocks didn't get that memo. Each and every <a href=\"https://laohu8.com/S/AONE\">one</a> of these companies is on track to, at minimum, quintuple their sales over a four-year period, according to Wall Street's consensus revenue estimate for 2024 (or fiscal 2025). You could rightly say that these are five of the fastest-growing large-cap stocks on the planet.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ccad26103b3c97bbb65d0cad160f21b9\" tg-width=\"700\" tg-height=\"489\"><span>Image source: Getty Images.</span></p>\n<h2>Sea Limited: Implied four-year sales growth of 400%</h2>\n<p>Who said companies with market caps in excess of $100 billion can't grow like their smaller competitors? According to analysts, Singapore-based <b>Sea Limited</b> (NYSE:SE) is expected to see its full-year sales skyrocket from $4.39 billion in 2020 to about $21.9 billion in 2024. That works out to a quintupling in full-year revenue in four years.</p>\n<p>Sea's secret sauce (say that three times fast) is that it has three rapidly growing operating segments. For the moment, it's being anchored by its digital gaming operations. The company ended March with close to 649 million active users, 12.3% of which were paying to play. That's well above the industry average, and it's notably higher than the 8.9% of quarterly active users who were paying <a href=\"https://laohu8.com/S/AONE.U\">one</a> year ago.</p>\n<p>However, the superstar for this company is its e-commerce platform, Shopee. It's the top shopping app downloaded in Southeastern Asia, and it's becoming especially popular in Brazil. In the first quarter of 2021, Shopee saw $12.6 billion in gross merchandise value (GMV) purchased. For some context here, Shopee did $10.3 billion in GMV in all of 2018. Both the coronavirus pandemic and the rise of the middle class throughout Southeastern Asia is driving online purchases.</p>\n<p>Lastly, Sea has its rapidly growing digital financial services segment. More than 26 million people were paying for mobile wallet services at the end of March. Since the company targets a number of underbanked emerging markets, this digital financial services segment could be a major long-term growth driver.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/51b9e73cc74dad844548f15906c23624\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>Plug Power: Implied four-year sales growth of 404%</h2>\n<p>Companies focused on renewable energy solutions should be among the fastest growing this decade. Over the next four years investors will struggle to find a green-energy stock expanding quicker than hydrogen fuel-cell solutions provider <b>Plug Power</b> (NASDAQ:PLUG). After delivering $337 million in sales in 2020, Plug has guided for $1.7 billion in full-year revenue for 2024. That's a cool 404% increase, if it comes to fruition.</p>\n<p>For the time being, climate change is Plug Power's best friend. Joe Biden winning the presidency last year, coupled with Democrats regaining control of the Senate by the narrowest of margins, gives the current administration an opportunity to pass a clean energy bill. While it's unclear what a final infrastructure bill might look like, it's almost a certainty that clean vehicle solutions, such as those developed by Plug Power, will benefit.</p>\n<p>Additionally, the company secured two joint ventures just days apart in January. First, SK Group took a 10% equity stake in the company, with the duo aiming to introduce hydrogen fuel-cell-powered vehicles and hydrogen refilling stations in South Korea. A few days later, Plug landed a deal with French automaker <b>Renault</b> that'll see the two go after Europe's light commercial vehicle market. Both joint ventures should result in Plug Power's orders catapulting higher.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8db519446ea812ab6b8023df3f60f0c3\" tg-width=\"700\" tg-height=\"393\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a>: Implied four-year sales growth of 559%</h2>\n<p>The cloud computing space is home to dozens of fast-growing companies, none of which appear to be increasing its sales faster than cloud data-warehousing company <b>Snowflake</b> (NYSE:SNOW). In fiscal 2021, Snowflake's sales grew by 124% to $592 million. But based on Wall Street's consensus for fiscal 2025, it's on track to generate $3.9 billion in revenue. This would represent a four-year increase of 559%.</p>\n<p>What makes Snowflake so special is the company's competitive advantages. For example, it's shunned subscriptions in favor of a pay-as-you-go operating model. Customers pay for the amount of data they store and the number of Snowflake Compute Credits used. This allows the company's clients to keep better tabs on their expenses.</p>\n<p>Also, since Snowflake's solutions are built atop the most popular cloud infrastructure platforms, customers can share data seamlessly, even across competing services.</p>\n<p>Though it's the fastest-growing cloud stock, Snowflake is also one of the priciest. It's currently valued at 67 times projected sales for fiscal 2022 and roughly 19 times estimated sales four years from now. But if the company makes good on its fiscal 2029 outlook of $10 billion in product sales, paying this premium may be well worth it.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/96d1687ba107475c062f0147fa401ff2\" tg-width=\"700\" tg-height=\"375\"><span>The NIO EC6 EV crossover SUV. Image source: NIO.</span></p>\n<h2>NIO: Implied four-year sales growth of 561%</h2>\n<p>Another absolute beast of a growth trend this decade is the rise of electric vehicles (EV). Though <b>Tesla</b>&nbsp;and the U.S. EV market tend to get a lot of attention, the biggest opportunity is actually China. That's why <b>NIO</b> (NYSE:NIO) finds itself as one of the fastest-growing large-cap stocks on the planet. If all goes well, full-year sales can catapult from about $2.5 billion in 2020 to $16.8 billion in 2024. That's a sales increase of approximately 561%.</p>\n<p>Despite a global chip shortage, NIO has shown Wall Street that it can effectively scale its production. After delivering 20,060 vehicles in the first quarter, the company is on pace to deliver between 21,000 and 22,000 EVs in the second quarter. Once global chip supply issues are resolved, NIO will look to boost its annual delivery capacity to around 150,000 EVs.</p>\n<p>For NIO, innovation is extremely important. It's been introducing one new vehicle each year, with the sportier EC6 crossover SUV hitting showrooms last summer. It's quickly become a hit with EV buyers.</p>\n<p>Additionally, NIO introduced a battery-as-a-service program. For a monthly fee, this subscription service allows buyers to replace or upgrade their vehicle's batteries. It also reduces the initial purchase price of the vehicle. Though NIO is giving up near-term margin by reducing the purchase price of its EVs, it's keeping buyers loyal and generating very high margin residual service revenue.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/849b25e21ebbcd8fae1e28f0543300db\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>Novavax: Implied four-year sales growth of 1,118%</h2>\n<p>The crème de la crème of fast-growing large-cap companies is biotech stock <b>Novavax</b> (NASDAQ:NVAX). Following a pandemic-ravaged year where it brought in $476 million in sales, Wall Street is looking for Novavax to generate $5.8 billion in annual revenue in 2024. That's your run-of-the-mill sales increase of 1,118% over the coming four years.</p>\n<p>As you may have rightly guessed, Novavax's core catalyst is a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, NVX-CoV2373 (these scientific names just roll off the tongue), demonstrated nearly 90% efficacy in a large U.K. study, and recently reported a 90.4% trial efficacy in the United States.&nbsp; With efficacy rates this high, Novavax could potentially displace <b>Johnson &amp; Johnson</b>'s single-dose vaccine, which offered an efficacy of 72%.</p>\n<p>Though you'd think this was a cut-and-dried success story, Novavax has delayed its emergency-use authorization filings in Europe, the U.S., and U.K. until the third quarter, and it likely won't be at full production capacity till the fourth quarter. This waiting game has caused wild vacillations in Novavax's share price of late.</p>\n<p>Nevertheless, Novavax has a good chance of being one of the primary COVID-19 vaccines used in emerging markets, and it could become a key player if booster shots become necessary.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-28 15:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/27/5-of-fastest-growing-large-cap-stocks-on-planet/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a decade, growth stocks have been all the rage on Wall Street. Historically low lending rates, dovish monetary policy, and a free-spending Capitol Hill (at least during the pandemic) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/27/5-of-fastest-growing-large-cap-stocks-on-planet/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd","PLUG":"普拉格能源","SNOW":"Snowflake","NVAX":"诺瓦瓦克斯医药","NIO":"蔚来"},"source_url":"https://www.fool.com/investing/2021/06/27/5-of-fastest-growing-large-cap-stocks-on-planet/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146002845","content_text":"For more than a decade, growth stocks have been all the rage on Wall Street. Historically low lending rates, dovish monetary policy, and a free-spending Capitol Hill (at least during the pandemic) have allowed fast-growing companies to thrive.\nTypically, it's smaller companies that generate some of the fastest sales growth, while large-cap stocks (those with market caps of at least $10 billion) grow at a more tempered pace. Larger companies are more likely to have time-tested or mature operating models, making it less common that they generate eye-popping revenue growth.\nHowever, the following large-cap stocks didn't get that memo. Each and every one of these companies is on track to, at minimum, quintuple their sales over a four-year period, according to Wall Street's consensus revenue estimate for 2024 (or fiscal 2025). You could rightly say that these are five of the fastest-growing large-cap stocks on the planet.\nImage source: Getty Images.\nSea Limited: Implied four-year sales growth of 400%\nWho said companies with market caps in excess of $100 billion can't grow like their smaller competitors? According to analysts, Singapore-based Sea Limited (NYSE:SE) is expected to see its full-year sales skyrocket from $4.39 billion in 2020 to about $21.9 billion in 2024. That works out to a quintupling in full-year revenue in four years.\nSea's secret sauce (say that three times fast) is that it has three rapidly growing operating segments. For the moment, it's being anchored by its digital gaming operations. The company ended March with close to 649 million active users, 12.3% of which were paying to play. That's well above the industry average, and it's notably higher than the 8.9% of quarterly active users who were paying one year ago.\nHowever, the superstar for this company is its e-commerce platform, Shopee. It's the top shopping app downloaded in Southeastern Asia, and it's becoming especially popular in Brazil. In the first quarter of 2021, Shopee saw $12.6 billion in gross merchandise value (GMV) purchased. For some context here, Shopee did $10.3 billion in GMV in all of 2018. Both the coronavirus pandemic and the rise of the middle class throughout Southeastern Asia is driving online purchases.\nLastly, Sea has its rapidly growing digital financial services segment. More than 26 million people were paying for mobile wallet services at the end of March. Since the company targets a number of underbanked emerging markets, this digital financial services segment could be a major long-term growth driver.\nImage source: Getty Images.\nPlug Power: Implied four-year sales growth of 404%\nCompanies focused on renewable energy solutions should be among the fastest growing this decade. Over the next four years investors will struggle to find a green-energy stock expanding quicker than hydrogen fuel-cell solutions provider Plug Power (NASDAQ:PLUG). After delivering $337 million in sales in 2020, Plug has guided for $1.7 billion in full-year revenue for 2024. That's a cool 404% increase, if it comes to fruition.\nFor the time being, climate change is Plug Power's best friend. Joe Biden winning the presidency last year, coupled with Democrats regaining control of the Senate by the narrowest of margins, gives the current administration an opportunity to pass a clean energy bill. While it's unclear what a final infrastructure bill might look like, it's almost a certainty that clean vehicle solutions, such as those developed by Plug Power, will benefit.\nAdditionally, the company secured two joint ventures just days apart in January. First, SK Group took a 10% equity stake in the company, with the duo aiming to introduce hydrogen fuel-cell-powered vehicles and hydrogen refilling stations in South Korea. A few days later, Plug landed a deal with French automaker Renault that'll see the two go after Europe's light commercial vehicle market. Both joint ventures should result in Plug Power's orders catapulting higher.\nImage source: Getty Images.\nSnowflake: Implied four-year sales growth of 559%\nThe cloud computing space is home to dozens of fast-growing companies, none of which appear to be increasing its sales faster than cloud data-warehousing company Snowflake (NYSE:SNOW). In fiscal 2021, Snowflake's sales grew by 124% to $592 million. But based on Wall Street's consensus for fiscal 2025, it's on track to generate $3.9 billion in revenue. This would represent a four-year increase of 559%.\nWhat makes Snowflake so special is the company's competitive advantages. For example, it's shunned subscriptions in favor of a pay-as-you-go operating model. Customers pay for the amount of data they store and the number of Snowflake Compute Credits used. This allows the company's clients to keep better tabs on their expenses.\nAlso, since Snowflake's solutions are built atop the most popular cloud infrastructure platforms, customers can share data seamlessly, even across competing services.\nThough it's the fastest-growing cloud stock, Snowflake is also one of the priciest. It's currently valued at 67 times projected sales for fiscal 2022 and roughly 19 times estimated sales four years from now. But if the company makes good on its fiscal 2029 outlook of $10 billion in product sales, paying this premium may be well worth it.\nThe NIO EC6 EV crossover SUV. Image source: NIO.\nNIO: Implied four-year sales growth of 561%\nAnother absolute beast of a growth trend this decade is the rise of electric vehicles (EV). Though Tesla and the U.S. EV market tend to get a lot of attention, the biggest opportunity is actually China. That's why NIO (NYSE:NIO) finds itself as one of the fastest-growing large-cap stocks on the planet. If all goes well, full-year sales can catapult from about $2.5 billion in 2020 to $16.8 billion in 2024. That's a sales increase of approximately 561%.\nDespite a global chip shortage, NIO has shown Wall Street that it can effectively scale its production. After delivering 20,060 vehicles in the first quarter, the company is on pace to deliver between 21,000 and 22,000 EVs in the second quarter. Once global chip supply issues are resolved, NIO will look to boost its annual delivery capacity to around 150,000 EVs.\nFor NIO, innovation is extremely important. It's been introducing one new vehicle each year, with the sportier EC6 crossover SUV hitting showrooms last summer. It's quickly become a hit with EV buyers.\nAdditionally, NIO introduced a battery-as-a-service program. For a monthly fee, this subscription service allows buyers to replace or upgrade their vehicle's batteries. It also reduces the initial purchase price of the vehicle. Though NIO is giving up near-term margin by reducing the purchase price of its EVs, it's keeping buyers loyal and generating very high margin residual service revenue.\nImage source: Getty Images.\nNovavax: Implied four-year sales growth of 1,118%\nThe crème de la crème of fast-growing large-cap companies is biotech stock Novavax (NASDAQ:NVAX). Following a pandemic-ravaged year where it brought in $476 million in sales, Wall Street is looking for Novavax to generate $5.8 billion in annual revenue in 2024. That's your run-of-the-mill sales increase of 1,118% over the coming four years.\nAs you may have rightly guessed, Novavax's core catalyst is a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, NVX-CoV2373 (these scientific names just roll off the tongue), demonstrated nearly 90% efficacy in a large U.K. study, and recently reported a 90.4% trial efficacy in the United States.  With efficacy rates this high, Novavax could potentially displace Johnson & Johnson's single-dose vaccine, which offered an efficacy of 72%.\nThough you'd think this was a cut-and-dried success story, Novavax has delayed its emergency-use authorization filings in Europe, the U.S., and U.K. until the third quarter, and it likely won't be at full production capacity till the fourth quarter. This waiting game has caused wild vacillations in Novavax's share price of late.\nNevertheless, Novavax has a good chance of being one of the primary COVID-19 vaccines used in emerging markets, and it could become a key player if booster shots become necessary.","news_type":1},"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899143480,"gmtCreate":1628171077640,"gmtModify":1703502504850,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Yay... like and comment what you think..","listText":"Yay... like and comment what you think..","text":"Yay... like and comment what you think..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/899143480","repostId":"2157439561","repostType":4,"repost":{"id":"2157439561","kind":"highlight","pubTimestamp":1628164500,"share":"https://ttm.financial/m/news/2157439561?lang=&edition=fundamental","pubTime":"2021-08-05 19:55","market":"us","language":"en","title":"3 Unstoppable Healthcare Stocks to Buy Now and Hold Forever","url":"https://stock-news.laohu8.com/highlight/detail?id=2157439561","media":"Motley Fool","summary":"Here are some terrific options for investors who just want to set it and forget it.","content":"<p>Has the stock market's ups and downs been getting to you? Well, I've got some good news that your stockbroker doesn't want you to hear: Investors who trade less generally outperform investors who are constantly buying and selling their stocks.</p>\n<p>When it comes to holding your stocks for the long run, it sure helps to buy businesses that can produce a growing profit. Here are three healthcare companies that created the economic niches that they still dominate. Read on to see why investors can expect them to keep performing for the long run.</p>\n<p><img src=\"https://static.tigerbbs.com/9e2bf6db4d027a881b299971bce99bbf\" tg-width=\"700\" tg-height=\"555\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Align Technology</h3>\n<p><b>Align Technology</b> (NASDAQ:ALGN) markets the leading brand of clear aligners, and business is good. Coronavirus-related lockdowns last year made it hard for potential new customers to see their dentist and get the inside of their mouths mapped out. The COVID-19 pandemic proved that clear aligner brands that require less interaction with dentists aren't a threat to Align Technology's business model.</p>\n<p>The company recently reported top-line revenue that more than doubled year over year to a little over $1 billion. This was 13% more than during the previous quarter and the first time the company needed 10 figures to report quarterly revenue.</p>\n<p>Placements of Align Technology's proprietary scanner, called iTero, pay for themselves within less than a year for dentists and less than six months for orthodontic practices. With such favorable economics, it's no wonder imaging-system revenues are rising even faster at the moment than sales of the clear aligners themselves.</p>\n<p>For long-term investors, the most heartwarming figure in Align's recent financial statements is <a href=\"https://laohu8.com/S/AONE.U\">one</a> that management isn't necessarily proud of. Average selling prices for non-comprehensive products have been stuck in a range between $1,000 and $1,050 for over a year.</p>\n<p>Align Technology is already a sustainably profitable company, while its largest competitor, <b>SmileDirectClub</b>, is still posting significant losses, despite recognizing an average aligner sales price above $1,700 for the past year.</p>\n<h3>Intuitive Surgical</h3>\n<p><b>Intuitive Surgical</b> (NASDAQ:ISRG) is a pioneer of robotic-assisted surgery and is going to be a leader in this space for the foreseeable future. There are other companies manufacturing robot-assisted surgical systems, but they generally aren't interested in competing directly with Intuitive Surgical for specific procedures.</p>\n<p>Intuitive Surgical's market position is partly held up by enormous switching costs that hospitals need to consider before training their surgical teams to operate with a competitor's robotic-assisted system. There's also a growing body of real-world evidence supporting the value proposition Intuitive Surgical uses to market its da Vinci brand to hospitals.</p>\n<p>A little more than half of Intuitive Surgical's revenue comes from sales of instruments and accessories that need to be replaced with every procedure. Last year's COVID-19-related lockdowns led to an uncharacteristic dip in procedure volume, but demand has bounced back stronger than ever. Procedure volume rose 68% year over year in the second quarter.</p>\n<p>Over the past two years, the number of da Vinci procedures performed rose at an impressive annual growth rate of 16.5%. With its lead position well guarded, Intuitive Surgical shareholders can reasonably expect steady gains for many years to come.</p>\n<p><img src=\"https://static.tigerbbs.com/0eb83ed6f0c694d160bbb9dcc0ac0aac\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h2>Veeva Systems</h2>\n<p>Medical-device manufacturers, big pharmaceutical companies, and biotech start-ups increasingly rely on <b>Veeva Systems</b>' (NYSE:VEEV) suite of cloud services. The steady and high-margin subscription revenue these bolt-on services generate is creating a virtuous cycle that's cementing this company's unique position.</p>\n<p>Pharma sales representatives, drug manufacturing facilities, biomedical laboratories, and clinical trials throw out heaps of information that highly regulated businesses need to keep at their fingertips. There are other software vendors out there that address one problem or another that life science businesses run into. None are nearly as complete as Veeva Systems, and its offerings keep growing.</p>\n<p>For example, Veeva Systems just acquired Learnaboutgmp, a cloud-based training service provider. At the moment, Learnaboutgmp is focused on keeping life-science industry employees up to speed regarding good manufacturing practices. It's about to help train employees on how to make the most out of Veeva's service offerings, too.</p>\n<p>During Veeva's fiscal second quarter, which ended April 30, 2021, subscription revenue rose 26% year over year. Over the same period, cash generated by the company's highly profitable operation soared 70% to $478 million. This is more than enough for Veeva Systems to make acquisitions like Learnaboutgmp that keep clients renewing and upgrading their subscriptions year after year.</p>\n<p>Shares of all three of these companies trade at earnings multiples that could make a value investor blush. With a lack of competitive threats to impede their progress, though, it's just a matter of time before they grow into their steep valuations.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Unstoppable Healthcare Stocks to Buy Now and Hold Forever</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Unstoppable Healthcare Stocks to Buy Now and Hold Forever\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-05 19:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/05/3-unstoppable-healthcare-stocks-to-buy-now-and-hol/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Has the stock market's ups and downs been getting to you? Well, I've got some good news that your stockbroker doesn't want you to hear: Investors who trade less generally outperform investors who are ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/05/3-unstoppable-healthcare-stocks-to-buy-now-and-hol/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VEEV":"Veeva Systems Inc.","ALGN":"艾利科技","HR":"医疗保健房地产信托","ISRG":"直觉外科公司","HCSG":"医疗保健服务"},"source_url":"https://www.fool.com/investing/2021/08/05/3-unstoppable-healthcare-stocks-to-buy-now-and-hol/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157439561","content_text":"Has the stock market's ups and downs been getting to you? Well, I've got some good news that your stockbroker doesn't want you to hear: Investors who trade less generally outperform investors who are constantly buying and selling their stocks.\nWhen it comes to holding your stocks for the long run, it sure helps to buy businesses that can produce a growing profit. Here are three healthcare companies that created the economic niches that they still dominate. Read on to see why investors can expect them to keep performing for the long run.\n\nImage source: Getty Images.\nAlign Technology\nAlign Technology (NASDAQ:ALGN) markets the leading brand of clear aligners, and business is good. Coronavirus-related lockdowns last year made it hard for potential new customers to see their dentist and get the inside of their mouths mapped out. The COVID-19 pandemic proved that clear aligner brands that require less interaction with dentists aren't a threat to Align Technology's business model.\nThe company recently reported top-line revenue that more than doubled year over year to a little over $1 billion. This was 13% more than during the previous quarter and the first time the company needed 10 figures to report quarterly revenue.\nPlacements of Align Technology's proprietary scanner, called iTero, pay for themselves within less than a year for dentists and less than six months for orthodontic practices. With such favorable economics, it's no wonder imaging-system revenues are rising even faster at the moment than sales of the clear aligners themselves.\nFor long-term investors, the most heartwarming figure in Align's recent financial statements is one that management isn't necessarily proud of. Average selling prices for non-comprehensive products have been stuck in a range between $1,000 and $1,050 for over a year.\nAlign Technology is already a sustainably profitable company, while its largest competitor, SmileDirectClub, is still posting significant losses, despite recognizing an average aligner sales price above $1,700 for the past year.\nIntuitive Surgical\nIntuitive Surgical (NASDAQ:ISRG) is a pioneer of robotic-assisted surgery and is going to be a leader in this space for the foreseeable future. There are other companies manufacturing robot-assisted surgical systems, but they generally aren't interested in competing directly with Intuitive Surgical for specific procedures.\nIntuitive Surgical's market position is partly held up by enormous switching costs that hospitals need to consider before training their surgical teams to operate with a competitor's robotic-assisted system. There's also a growing body of real-world evidence supporting the value proposition Intuitive Surgical uses to market its da Vinci brand to hospitals.\nA little more than half of Intuitive Surgical's revenue comes from sales of instruments and accessories that need to be replaced with every procedure. Last year's COVID-19-related lockdowns led to an uncharacteristic dip in procedure volume, but demand has bounced back stronger than ever. Procedure volume rose 68% year over year in the second quarter.\nOver the past two years, the number of da Vinci procedures performed rose at an impressive annual growth rate of 16.5%. With its lead position well guarded, Intuitive Surgical shareholders can reasonably expect steady gains for many years to come.\n\nImage source: Getty Images.\nVeeva Systems\nMedical-device manufacturers, big pharmaceutical companies, and biotech start-ups increasingly rely on Veeva Systems' (NYSE:VEEV) suite of cloud services. The steady and high-margin subscription revenue these bolt-on services generate is creating a virtuous cycle that's cementing this company's unique position.\nPharma sales representatives, drug manufacturing facilities, biomedical laboratories, and clinical trials throw out heaps of information that highly regulated businesses need to keep at their fingertips. There are other software vendors out there that address one problem or another that life science businesses run into. None are nearly as complete as Veeva Systems, and its offerings keep growing.\nFor example, Veeva Systems just acquired Learnaboutgmp, a cloud-based training service provider. At the moment, Learnaboutgmp is focused on keeping life-science industry employees up to speed regarding good manufacturing practices. It's about to help train employees on how to make the most out of Veeva's service offerings, too.\nDuring Veeva's fiscal second quarter, which ended April 30, 2021, subscription revenue rose 26% year over year. Over the same period, cash generated by the company's highly profitable operation soared 70% to $478 million. This is more than enough for Veeva Systems to make acquisitions like Learnaboutgmp that keep clients renewing and upgrading their subscriptions year after year.\nShares of all three of these companies trade at earnings multiples that could make a value investor blush. With a lack of competitive threats to impede their progress, though, it's just a matter of time before they grow into their steep valuations.","news_type":1},"isVote":1,"tweetType":1,"viewCount":453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160479059,"gmtCreate":1623805417671,"gmtModify":1703819908967,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Good to read. Like and comment, please&nbsp;","listText":"Good to read. Like and comment, please&nbsp;","text":"Good to read. Like and comment, please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160479059","repostId":"1179402047","repostType":4,"isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186877619,"gmtCreate":1623488395931,"gmtModify":1704204995409,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186877619","repostId":"2142202973","repostType":4,"repost":{"id":"2142202973","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623447457,"share":"https://ttm.financial/m/news/2142202973?lang=&edition=fundamental","pubTime":"2021-06-12 05:37","market":"us","language":"en","title":"Novavax says COVID-19 vaccine shows immune response against Beta virus variant","url":"https://stock-news.laohu8.com/highlight/detail?id=2142202973","media":"Reuters","summary":"June 11 (Reuters) - Novavax Inc said on Friday its experimental COVID-19 vaccine showed immune respo","content":"<p>June 11 (Reuters) - Novavax Inc said on Friday its experimental COVID-19 vaccine showed immune response and protection against the highly contagious coronavirus variant originally identified in South Africa in a clinical trial.</p>\n<p>The vaccine, NVX-CoV2373, is being tested in multiple trials but has yet to be authorized for use in any country.</p>\n<p>Novavax also said studies in mice and baboons found that a different vaccine specifically targeting the South African variant now known as Beta produced immune response and protection, and that it expected to conduct further clinical testing of the Beta-focused vaccine in the fall.</p>\n<p>The company said testing of blood serum of thirty participants of a mid-stage trial who had received both doses of NVX-CoV2373 revealed robust antibody responses to the original version of the coronavirus as well as against the Alpha variant first found in the UK and the Beta variant.</p>\n<p>However, the response against the Beta variant was slightly less, Novavax said.</p>\n<p>The European Medicines Agency started a rolling review of the Novavax shot in February. Data from its pivotal U.S. and Mexico trial is expected to be released in the current quarter.</p>\n<p>The company said the new data is available on the online preprint server bioRxiv and has been submitted for peer review.</p>\n<p>(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli and Bill Berkrot)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax says COVID-19 vaccine shows immune response against Beta virus variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax says COVID-19 vaccine shows immune response against Beta virus variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 05:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June 11 (Reuters) - Novavax Inc said on Friday its experimental COVID-19 vaccine showed immune response and protection against the highly contagious coronavirus variant originally identified in South Africa in a clinical trial.</p>\n<p>The vaccine, NVX-CoV2373, is being tested in multiple trials but has yet to be authorized for use in any country.</p>\n<p>Novavax also said studies in mice and baboons found that a different vaccine specifically targeting the South African variant now known as Beta produced immune response and protection, and that it expected to conduct further clinical testing of the Beta-focused vaccine in the fall.</p>\n<p>The company said testing of blood serum of thirty participants of a mid-stage trial who had received both doses of NVX-CoV2373 revealed robust antibody responses to the original version of the coronavirus as well as against the Alpha variant first found in the UK and the Beta variant.</p>\n<p>However, the response against the Beta variant was slightly less, Novavax said.</p>\n<p>The European Medicines Agency started a rolling review of the Novavax shot in February. Data from its pivotal U.S. and Mexico trial is expected to be released in the current quarter.</p>\n<p>The company said the new data is available on the online preprint server bioRxiv and has been submitted for peer review.</p>\n<p>(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli and Bill Berkrot)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142202973","content_text":"June 11 (Reuters) - Novavax Inc said on Friday its experimental COVID-19 vaccine showed immune response and protection against the highly contagious coronavirus variant originally identified in South Africa in a clinical trial.\nThe vaccine, NVX-CoV2373, is being tested in multiple trials but has yet to be authorized for use in any country.\nNovavax also said studies in mice and baboons found that a different vaccine specifically targeting the South African variant now known as Beta produced immune response and protection, and that it expected to conduct further clinical testing of the Beta-focused vaccine in the fall.\nThe company said testing of blood serum of thirty participants of a mid-stage trial who had received both doses of NVX-CoV2373 revealed robust antibody responses to the original version of the coronavirus as well as against the Alpha variant first found in the UK and the Beta variant.\nHowever, the response against the Beta variant was slightly less, Novavax said.\nThe European Medicines Agency started a rolling review of the Novavax shot in February. Data from its pivotal U.S. and Mexico trial is expected to be released in the current quarter.\nThe company said the new data is available on the online preprint server bioRxiv and has been submitted for peer review.\n(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli and Bill Berkrot)","news_type":1},"isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146792289,"gmtCreate":1626098691541,"gmtModify":1703753375271,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Good to know","listText":"Good to know","text":"Good to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/146792289","repostId":"1167324972","repostType":4,"isVote":1,"tweetType":1,"viewCount":565,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157642091,"gmtCreate":1625581561413,"gmtModify":1703744345342,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Great to read..like and comment please","listText":"Great to read..like and comment please","text":"Great to read..like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157642091","repostId":"1107037757","repostType":4,"repost":{"id":"1107037757","kind":"news","pubTimestamp":1625564660,"share":"https://ttm.financial/m/news/1107037757?lang=&edition=fundamental","pubTime":"2021-07-06 17:44","market":"us","language":"en","title":"Nio Expected To Gross 5% More EV Deliveries In 2021 Than Previous Forecast, Says CICC","url":"https://stock-news.laohu8.com/highlight/detail?id=1107037757","media":"Benzinga","summary":"China International Capital Corporation Limited has updated its forecast for Nio Inc, saying it expects the  Chinese electric vehicle maker to sell 98,000 cars in 2021, 5% more than its previous estimate, as per a cnEVpostreport.What Happened:The China-based investment bank estimates Nio’s production and sales to remain strong in the second half of the year.Nio delivered 21,896 units in the second quarter,near the upper end of the company's 21,000- to 22,000-unit delivery guidance, in line with ","content":"<p>China International Capital Corporation Limited has updated its forecast for&nbsp;<b>Nio Inc</b>(NYSE:NIO), saying it expects&nbsp;the&nbsp; Chinese electric vehicle maker&nbsp;to sell 98,000 cars in 2021, 5% more than its previous estimate, as per a cnEVpostreport.</p>\n<p><b>What Happened:</b>The China-based investment bank estimates Nio’s production and sales to remain strong in the second half of the year.</p>\n<p>Nio&nbsp;delivered 21,896 units in the second quarter,near the upper end of the company's 21,000-&nbsp;to 22,000-unit delivery guidance, in line with market expectations.</p>\n<p>The investment bank also raised the sales volume forecast for rival&nbsp;<b>Li Auto</b>(NASDAQ:LI) to 90,000 units, an increase of 12.5%.</p>\n<p>Li Auto’s&nbsp;second-quarter deliveriessoared 166%&nbsp;to 17,575 vehicles compared with a year ago.</p>\n<p><b>Price Action:</b>Nio shares closed 0.98% lower at $50.40 on Friday, while&nbsp;Li Auto stock closed 5.8% lower at $32.67.</p>\n<p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nio Expected To Gross 5% More EV Deliveries In 2021 Than Previous Forecast, Says CICC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNio Expected To Gross 5% More EV Deliveries In 2021 Than Previous Forecast, Says CICC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-06 17:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/analyst-ratings/analyst-color/21/07/21850578/nio-expected-to-gross-5-more-ev-deliveries-in-2021-than-previous-forecast-says-cicc><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>China International Capital Corporation Limited has updated its forecast for Nio Inc(NYSE:NIO), saying it expects the  Chinese electric vehicle maker to sell 98,000 cars in 2021, 5% more than its ...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/21/07/21850578/nio-expected-to-gross-5-more-ev-deliveries-in-2021-than-previous-forecast-says-cicc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","NIO":"蔚来"},"source_url":"https://www.benzinga.com/analyst-ratings/analyst-color/21/07/21850578/nio-expected-to-gross-5-more-ev-deliveries-in-2021-than-previous-forecast-says-cicc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107037757","content_text":"China International Capital Corporation Limited has updated its forecast for Nio Inc(NYSE:NIO), saying it expects the  Chinese electric vehicle maker to sell 98,000 cars in 2021, 5% more than its previous estimate, as per a cnEVpostreport.\nWhat Happened:The China-based investment bank estimates Nio’s production and sales to remain strong in the second half of the year.\nNio delivered 21,896 units in the second quarter,near the upper end of the company's 21,000- to 22,000-unit delivery guidance, in line with market expectations.\nThe investment bank also raised the sales volume forecast for rival Li Auto(NASDAQ:LI) to 90,000 units, an increase of 12.5%.\nLi Auto’s second-quarter deliveriessoared 166% to 17,575 vehicles compared with a year ago.\nPrice Action:Nio shares closed 0.98% lower at $50.40 on Friday, while Li Auto stock closed 5.8% lower at $32.67.","news_type":1},"isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150962243,"gmtCreate":1624883308182,"gmtModify":1703846929156,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Great article.&nbsp;","listText":"Great article.&nbsp;","text":"Great article.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/150962243","repostId":"150917061","repostType":1,"repost":{"id":150917061,"gmtCreate":1624881997249,"gmtModify":1703846906458,"author":{"id":"3514329116425907","authorId":"3514329116425907","name":"小虎AV","avatar":"https://static.tigerbbs.com/91101bd3142b32495c3131036d5f8afa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3514329116425907","idStr":"3514329116425907"},"themes":[],"htmlText":"\n \n \n  【一分鐘帶你看老虎7週年上海場OpenDay】一起來看攝影師都捕捉到了哪些精彩瞬間！還有我們最帥氣/美麗的虎友們~ <a href=\"https://laohu8.com/S/TIGR\">$老虎證券(TIGR)$</a>\n \n","listText":"【一分鐘帶你看老虎7週年上海場OpenDay】一起來看攝影師都捕捉到了哪些精彩瞬間！還有我們最帥氣/美麗的虎友們~ <a href=\"https://laohu8.com/S/TIGR\">$老虎證券(TIGR)$</a>","text":"【一分鐘帶你看老虎7週年上海場OpenDay】一起來看攝影師都捕捉到了哪些精彩瞬間！還有我們最帥氣/美麗的虎友們~ $老虎證券(TIGR)$","images":[{"img":"https://static.tigerbbs.com/e9ad2a5df2e61fbb8343c34b6da06dcc","width":"0","height":"0"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/150917061","isVote":1,"tweetType":2,"object":{"id":"dac7e3fba82d4a1192afbb60b9436b7c","tweetId":"150917061","videoUrl":"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/6a151b8a3701925920047838458/NVuSBFuyKxgA.mp4","poster":"https://static.tigerbbs.com/e9ad2a5df2e61fbb8343c34b6da06dcc"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129612956,"gmtCreate":1624370784675,"gmtModify":1703834721676,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>to the moon !!!","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>to the moon !!!","text":"$BioNTech SE(BNTX)$to the moon !!!","images":[{"img":"https://static.tigerbbs.com/3108a2ec94ffe934c9dfba402ae06dee","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129612956","isVote":1,"tweetType":1,"viewCount":126,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":166706339,"gmtCreate":1624024281721,"gmtModify":1703826880490,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Great. Like and comment pls","listText":"Great. Like and comment pls","text":"Great. Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166706339","repostId":"1166489816","repostType":4,"repost":{"id":"1166489816","kind":"news","pubTimestamp":1624009298,"share":"https://ttm.financial/m/news/1166489816?lang=&edition=fundamental","pubTime":"2021-06-18 17:41","market":"us","language":"en","title":"Dosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1166489816","media":"seekingalpha","summary":"BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine ","content":"<ul>\n <li>BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase&nbsp;2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed by Regeneron(NASDAQ:REGN)and Sanofi(NASDAQ:SNY)in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma.</li>\n <li>The trial is enrolling a total of 120 patients. The primary endpoint is the overall response rate (ORR) of BNT111 in combination with Libtayo.</li>\n <li>Secondary endpoints include ORR in the single agent arms, duration of response, and safety.</li>\n <li>The first patient has been dosed in the EU. BioNTech retains global commercial rights to BNT111.</li>\n <li>This Phase 2 clinical trial is based on previous results from the Phase 1 Lipo-MERIT dose escalation trial that demonstrated a favorable safety profile in 89 patients with advanced melanoma.</li>\n <li>The Company also plans to start randomized Phase 2 trials with mRNA vaccine product candidates in two additional programs in 2021 (FixVac: BNT113 and iNeST: BNT122).</li>\n <li>The BNT111-01 trial is being conducted in collaboration with Regeneron.</li>\n <li>BioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 17:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed ...</p>\n\n<a href=\"https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1166489816","content_text":"BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed by Regeneron(NASDAQ:REGN)and Sanofi(NASDAQ:SNY)in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma.\nThe trial is enrolling a total of 120 patients. The primary endpoint is the overall response rate (ORR) of BNT111 in combination with Libtayo.\nSecondary endpoints include ORR in the single agent arms, duration of response, and safety.\nThe first patient has been dosed in the EU. BioNTech retains global commercial rights to BNT111.\nThis Phase 2 clinical trial is based on previous results from the Phase 1 Lipo-MERIT dose escalation trial that demonstrated a favorable safety profile in 89 patients with advanced melanoma.\nThe Company also plans to start randomized Phase 2 trials with mRNA vaccine product candidates in two additional programs in 2021 (FixVac: BNT113 and iNeST: BNT122).\nThe BNT111-01 trial is being conducted in collaboration with Regeneron.\nBioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant","news_type":1},"isVote":1,"tweetType":1,"viewCount":161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161253229,"gmtCreate":1623930571461,"gmtModify":1703823764423,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Impressive.. like and comment","listText":"Impressive.. like and comment","text":"Impressive.. like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/161253229","repostId":"1162768247","repostType":4,"isVote":1,"tweetType":1,"viewCount":80,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184412057,"gmtCreate":1623721432879,"gmtModify":1704209522921,"author":{"id":"3586511265760559","authorId":"3586511265760559","name":"Pierroye","avatar":"https://static.tigerbbs.com/264cd7a6ef3b6658ac33143689e3ec09","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586511265760559","idStr":"3586511265760559"},"themes":[],"htmlText":"Comment please","listText":"Comment please","text":"Comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184412057","repostId":"1146208169","repostType":4,"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}